Research
LSP Bibliography
2576724
IXMHRBF6
LSP paper
1
national-library-of-medicine-grant-proposals
50
date
desc
year
1
2179
https://hits.harvard.edu/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A450%2C%22request_next%22%3A50%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22S4Q255Y4%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kader%20et%20al.%22%2C%22parsedDate%22%3A%222026-09-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKader%20T%2C%20Chen%20YA%2C%20Hug%20CB%2C%20Lin%20JR%2C%20Muhlich%20JL%2C%20Coy%20S%2C%20Jung%20E%2C%20Schwartz%20LE%2C%20Fazio%20T%2C%20Chiu%20C%2C%20Ryall%20ST%2C%20Drescher%20CW%2C%20Sorger%20PK%2C%20Drapkin%20R%2C%20Santagata%20S.%20Spatial%20Integration%20of%20Protein%20and%20Chromosomal%20States%20Reveals%20Early%20Copy-Number%20Changes%20and%20Genotype-Associated%20Immune%20Neighborhoods%20in%20Serous%20Ovarian%20Cancer%20Evolution.%20Cancer%20Discov.%202026%20Sept%201%3B16%289%29%3A1750%26%23x2013%3B1764.%20PMCID%3A%20PMC13530990%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Spatial%20Integration%20of%20Protein%20and%20Chromosomal%20States%20Reveals%20Early%20Copy-Number%20Changes%20and%20Genotype-Associated%20Immune%20Neighborhoods%20in%20Serous%20Ovarian%20Cancer%20Evolution%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanjina%22%2C%22lastName%22%3A%22Kader%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%20B.%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Euihye%22%2C%22lastName%22%3A%22Jung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%20E.%22%2C%22lastName%22%3A%22Schwartz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Fazio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Crystal%22%2C%22lastName%22%3A%22Chiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20T.%22%2C%22lastName%22%3A%22Ryall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20W.%22%2C%22lastName%22%3A%22Drescher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronny%22%2C%22lastName%22%3A%22Drapkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22Detecting%20chromosomal%20copy-number%20alterations%20together%20with%20protein-defined%20cell%20states%20in%20intact%20tissue%20is%20critical%20for%20understanding%20early%20clonal%20evolution%20and%20microenvironmental%20interactions%20in%20cancer.%20We%20developed%20ORION-FISH%2C%20which%20integrates%20high-plex%20tissue%20imaging%20with%20a%20morphology-preserving%20DNA%20fluorescence%20in%20situ%20hybridization%20%28DNA-FISH%29%20workflow%20and%20single-cell%20registration%2C%20yielding%20measurements%20concordant%20with%20clinical%20FISH.%20In%20high-grade%20serous%20ovarian%20carcinoma%20%28HGSOC%29%2C%20ORION-FISH%20recapitulated%20known%20chromosomal%20changes%20while%20revealing%20subclonal%20heterogeneity%20missed%20by%20targeted%20sequencing.%20Applied%20to%20serous%20tubal%20intraepithelial%20carcinomas%2C%20precursors%20of%20HGSOC%2C%20ORION-FISH%20identified%20intermixed%20epithelial%20cells%20with%20MYC%20or%20CCNE1%20copy-number%20gains%2C%20as%20well%20as%20concurrent%20alterations%20associated%20with%20distinct%20immune%20microenvironments.%20In%20addition%2C%20epithelial%20cells%20with%20MYC%20and%20CCNE1%20copy-number%20gains%20were%20detected%20in%20morphologically%20normal%20fallopian%20tube%20epithelium%2C%20along%20with%20rare%20MDM4%20increases%20across%20epithelial%20lineages.%20Together%2C%20ORION-FISH%20provides%20a%20framework%20linking%20chromosomal%20copy-number%20states%20to%20protein-defined%20phenotypes%20within%20preserved%20tissue%20architecture%2C%20enabling%20context-aware%20interrogation%20of%20early%20copy-number%20diversification%20at%20single-cell%20resolution.%5CnSIGNIFICANCE%3A%20We%20introduce%20ORION-FISH%2C%20a%20spatially%20resolved%20workflow%20integrating%20multiplexed%20protein%20imaging%20with%20DNA-FISH%20to%20map%20genomic%20alterations%20within%20intact%20tissues.%20Applying%20this%20approach%20to%20ovarian%20cancer%20precursors%20reveals%20early%20copy-number%20diversification%20and%20associations%20with%20the%20local%20immune%20context%2C%20providing%20a%20foundation%20for%20studying%20how%20genomic%20and%20microenvironmental%20states%20coevolve%20during%20tumor%20initiation.%22%2C%22date%22%3A%222026-09-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1158%5C%2F2159-8290.CD-26-0171%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241999663%22%2C%22PMCID%22%3A%22PMC13530990%22%2C%22ISSN%22%3A%222159-8290%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-10-05T18%3A18%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22RQ78L9B7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yue%20et%20al.%22%2C%22parsedDate%22%3A%222026-08-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EYue%20S%2C%20Guo%20Z%2C%20Pan%20C%2C%20Jing%20XA%2C%20Tao%20L%2C%20Nguyen%20T%2C%20Tang%20J%2C%20Chan%20Y%2C%20Contreras-Trujillo%20H%2C%20Jiang%20D%2C%20Yan%20X%2C%20Xiang%20H%2C%20Liu%20X%2C%20Bloom%20C%2C%20Ediriwickrema%20A%2C%20Koschade%20S%2C%20Wang%20X%2C%20Wang%20Z%2C%20Shu%20N%2C%20Shi%20Y%2C%20McKim%20DB%2C%20Lu%20R%2C%20Majeti%20R%2C%20Zhang%20C%2C%20Ying%20QL.%20Expansion%20and%20CAR%20engineering%20of%20granulocyte-monocyte%20progenitors%20for%20cellular%20immunotherapy.%20Cell.%202026%20Aug%2020%3B189%2817%29%3A5378-5395.e11.%20PMID%3A%2042320470%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Expansion%20and%20CAR%20engineering%20of%20granulocyte-monocyte%20progenitors%20for%20cellular%20immunotherapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shi%22%2C%22lastName%22%3A%22Yue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zheng%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Crystal%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xueyuan%20A.%22%2C%22lastName%22%3A%22Jing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Litao%22%2C%22lastName%22%3A%22Tao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tai%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiaqi%22%2C%22lastName%22%3A%22Tang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanpui%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Humberto%22%2C%22lastName%22%3A%22Contreras-Trujillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Du%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xue%22%2C%22lastName%22%3A%22Yan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hang%22%2C%22lastName%22%3A%22Xiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xugeng%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Celia%22%2C%22lastName%22%3A%22Bloom%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asiri%22%2C%22lastName%22%3A%22Ediriwickrema%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastian%22%2C%22lastName%22%3A%22Koschade%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziyuan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalie%22%2C%22lastName%22%3A%22Shu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yingxiao%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20B.%22%2C%22lastName%22%3A%22McKim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rong%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravindra%22%2C%22lastName%22%3A%22Majeti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chao%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi-Long%22%2C%22lastName%22%3A%22Ying%22%7D%5D%2C%22abstractNote%22%3A%22Engineered%20macrophages%20are%20promising%20for%20tumor%20immunotherapy%20but%20are%20limited%20by%20poor%20ex%20vivo%20expansion%2C%20genetic%20tractability%2C%20and%20biodistribution%20after%20transfer.%20Here%2C%20we%20develop%20defined%20culture%20conditions%20that%20enable%20long-term%20expansion%20of%20mouse%20and%20human%20granulocyte-monocyte%20progenitors%20%28GMPs%29%20while%20preserving%20progenitor%20identity%20and%20myeloid%20potential%2C%20establishing%20GMPs%20as%20a%20renewable%20engineering%20platform.%20Mechanistically%2C%20we%20identify%20myeloperoxidase%20as%20a%20regulator%20of%20GMP%20proliferation.%20Expanded%20GMPs%20are%20readily%20engineered%20and%2C%20after%20transfer%2C%20seed%20hematopoietic%20niches%20and%20generate%20donor-derived%20myelopoiesis%20that%20restores%20antibacterial%20defense%20in%20chronic%20granulomatous%20disease%20mice%20and%20yields%20abundant%20tumor-infiltrating%20macrophages.%20GMPs%20engineered%20with%20chimeric%20antigen%20receptors%20%28CARs%29%20suppress%20CD19-positive%20leukemia%20and%20human%20epidermal%20growth%20factor%20receptor%202%20%28HER2%29-positive%20solid%20tumors.%20We%20further%20introduce%20a%20CAR%20incorporating%20an%20immunoglobulin%20G%20%28IgG%29%20Fc%20domain%20that%20recruits%20host%20Fc%20receptor-expressing%20phagocytes%2C%20enables%20T%20cell%20priming%20across%20major%20histocompatibility%20complex%20%28MHC%29%20mismatch%2C%20and%20enhances%20efficacy%20in%20immunocompetent%20allogeneic%20cancer%20models.%20Together%2C%20these%20findings%20establish%20expandable%20GMPs%20as%20a%20scalable%20platform%20for%20engineered%20immunotherapy.%22%2C%22date%22%3A%222026-08-20%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2026.05.043%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2242320470%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221097-4172%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-10-06T18%3A01%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22IEDIMCAC%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rudra%20Gupta%20et%20al.%22%2C%22parsedDate%22%3A%222026-07-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERudra%20Gupta%20T%2C%20Polley%20MYC%2C%20Redd%20R%2C%20Lee%20EQ%2C%20Arrillaga-Romany%20I%2C%20Gilbert%20MR%2C%20Tan%20Y%2C%20Touat%20M%2C%20Drappatz%20J%2C%20Welch%20MR%2C%20Galanis%20E%2C%20Ahluwalia%20MS%2C%20Colman%20H%2C%20Nabors%20LB%2C%20Hepel%20J%2C%20Elinzano%20H%2C%20Schiff%20D%2C%20Chukwueke%20UN%2C%20Beroukhim%20R%2C%20Nayak%20L%2C%20McFaline-Figueroa%20JR%2C%20Batchelor%20TT%2C%20Kaley%20TJ%2C%20Lu-Emerson%20C%2C%20Mellinghoff%20IK%2C%20Bi%20WL%2C%20Arnaout%20O%2C%20Peruzzi%20PP%2C%20Haas-Kogan%20D%2C%20Tanguturi%20S%2C%20Aizer%20A%2C%20Doherty%20L%2C%20Santagata%20S%2C%20Meredith%20DM%2C%20Chiocca%20EA%2C%20Reardon%20DA%2C%20Ligon%20KL%2C%20Weller%20M%2C%20Mehta%20MP%2C%20Wen%20PY%2C%20Trippa%20L%2C%20Rahman%20R.%20Treatment%20Effect%20Reanalysis%20of%20the%20Randomized%20Individual%20Screening%20Trial%20of%20Innovative%20Glioblastoma%20Therapy%20in%20Newly%20Diagnosed%20Glioblastoma%20With%20External%20Control%20Data.%20J%20Clin%20Oncol.%202026%20July%2020%3B44%2821%29%3A2048%26%23x2013%3B2058.%20PMCID%3A%20PMC13418303%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20Effect%20Reanalysis%20of%20the%20Randomized%20Individual%20Screening%20Trial%20of%20Innovative%20Glioblastoma%20Therapy%20in%20Newly%20Diagnosed%20Glioblastoma%20With%20External%20Control%20Data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tulika%22%2C%22lastName%22%3A%22Rudra%20Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mei-Yin%20C.%22%2C%22lastName%22%3A%22Polley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Redd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eudocia%20Q.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabel%22%2C%22lastName%22%3A%22Arrillaga-Romany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20R.%22%2C%22lastName%22%3A%22Gilbert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yujue%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Touat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Drappatz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20R.%22%2C%22lastName%22%3A%22Welch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evanthia%22%2C%22lastName%22%3A%22Galanis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manmeet%20S.%22%2C%22lastName%22%3A%22Ahluwalia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Howard%22%2C%22lastName%22%3A%22Colman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Burt%22%2C%22lastName%22%3A%22Nabors%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaroslaw%22%2C%22lastName%22%3A%22Hepel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinrich%22%2C%22lastName%22%3A%22Elinzano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Schiff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ugonma%20N.%22%2C%22lastName%22%3A%22Chukwueke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rameen%22%2C%22lastName%22%3A%22Beroukhim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lakshmi%22%2C%22lastName%22%3A%22Nayak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Ricardo%22%2C%22lastName%22%3A%22McFaline-Figueroa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tracy%20T.%22%2C%22lastName%22%3A%22Batchelor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20J.%22%2C%22lastName%22%3A%22Kaley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Lu-Emerson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ingo%20K.%22%2C%22lastName%22%3A%22Mellinghoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Arnaout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pier%20Paolo%22%2C%22lastName%22%3A%22Peruzzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daphne%22%2C%22lastName%22%3A%22Haas-Kogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shyam%22%2C%22lastName%22%3A%22Tanguturi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ayal%22%2C%22lastName%22%3A%22Aizer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Doherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Meredith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Antonio%22%2C%22lastName%22%3A%22Chiocca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Weller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minesh%20P.%22%2C%22lastName%22%3A%22Mehta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20Y.%22%2C%22lastName%22%3A%22Wen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Trippa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rifaquat%22%2C%22lastName%22%3A%22Rahman%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Integrating%20external%20control%20data%20into%20clinical%20trial%20designs%20and%20analyses%20has%20the%20potential%20to%20accelerate%20drug%20development%20processes.%20We%20reanalyzed%20the%20three%20experimental%20arms%20of%20the%20Individual%20Screening%20Trial%20of%20Innovative%20Glioblastoma%20Therapy%20%28INSIGhT%29%2C%20a%20randomized%20phase%20II%20platform%20trial%20in%20newly%20diagnosed%20O6-methylguanine-DNA%20methyltransferase-unmethylated%20glioblastoma%20%28ClinicalTrials.gov%20identifier%3A%20NCT02977780%29.%20To%20evaluate%20the%20validity%20of%20using%20external%20data%20sets%2C%20we%20compared%20treatment%20effect%20estimates%20based%20on%20internal%20INSIGhT%20control%20data%20and%20matched%20external%20control%20data.%5CnMETHODS%3A%20The%20three%20experimental%20arms%20of%20INSIGhT%20%28abemaciclib%20%5Bn%20%3D%2072%5D%2C%20neratinib%20%5Bn%20%3D%2080%5D%2C%20and%20CC-115%20%5Bn%20%3D%2012%5D%29%20did%20not%20improve%20survival%20compared%20with%20internal%20controls%20%28standard%20chemoradiation%20%5Bn%20%3D%2070%5D%29.%20We%20derived%20external%20control%20patient-level%20data%20from%20multiple%20real-world%20and%20clinical%20trial%20data%20sets.%20We%20applied%20propensity%20score%20matching%20and%20Cox%20proportional%20hazards%20models%20to%20estimate%20treatment%20effects%20with%20external%20controls.%20Additionally%2C%20using%20this%20glioblastoma%20%28GBM%29%20data%20collection%2C%20we%20specified%20simulation%20scenarios%20to%20evaluate%20trial%20designs%20that%20integrate%20external%20controls.%5CnRESULTS%3A%20After%20matching%20to%20external%20controls%2C%20no%20survival%20benefit%20was%20observed%20for%20patients%20receiving%20abemaciclib%20%28hazard%20ratio%20%5BHR%5D%2C%201.00%20%5B95%25%20CI%2C%200.75%20to%201.34%5D%29%2C%20neratinib%20%28HR%2C%200.93%20%5B95%25%20CI%2C%200.70%20to%201.24%5D%29%2C%20or%20CC-115%20%28HR%2C%200.88%20%5B95%25%20CI%2C%200.41%20to%201.88%5D%29.%20Simulations%2C%20together%20with%20the%20INSIGhT%20data%20and%20a%20collection%20of%20GBM%20data%20sets%2C%20allowed%20us%20to%20examine%20efficiencies%20and%20risks%20of%20clinical%20trial%20designs%20that%20leverage%20external%20control%20data.%5CnCONCLUSION%3A%20The%20use%20of%20carefully%20matched%20external%20controls%2C%20to%20replace%20or%20augment%20the%20internal%20controls%20of%20INSIGhT%2C%20produced%20treatment%20effect%20estimates%20that%20were%20similar%20to%20previously%20published%20analyses.%20Single-arm%20trial%20designs%20and%20hybrid%20randomized%20designs%20incorporating%20propensity%20score-matched%20external%20control%20data%20evaluated%20treatment%20effects%20in%20the%20early-phase%20testing%20of%20experimental%20therapies%20in%20newly%20diagnosed%20GBM.%20The%20validity%20of%20this%20approach%20and%20risks%20of%20bias%20depended%20on%20the%20availability%20of%20comprehensive%20and%20accurate%20data%20on%20all%20potential%20confounders%2C%20in%20the%20absence%20of%20unmeasured%20confounding.%22%2C%22date%22%3A%222026-07-20%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1200%5C%2FJCO-25-01586%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2242172567%22%2C%22PMCID%22%3A%22PMC13418303%22%2C%22ISSN%22%3A%221527-7755%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-10-05T18%3A14%3A52Z%22%7D%7D%2C%7B%22key%22%3A%2242RTECQD%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ma%20et%20al.%22%2C%22parsedDate%22%3A%222026-06-30%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMa%20Y%2C%20Tagore%20M%2C%20Hunter%20MV%2C%20Huang%20TH%2C%20Montal%20E%2C%20Weiss%20JM%2C%20Shi%20Y%2C%20Vallius%20T%2C%20Sorger%20PK%2C%20White%20RM.%20Restraint%20of%20melanoma%20progression%20by%20cells%20in%20the%20local%20skin%20environment.%20Elife.%202026%20June%2030%3B13%3ARP101974.%20PMCID%3A%20PMC13318302%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Restraint%20of%20melanoma%20progression%20by%20cells%20in%20the%20local%20skin%20environment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yilun%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohita%22%2C%22lastName%22%3A%22Tagore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miranda%20V.%22%2C%22lastName%22%3A%22Hunter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ting-Hsiang%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Montal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Weiss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yingxiao%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20M.%22%2C%22lastName%22%3A%22White%22%7D%5D%2C%22abstractNote%22%3A%22Keratinocytes%2C%20the%20dominant%20cell%20type%20in%20the%20melanoma%20microenvironment%20during%20tumor%20initiation%2C%20exhibit%20diverse%20effects%20on%20melanoma%20progression.%20Using%20a%20zebrafish%20model%20of%20melanoma%20and%20human%20cell%20co-cultures%2C%20we%20observed%20that%20keratinocytes%20undergo%20an%20epithelial-mesenchymal%20transition%20%28EMT%29-like%20transformation%20in%20the%20presence%20of%20melanoma%2C%20reminiscent%20of%20their%20behavior%20during%20wound%20healing.%20Surprisingly%2C%20overexpression%20of%20the%20EMT-transcription%20factor%20Twist%20in%20keratinocytes%20led%20to%20improved%20overall%20survival%20in%20zebrafish%20melanoma%20models%2C%20despite%20no%20change%20in%20tumor%20initiation%20rates.%20This%20survival%20benefit%20was%20attributed%20to%20reduced%20melanoma%20invasion%2C%20as%20confirmed%20by%20human%20cell%20co-culture%20assays.%20Single-cell%20RNA-sequencing%20revealed%20a%20unique%20melanoma%20cell%20cluster%20in%20the%20Twist-overexpressing%20condition%2C%20exhibiting%20a%20more%20differentiated%2C%20less%20invasive%20phenotype.%20Further%20analysis%20nominated%20homotypic%20jam3b-jam3b%20and%20pgrn-sort1a%20interactions%20between%20Twist-overexpressing%20keratinocytes%20and%20melanoma%20cells%20as%20potential%20mediators%20of%20the%20invasive%20restraint.%20Our%20findings%20suggest%20that%20EMT%20in%20the%20tumor%20microenvironment%20may%20paradoxically%20limit%20melanoma%20invasion%20through%20altered%20cell-cell%20interactions.%22%2C%22date%22%3A%222026-06-30%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.7554%5C%2FeLife.101974%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2242378027%22%2C%22PMCID%22%3A%22PMC13318302%22%2C%22ISSN%22%3A%222050-084X%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T13%3A32%3A27Z%22%7D%7D%2C%7B%22key%22%3A%228TY2TYA9%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zamora%20et%20al.%22%2C%22parsedDate%22%3A%222026-06-24%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZamora%20AD%2C%20Pai%20SV%2C%20Mears%20KS%2C%20Rossine%20F%2C%20Owen%20SV%2C%20Baym%20M.%20SOS-mediated%20prophage%20induction%20constrains%20resistance%20evolution%20to%20DNA-damaging%20antibiotics%20%5BInternet%5D.%20bioRxiv%3B%202026%20%5Bcited%202026%20July%2017%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.06.23.733845%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.06.23.733845%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22SOS-mediated%20prophage%20induction%20constrains%20resistance%20evolution%20to%20DNA-damaging%20antibiotics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20D.%22%2C%22lastName%22%3A%22Zamora%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shreyas%20V.%22%2C%22lastName%22%3A%22Pai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kepler%20S.%22%2C%22lastName%22%3A%22Mears%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Rossine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Si%5Cu00e2n%20V.%22%2C%22lastName%22%3A%22Owen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20Most%20naturally%20occurring%20bacteria%20are%20lysogens%2C%20encoding%20one%20or%20more%20temperate%20phages%20%28prophages%29%20integrated%20into%20their%20genome.%20As%20prophages%20are%20induced%20by%20the%20bacterial%20SOS%20response%2C%20DNA-damaging%20antibiotics%20can%20trigger%20SOS-mediated%20prophage%20induction%2C%20where%20prophages%20undergo%20lytic%20replication%20and%20lyse%20their%20host%2C%20even%20at%20sub-inhibitory%20concentrations.%20This%20prophage-antibiotic%20synergy%20therefore%20sensitizes%20lysogenic%20hosts%20to%20DNA-damaging%20antibiotics.%20However%2C%20the%20mechanism%20by%20which%20prophage-induced%20sensitization%20affects%20the%20evolution%20of%20resistance%20against%20these%20agents%20is%20unclear.%20Here%20we%20show%20that%20ciprofloxacin-resistant%20lysogens%20arise%20less%20frequently%20but%20exhibit%20higher%20levels%20of%20resistance%20following%20selection.%20Whole-genome%20sequencing%20showed%20that%20increased%20lysogen%20resistance%20arose%20from%20selection%20towards%20mutations%20in%20drug%20targets%2C%20efflux%20pathways%2C%20and%20stress%20response%20regulators%20that%20reduce%20antibiotic%20efficacy%20or%20alter%20SOS%20induction.%20Consistent%20with%20this%20result%2C%20resistant%20lysogens%20exhibited%20a%20dampened%20SOS%20response%2C%20suggesting%20that%20prophage%20induction%20imposes%20an%20additional%20selective%20filter%20on%20their%20hosts%20by%20eliminating%20mutants%20that%20experience%20sufficient%20DNA%20damage%20to%20activate%20the%20SOS%20response.%20By%20contrast%2C%20prophage%20carriage%20had%20no%20effect%20on%20sensitivity%20or%20resistance%20evolution%20for%20antibiotics%20where%20DNA%20damage%20occurs%20downstream%20of%20the%20primary%20mechanism%20of%20action.%20Together%2C%20these%20findings%20indicate%20that%20prophage%20induction%20acts%20as%20an%20evolutionary%20bottleneck%20that%20restricts%20many%20resistance%20trajectories%20while%20favoring%20the%20emergence%20of%20rarer%2C%20large-effect%20mutations%2C%20potentially%20accelerating%20the%20evolution%20of%20high-level%20resistance.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222026-06-24%22%2C%22DOI%22%3A%2210.64898%5C%2F2026.06.23.733845%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.06.23.733845%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-10-06T18%3A01%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22MJCBIMT6%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gonzalez%20Castro%20et%20al.%22%2C%22parsedDate%22%3A%222026-06-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGonzalez%20Castro%20LN%2C%20Wu%20YC%2C%20Lin%20JR%2C%20Santiago-Ribeiro%20MJ%2C%20Laurenge%20A%2C%20Carpentier%20A%2C%20Coy%20S%2C%20Lin%20NU%2C%20Mokhtari%20K%2C%20Ligon%20KL%2C%20Touat%20M%2C%20Santagata%20S.%20Clinical%20responses%20to%20trastuzumab%20deruxtecan%20in%20molecularly%20defined%20ependymoma.%20NPJ%20Precis%20Oncol.%202026%20June%2020%3B%20PMID%3A%2042321415%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20responses%20to%20trastuzumab%20deruxtecan%20in%20molecularly%20defined%20ependymoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20Nicolas%22%2C%22lastName%22%3A%22Gonzalez%20Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi-Chien%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria-Joao%22%2C%22lastName%22%3A%22Santiago-Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alice%22%2C%22lastName%22%3A%22Laurenge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Carpentier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%20U.%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karima%22%2C%22lastName%22%3A%22Mokhtari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20L.%22%2C%22lastName%22%3A%22Ligon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mehdi%22%2C%22lastName%22%3A%22Touat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20evidence%20that%20antibody%20drug%20conjugates%20%28ADCs%29%20are%20active%20in%20brain%20metastases%2C%20their%20role%20in%20primary%20central%20nervous%20system%20%28CNS%29%20tumors%20remains%20unclear.%20We%20report%20two%20adults%20with%20molecularly%20defined%20ependymoma%20-%20a%20MYCN-amplified%20spinal%20tumor%20with%20intracranial%20dissemination%20and%20a%20supratentorial%20ZFTA-RELA-fused%20tumor%20with%20multiple%20recurrences%20-%20who%20demonstrated%20radiographic%20response%20and%5C%2For%20durable%20clinical%20and%20metabolic%20stability%20with%20trastuzumab%20deruxtecan%20%28T-DXd%29.%20HER2%20expression%20was%20identified%20by%20immunohistochemistry%20in%20both%20tumors%2C%20consistent%20with%20prior%20systematic%20profiling%20of%20ADC%20targets%20in%20CNS%20tumors.%20Multiplexed%20imaging%20showed%20broad%20but%20heterogeneous%20HER2%20expression%20across%20tumor%20states%20in%20both%20cases%3B%20in%20the%20MYCN-amplified%20tumor%2C%20this%20occurred%20alongside%20EGFR%5C%2FMAPK-enriched%20proliferative%20niches%2C%20whereas%20the%20ZFTA-RELA%20tumor%20showed%20more%20diffuse%20organization%20without%20strong%20coupling%20of%20EGFR%20and%20proliferation.%20These%20findings%20provide%20early%20clinical%20evidence%20supporting%20HER2-directed%20ADCs%20in%20ependymoma%20and%20highlight%20the%20value%20of%20integrated%20molecular%20and%20spatial%20profiling%20in%20interpreting%20therapeutic%20response%20in%20rare%20CNS%20tumors.%22%2C%22date%22%3A%222026-06-20%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41698-026-01514-x%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2242321415%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222397-768X%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T15%3A12%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22A7NG9G5N%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Xu%20et%20al.%22%2C%22parsedDate%22%3A%222026-06-09%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EXu%20R%2C%20Wu%20G%2C%20Rice%20S%2C%20Booker%20M%2C%20Weekes%20J%2C%20Bell%20H%2C%20Gao%20Y%2C%20Nirmal%20AJ%2C%20Liu%20H%2C%20Ciantra%20Z%2C%20Luo%20Q%2C%20Fortune%20A%2C%20Whalen%20K%2C%20Guanci%20T%2C%20Wan%20Y%2C%20Louissaint%20A%2C%20Nordberg%20JJ%2C%20Lin%20JR%2C%20Hemann%20M%2C%20Manalis%20SR%2C%20Armand%20P%2C%20Smith%20E%2C%20Jacobson%20CA%2C%20Tolstorukov%20M%2C%20Murakami%20MA%2C%20Sorger%20PK%2C%20Weinstock%20DM%2C%20Song%20L%2C%20Lane%20AA.%20Live-cell%20Pick-Seq%20%28LiP-Seq%29%3A%20Interrogating%20ultra-rare%20mantle%20cell%20lymphoma%20persistent%20cells%20after%20CART19%20therapy.%20Blood%20Adv.%202026%20June%209%3B10%2811%29%3A3845%26%23x2013%3B3855.%20PMCID%3A%20PMC13234471%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Live-cell%20Pick-Seq%20%28LiP-Seq%29%3A%20Interrogating%20ultra-rare%20mantle%20cell%20lymphoma%20persistent%20cells%20after%20CART19%20therapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ran%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gongwei%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siobhan%22%2C%22lastName%22%3A%22Rice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Booker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jenalyn%22%2C%22lastName%22%3A%22Weekes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hayden%22%2C%22lastName%22%3A%22Bell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yifei%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huiyun%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoe%22%2C%22lastName%22%3A%22Ciantra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qingyu%22%2C%22lastName%22%3A%22Luo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Fortune%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karley%22%2C%22lastName%22%3A%22Whalen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%22%2C%22lastName%22%3A%22Guanci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yifei%22%2C%22lastName%22%3A%22Wan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abner%22%2C%22lastName%22%3A%22Louissaint%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20J.%22%2C%22lastName%22%3A%22Nordberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Hemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20R.%22%2C%22lastName%22%3A%22Manalis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Armand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caron%20A.%22%2C%22lastName%22%3A%22Jacobson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Tolstorukov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20A.%22%2C%22lastName%22%3A%22Murakami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Weinstock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20A.%22%2C%22lastName%22%3A%22Lane%22%7D%5D%2C%22abstractNote%22%3A%22Many%20cancer%20therapies%20induce%20high%20response%20rates%2C%20with%20some%20resulting%20in%20undetectable%20disease%20as%20assessed%20using%20standard%20clinical%20assays.%20This%20is%20particularly%20true%20in%20leukemia%20and%20lymphoma%2C%20in%20which%20patients%20often%20achieve%20deep%20remission%20yet%20ultimately%20experience%20relapse.%20These%20outcomes%20highlight%20a%20critical%20need%20to%20better%20understand%20ultrarare%20persistent%20cells%20that%20survive%20therapy%20but%20remain%20inaccessible%20to%20current%20techniques.%20Here%2C%20we%20developed%20Live-cell%20Pick-Seq%20%28LiP-Seq%29%2C%20an%20advanced%20platform%20leveraging%20multiplexed%20live-cell%20imaging%20to%20identify%20and%20retrieve%20individual%20target%20cells%20for%20downstream%20analysis.%20LiP-Seq%20enables%20high-resolution%20transcriptomic%20profiling%20of%20single%2C%20viable%20lymphoma%20cells%20present%20at%20frequencies%20as%20low%20as%2010-6%2C%20providing%20a%20technological%20window%20into%20the%20biology%20of%20these%20elusive%20reservoirs.%20Applying%20this%20method%20to%20patients%20with%20mantle%20cell%20lymphoma%20after%20treatment%20with%20CD19%20chimeric%20antigen%20receptor%20T-cell%20%28CAR-T%29%20therapy%2C%20we%20identified%20recurrent%20upregulation%20of%20the%20immune%20modulator%20IFITM2%20in%20the%20persistent%20cell%20fraction.%20Functional%20validation%20demonstrated%20that%20IFITM2%20overexpression%20conferred%20protection%20against%20CAR-T%20cytotoxicity%20in%20vitro%2C%20implicating%20it%20as%20a%20potential%20survival%20mechanism%20under%20therapeutic%20pressure.%20Our%20results%20provide%2C%20to%20our%20knowledge%2C%20the%20first%20transcriptomic%20characterization%20of%20viable%2C%20ultrarare%20persistent%20cells%20using%20LiP-Seq%2C%20establishing%20a%20new%20paradigm%20for%20identifying%20and%20targeting%20features%20that%20may%20enable%20treatment%20evasion.%22%2C%22date%22%3A%222026-06-09%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1182%5C%2Fbloodadvances.2025016688%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241855504%22%2C%22PMCID%22%3A%22PMC13234471%22%2C%22ISSN%22%3A%222473-9537%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T03%3A04%3A04Z%22%7D%7D%2C%7B%22key%22%3A%2275QDX2S2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Ogbonna%20et%20al.%22%2C%22parsedDate%22%3A%222026-06-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EOgbonna%20EC%2C%20Talemi%20SR%2C%20Maliga%20Z%2C%20Zhao%20Z%2C%20Yapp%20C%2C%20Pant%20SM%2C%20Lu%20YD%2C%20Muhlich%20J%2C%20Gagn%26%23xE9%3B%20A%2C%20Martinot%20AJ%2C%20Coy%20S%2C%20Santagata%20S%2C%20Shih%20AR%2C%20Solomon%20IH%2C%20Naidoo%20T%2C%20Aldridge%20BB%2C%20Steyn%20AJC%2C%20Sorger%20PK.%20Modeling%20development%20of%20tertiary%20lymphoid%20structures%20in%20pulmonary%20tuberculosis%20by%203D%20profiling%20and%20trajectory%20analysis%20%5BInternet%5D.%20bioRxiv%3B%202026%20%5Bcited%202026%20June%208%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.06.02.725201%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.06.02.725201%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Modeling%20development%20of%20tertiary%20lymphoid%20structures%20in%20pulmonary%20tuberculosis%20by%203D%20profiling%20and%20trajectory%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%20C.%22%2C%22lastName%22%3A%22Ogbonna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soheil%20R.%22%2C%22lastName%22%3A%22Talemi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziyuan%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shishir%20M.%22%2C%22lastName%22%3A%22Pant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%20Daniel%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22Gagn%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20J.%22%2C%22lastName%22%3A%22Martinot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20R.%22%2C%22lastName%22%3A%22Shih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isaac%20H.%22%2C%22lastName%22%3A%22Solomon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Threnesan%22%2C%22lastName%22%3A%22Naidoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bree%20B.%22%2C%22lastName%22%3A%22Aldridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrie%20J.C.%22%2C%22lastName%22%3A%22Steyn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Tertiary%20lymphoid%20structures%20%28TLSs%29%20are%20sites%20of%20immune%20organization%20in%20peripheral%20tissues%20that%20arise%20from%20chronic%20inflammation.%20They%20play%20important%20roles%20in%20infection%20control%20and%20cancer%20but%20the%20mechanisms%20controlling%20their%20formation%20remain%20only%20partly%20understood.%20Here%2C%20we%20combine%20high-plex%20imaging%2C%20serial-section%203D%20reconstruction%2C%20and%20optimal%20transport%20trajectory%20modeling%20to%20reconstruct%20TLSs%20in%20human%20lungs%20infected%20with%20Mycobacterium%20tuberculosis.%20We%20find%20that%20the%20extended%20and%20irregular%20shape%20of%20TLSs%20is%20poorly%20captured%20by%202D%20histopathology%20or%20spatial%20profiling%2C%20making%20assessment%20of%20developmental%20stage%20%28early%2C%20primary%2C%20or%20secondary%29%20error%20prone.%20In%20contrast%2C%20modeling%20TLS%20development%20in%203D%20using%20optimal%20transport%20reveals%20two%20trajectories%20that%20differ%20in%20the%20timing%20and%20coordination%20of%20follicular%20dendritic%20cell%20association%2C%20germinal%20center%20consolidation%2C%20and%20position%20within%20the%20tissue.%20These%20findings%20highlight%20the%20value%20of%20volumetric%20analysis%20in%20understanding%20immune%20organization%20and%20provide%20new%20insights%20into%20TLS%20biology.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222026-06-07%22%2C%22DOI%22%3A%2210.64898%5C%2F2026.06.02.725201%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.06.02.725201%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T13%3A37%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22JMLPSW8S%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Li%20and%20Mitchison%22%2C%22parsedDate%22%3A%222026-05-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELi%20B%2C%20Mitchison%20TJ.%20Rebinding%20drives%20cellular%20retention%20of%20small-molecule%20drugs%20with%20abundant%20targets.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202026%20May%2026%3B123%2821%29%3Ae2531949123.%20PMCID%3A%20PMC13213988%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rebinding%20drives%20cellular%20retention%20of%20small-molecule%20drugs%20with%20abundant%20targets%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Boyan%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20J.%22%2C%22lastName%22%3A%22Mitchison%22%7D%5D%2C%22abstractNote%22%3A%22Many%20small-molecule%20antitumor%20drugs%20are%20administered%20far%20less%20frequently%20than%20would%20be%20predicted%20from%20their%20plasma%20half-lives%2C%20in%20part%20because%20their%20efficacy%20is%20driven%20by%20prolonged%20retention%20within%20tumors.%20Drug%20retention%20can%20be%20caused%20by%20nonspecific%20protein%20binding%2C%20low%20membrane%20permeability%2C%20sequestration%20in%20acidic%20compartments%2C%20slow%20target%20dissociation%2C%20and%20rebinding%20to%20empty%20target%20sites%2C%20but%20the%20field%20has%20lacked%20a%20quantitative%20framework%20and%20preclinical%20assays%20for%20discriminating%20these%20mechanisms%20and%20predicting%20retention%20in%20vivo.%20We%20developed%20a%20theoretical%20framework%20and%20a%20simple%20two-drug%20assay%20for%20quantifying%20retention%20mechanisms%20in%20cell-based%20models.%20Application%20to%2013%20drugs%20with%208%20distinct%20intracellular%20targets%20revealed%20diverse%20retention%20mechanisms.%20Rebinding%20emerged%20as%20a%20potent%20driver%20of%20retention%20whose%20magnitude%20was%20predicted%20by%20the%20target-to-affinity%20ratio%20%28%5BTarget%5D%5C%2FKd%29.%20Rebinding%20slows%20the%20washout%20rates%20of%20important%20drugs%20such%20as%20taxanes%20and%20rapamycin%20by%20100-fold%20or%20more.%20It%20also%20explains%20the%20need%20for%20high%20loading%20concentrations.%20Our%20approach%20bridges%20a%20critical%20gap%20in%20pharmacology%20modeling%20and%20provides%20practical%20tools%20to%20guide%20the%20design%20of%20intermittent%20dosing%20regimens.%22%2C%22date%22%3A%222026-05-26%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1073%5C%2Fpnas.2531949123%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2242154562%22%2C%22PMCID%22%3A%22PMC13213988%22%2C%22ISSN%22%3A%221091-6490%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T15%3A02%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22RABUFDSJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Wong%20et%20al.%22%2C%22parsedDate%22%3A%222026-05-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWong%20AYH%2C%20Lu%20YD%2C%20Zhao%20Z%2C%20Zhou%20F%2C%20Park%20H%2C%20Maliga%20Z%2C%20Anang%20YNA%2C%20Coy%20S%2C%20Danuser%20G%2C%20Santagata%20S%2C%20Yapp%20C%2C%20Sorger%20PK.%20Volumetric%20Cyclic%20Immunofluorescence%20for%203D%20Spatial%20Profiling%20of%20Immune%20Structures%20in%20Human%20FFPE%20Tissue%20%5BInternet%5D.%20bioRxiv%3B%202026%20%5Bcited%202026%20May%2026%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.05.17.725158%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.05.17.725158%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Volumetric%20Cyclic%20Immunofluorescence%20for%203D%20Spatial%20Profiling%20of%20Immune%20Structures%20in%20Human%20FFPE%20Tissue%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20Y.%20H.%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%20Daniel%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziyuan%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hojeong%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yvonne%20N.%20A.%22%2C%22lastName%22%3A%22Anang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaudenz%22%2C%22lastName%22%3A%22Danuser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20The%20tissue-resident%20immune%20system%20involves%20complex%203D%20assemblies%20that%20interact%20with%20extended%20structures%20such%20as%20blood%20vessels%20and%20nerves.%20These%20interactions%20are%20difficult%20to%20study%20using%20conventional%202D%20profiling%20because%20they%20span%20many%20tissue%20sections.%20In%20animal%20tissues%2C%20volumetric%20imaging%20approaches%20such%20as%20light-sheet%20fluorescence%20microscopy%20%28LSFM%29%20are%20widely%20used%20to%20study%203D%20tissue%20organization%2C%20with%20labelling%20often%20aided%20by%20genetically%20encoded%20reporters%20and%20vascular%20dyes.%20In%20contrast%2C%20LSFM%20of%20human%20specimens%20remains%20underdeveloped%20because%20most%20clinical%20samples%20are%20available%20only%20as%20formalin-fixed%20paraffin-embedded%20%28FFPE%29%20tissue%2C%20limiting%20labeling%20strategies%20primarily%20to%20dyes%20and%20antibodies.%20Here%2C%20we%20present%20a%20volumetric%20cyclic%20immunofluorescence%20%28v-CyCIF%29%20and%20virtual%20H%26E%20toolbox%20that%20overcomes%20key%20barriers%20to%20multiplexed%20imaging%20of%20immune%20cells%20and%20nerves%20in%20human%20specimens%20up%20to%201%20mm%20thick.%20We%20use%20v-CyCIF%20to%20study%20neuroimmune%20interactions%20in%20normal%20and%20cancer%20tissues%20and%20to%20immunoprofile%20intact%20secondary%20and%20tertiary%20lymphoid%20structures.%20Re-embedding%20and%20sectioning%20of%20specimens%20following%20volumetric%20imaging%20enables%20high-plex%20high-resolution%20analysis%20of%20subcellular%20structures%20and%20cell-cell%20interactions%20associated%20with%20immune%20cell%20activity.%20v-CyCIF%20therefore%20provides%20a%20flexible%20framework%20for%20multi-scale%203D%20profiling%20of%20clinical%20specimens%20across%20imaging%20formats%20and%20resolutions.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222026-05-20%22%2C%22DOI%22%3A%2210.64898%5C%2F2026.05.17.725158%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.05.17.725158%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T13%3A39%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22BWS2D4A5%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Petrova%20et%20al.%22%2C%22parsedDate%22%3A%222026-05-19%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPetrova%20V%2C%20Mills%20CE%2C%20Hug%20C%2C%20Cetinkaya-Fisgin%20A%2C%20Splaine%20J%2C%20Fouladzadeh%20S%2C%20Hakim%20S%2C%20Powell%20R%2C%20Zhen%20S%2C%20Chung%20M%2C%20Bradshaw%20GA%2C%20Deng%20T%2C%20Singec%20I%2C%20Wang%20Q%2C%20Kawaguchi%20R%2C%20Jonnagaddala%20H%2C%20Barrett%20LB%2C%20Smith%20JA%2C%20Kalocsay%20M%2C%20Gyori%20BM%2C%20Hoke%20A%2C%20Sorger%20PK%2C%20Woolf%20CJ.%20A%20human%20iPSC-derived%20sensory%20neuron%20platform%20for%20high-throughput%20discovery%20of%20neuroprotectants%20against%20chemotherapy-induced%20peripheral%20neuropathy.%20Cell%20Rep%20Med.%202026%20May%2019%3B7%285%29%3A102787.%20PMCID%3A%20PMC13198234%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20human%20iPSC-derived%20sensory%20neuron%20platform%20for%20high-throughput%20discovery%20of%20neuroprotectants%20against%20chemotherapy-induced%20peripheral%20neuropathy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Veselina%22%2C%22lastName%22%3A%22Petrova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aysel%22%2C%22lastName%22%3A%22Cetinkaya-Fisgin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Splaine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sepideh%22%2C%22lastName%22%3A%22Fouladzadeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Hakim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rasheen%22%2C%22lastName%22%3A%22Powell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Zhen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tao%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ilyas%22%2C%22lastName%22%3A%22Singec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qing%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riki%22%2C%22lastName%22%3A%22Kawaguchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harathi%22%2C%22lastName%22%3A%22Jonnagaddala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%20B.%22%2C%22lastName%22%3A%22Barrett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20A.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmet%22%2C%22lastName%22%3A%22Hoke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifford%20J.%22%2C%22lastName%22%3A%22Woolf%22%7D%5D%2C%22abstractNote%22%3A%22Chemotherapy-induced%20peripheral%20neuropathy%20%28CIPN%29%20is%20a%20major%20dose-limiting%20side%20effect%20of%20cancer%20treatment%2C%20yet%20the%20lack%20of%20predictive%20human%20models%20continues%20to%20hinder%20therapeutic%20progress.%20Here%2C%20we%20establish%20a%20scalable%20and%20reproducible%20model%20of%20paclitaxel-induced%20axon%20degeneration%20and%20neurotoxicity%20in%20human%20iPSC-derived%20sensory%20neurons%2C%20suitable%20for%20high-throughput%20identification%20of%20neuroprotective%20compounds.%20Using%20this%20platform%2C%20we%20screen%20a%20library%20of%20192%20kinase%20inhibitors%20and%20identify%2019%20hits%20that%20commonly%20inhibit%20three%20STE20%20kinases-MAP4K4%2C%20MINK1%2C%20and%20TNIK.%20Genetic%20knockdown%20studies%20reveal%20that%20multi-kinase%20inhibition%20of%20these%20kinases%20is%20required%20for%20neuroprotection%20against%20paclitaxel.%20Consistently%2C%20selective%20pharmacological%20inhibition%20of%20the%20identified%20STE20%20kinases%20rescues%20paclitaxel-induced%20axon%20degeneration%20in%20iPSC-derived%20sensory%20neurons%20and%20primary%20human%20dorsal%20root%20ganglia%20%28DRG%29%20and%20preserves%20intraepidermal%20nerve%20fiber%20density%20in%20a%20mouse%20model%20of%20CIPN.%20Together%2C%20these%20findings%20establish%20a%20translational%20human%20sensory%20neuron%20platform%20that%20enables%20target%20validation%20and%20drug%20discovery%20for%20CIPN.%22%2C%22date%22%3A%222026-05-19%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.xcrm.2026.102787%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2242097147%22%2C%22PMCID%22%3A%22PMC13198234%22%2C%22ISSN%22%3A%222666-3791%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T03%3A29%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22KM7HU3L3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shi%20et%20al.%22%2C%22parsedDate%22%3A%222026-05-15%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EShi%20Y%2C%20Savchenko%20A%2C%20Brase%20JC%2C%20Reardon%20B%2C%20Ricker%20CA%2C%20Park%20J%2C%20Tarantino%20G%2C%20Manos%20MP%2C%20Huang%20AY%2C%20Van%20Allen%20EM%2C%20Garraway%20LA%2C%20Flaherty%20KT%2C%20Liu%20D.%20Genomic%2C%20Clinical%2C%20and%20Spatial%20Predictors%20of%20Durable%20Response%20to%20BRAF%5C%2FMEK%20Inhibition%20in%20%3Ci%3EBRAF%3C%5C%2Fi%3E%20-Mutant%20Melanoma%20%5BInternet%5D.%20bioRxiv%3B%202026%20%5Bcited%202026%20July%2017%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.05.09.721157%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.05.09.721157%3C%5C%2Fa%3E%20PMCID%3A%20PMC13192995%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Genomic%2C%20Clinical%2C%20and%20Spatial%20Predictors%20of%20Durable%20Response%20to%20BRAF%5C%2FMEK%20Inhibition%20in%20%3Ci%3EBRAF%3C%5C%2Fi%3E%20-Mutant%20Melanoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yingxiao%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Savchenko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%20Christoph%22%2C%22lastName%22%3A%22Brase%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brendan%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cora%20A.%22%2C%22lastName%22%3A%22Ricker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jihye%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giuseppe%22%2C%22lastName%22%3A%22Tarantino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20P.%22%2C%22lastName%22%3A%22Manos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20Y.%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliezer%20M.%22%2C%22lastName%22%3A%22Van%20Allen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Levi%20A.%22%2C%22lastName%22%3A%22Garraway%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20T.%22%2C%22lastName%22%3A%22Flaherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Liu%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20BRAF-targeted%20therapy%20%28BRAFi%5C%2FMEKi%29%20and%20immune%20checkpoint%20blockade%20%28anti%5Cu2013PD-1%5C%2Fanti-CTLA-4%29%20have%20transformed%20the%20treatment%20of%5Cn%20%20%20%20%20%20%20%20%20%20%20%20BRAF%5Cn%20%20%20%20%20%20%20%20%20%20%20%20-mutant%20metastatic%20melanoma.%20While%20most%20patients%20who%20respond%20to%20targeted%20therapy%20eventually%20progress%2C%20a%20subset%20derives%20durable%20benefit%2C%20and%20biomarkers%20to%20identify%20this%20subset%20would%20inform%20optimal%20treatment%20selection.%20In%20this%20study%2C%20we%20analyzed%20pre-treatment%20tumor%20samples%20from%20a%20clinically%20annotated%20cohort%20of%20155%20patients%20with%5Cn%20%20%20%20%20%20%20%20%20%20%20%20BRAF%5Cn%20%20%20%20%20%20%20%20%20%20%20%20-mutant%20metastatic%20melanoma%20treated%20with%20first-line%20BRAFi%5C%2FMEKi%20and%20followed%20for%20up%20to%20five%20years.%20We%20stratified%20patients%20into%20durable%20responders%20%28PFS%20%5Cu2265%2024%20months%29%20and%20rapid%20progressors%20%28PFS%20%3C%206%20months%20with%20progression%29%20and%20found%20that%20a%20global%20metric%20of%20tumor%20genomic%20heterogeneity%2C%20rather%20than%20individual%20gene%20alterations%2C%20distinguished%20these%20groups.%20Combining%20genomic%20heterogeneity%20with%20baseline%20tumor%20burden%20%28e.g.%2C%20lactate%20dehydrogenase%20%28LDH%29%20or%20radiographic%20lesion%20dimensions%29%2C%20we%20developed%20a%20parsimonious%20model%20that%20predicted%20durable%20responders%20with%20high%20precision%20and%20specificity.%20Notably%2C%20the%20analogous%20population%20of%20patients%20treated%20instead%20with%20immunotherapy%20were%20not%20durable%20responders%2C%20suggesting%20that%20the%20selected%20predictors%20of%20durable%20responders%20are%20targeted%20therapy%20specific.%20Spatial%20profiling%20of%20a%20subset%20of%20pre-treatment%20biopsies%20%28n%20%3D%2047%29%20demonstrated%20that%20high%20intratumoral%2C%20but%20not%20peritumoral%2C%20CD8%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%2B%5Cn%20%20%20%20%20%20%20%20%20%20%20%20T-cell%20infiltration%20correlated%20with%20prolonged%20survival%20on%20BRAF-targeted%20therapy%20and%20served%20as%20an%20independent%20predictive%20factor%20when%20considered%20with%20genomic%20heterogeneity%20and%20features%20of%20clinical%20tumor%20burden.%20Together%2C%20these%20findings%20highlight%20the%20distinct%20baseline%20intrinsic%20and%20extrinsic%20features%20underlying%20durable%20response%20to%20BRAF-targeted%20therapy%20and%20support%20their%20potential%20implication%20in%20guiding%20treatment%20selection%20for%20patients%20with%5Cn%20%20%20%20%20%20%20%20%20%20%20%20BRAF%5Cn%20%20%20%20%20%20%20%20%20%20%20%20-mutant%20metastatic%20melanoma.%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20One-Sentence%20Summary%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Integrated%20clinical%2C%20tumor%20genomic%2C%20and%20immune%20microenvironmental%20features%20predict%20durable%20responses%20to%20BRAF-targeted%20therapy.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222026-05-15%22%2C%22DOI%22%3A%2210.64898%5C%2F2026.05.09.721157%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.05.09.721157%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T14%3A58%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22ZIJ22CYU%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cheng%20et%20al.%22%2C%22parsedDate%22%3A%222026-05-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECheng%20X%2C%20Zhang%20Y%2C%20Qian%20C%2C%20Holdridge%20E%2C%20Ananda%20G%2C%20Jiang%20T%2C%20Ni%20J%2C%20Xie%20S%2C%20Gu%20H%2C%20Ji%20R%2C%20Ivanova%20EV%2C%20Nucci%20MR%2C%20Wang%20Z%2C%20Chen%20K%2C%20Kochupurakkal%20B%2C%20Freeman%20GJ%2C%20Shapiro%20GI%2C%20Liu%20J%2C%20Konstantinopoulos%20PA%2C%20Matulonis%20U%2C%20Zhao%20JJ.%20Targeting%20FGFR%20signaling%20overcomes%20therapeutic%20resistance%20and%20immune%20evasion%20in%20oncogenic%20PIK3CA-driven%20serous-like%20endometrial%20cancer.%20Nat%20Commun.%202026%20May%204%3B17%281%29%3A5994.%20PMCID%3A%20PMC13347040%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeting%20FGFR%20signaling%20overcomes%20therapeutic%20resistance%20and%20immune%20evasion%20in%20oncogenic%20PIK3CA-driven%20serous-like%20endometrial%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xin%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yadong%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Changli%22%2C%22lastName%22%3A%22Qian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erica%22%2C%22lastName%22%3A%22Holdridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guruprasad%22%2C%22lastName%22%3A%22Ananda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tao%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Ni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shaozhen%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hao%22%2C%22lastName%22%3A%22Gu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renlei%22%2C%22lastName%22%3A%22Ji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%20V.%22%2C%22lastName%22%3A%22Ivanova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marisa%20R.%22%2C%22lastName%22%3A%22Nucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhe%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaifu%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bose%22%2C%22lastName%22%3A%22Kochupurakkal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gordon%20J.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%20I.%22%2C%22lastName%22%3A%22Shapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joyce%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Panagiotis%20A.%22%2C%22lastName%22%3A%22Konstantinopoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ursula%22%2C%22lastName%22%3A%22Matulonis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20J.%22%2C%22lastName%22%3A%22Zhao%22%7D%5D%2C%22abstractNote%22%3A%22Serous%20endometrial%20cancer%20%28SEC%29%20is%20an%20aggressive%20subtype%20of%20endometrial%20cancer%20%28EC%29%20with%20poor%20prognosis%20and%20limited%20treatment%20options.%20Here%2C%20we%20develop%20a%20clinically%20relevant%2C%20immunocompetent%20serous-like%20mouse%20model%20incorporating%20oncogenic%20PIK3CA%20mutation%2C%20Trp53%20loss%2C%20and%20MYC%20overexpression.%20Using%20this%20model%20together%20with%20human%20EC%20cell%20lines%2C%20patient-derived%20organoids%20%28PDOs%29%2C%20xenografts%2C%20and%20patient%20datasets%2C%20we%20investigate%20mechanisms%20underlying%20resistance%20to%20PI3K%5Cu03b1-targeted%20therapy.%20Single-cell%20profiling%20reveals%20that%20FGFR1%5C%2F2%20upregulation%20associates%20with%20intrinsic%20resistance%2C%20whereas%20FGFR3%20characterizes%20acquired%20resistance.%20Dual%20FGFR%20and%20PI3K%5Cu03b1%20inhibition%20produces%20superior%20tumor%20control%20compared%20with%20either%20agent%20alone.%20Mechanistically%2C%20FGFR%20signaling%20promotes%20immune%20evasion%20by%20downregulating%20MHC-I%5C%2FHLA-mediated%20antigen%20presentation%20and%20enriching%20M2-type%20tumor-associated%20macrophages.%20FGFR%20inhibition%20reverses%20these%20changes%20and%20synergizes%20with%20anti-PD-1%20therapy%20to%20enhance%20antitumor%20immune%20responses%20and%20establish%20durable%20immune%20memory.%20Collectively%2C%20these%20findings%20identify%20FGFR%20signaling%20as%20a%20key%20driver%20of%20therapeutic%20resistance%20and%20immune%20escape%20in%20SEC%20and%20support%20FGFR-targeted%20combination%20strategies.%22%2C%22date%22%3A%222026-05-04%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-026-72544-z%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2242082487%22%2C%22PMCID%22%3A%22PMC13347040%22%2C%22ISSN%22%3A%222041-1723%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T15%3A04%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22S73HXRPP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guo%20et%20al.%22%2C%22parsedDate%22%3A%222026-05-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGuo%20X%2C%20Moynihan%20ZA%2C%20Driver%20J%2C%20Patel%20RV%2C%20Bhave%20VM%2C%20Maury%20EA%2C%20Knelson%20EH%2C%20Guo%20H%2C%20Lin%20JR%2C%20Coy%20SM%2C%20Wang%20A%2C%20Gupta%20S%2C%20Hoffman%20SE%2C%20Dunn%20IF%2C%20Dunn%20GP%2C%20Petti%20A%2C%20Choi%20BD%2C%20Choudhury%20A%2C%20Raleigh%20DR%2C%20Wei%20K%2C%20Reardon%20DA%2C%20Barbie%20D%2C%20Lederer%20JA%2C%20Santagata%20S%2C%20Bi%20WL.%20Meningioma%20microenvironment%20harbors%20a%20rich%20immune%20landscape%20that%20evolves%20with%20biological%20state.%20Neuro%20Oncol.%202026%20May%201%3B28%285%29%3A1193%26%23x2013%3B1208.%20PMCID%3A%20PMC13186497%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Meningioma%20microenvironment%20harbors%20a%20rich%20immune%20landscape%20that%20evolves%20with%20biological%20state%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaopeng%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%20A.%22%2C%22lastName%22%3A%22Moynihan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Driver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruchit%20V.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Varun%20M.%22%2C%22lastName%22%3A%22Bhave%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduardo%20A.%22%2C%22lastName%22%3A%22Maury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20H.%22%2C%22lastName%22%3A%22Knelson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hong%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%20M.%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saksham%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%20E.%22%2C%22lastName%22%3A%22Hoffman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20F.%22%2C%22lastName%22%3A%22Dunn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gavin%20P.%22%2C%22lastName%22%3A%22Dunn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Allegra%22%2C%22lastName%22%3A%22Petti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bryan%20D.%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abrar%22%2C%22lastName%22%3A%22Choudhury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20R.%22%2C%22lastName%22%3A%22Raleigh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Barbie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20A.%22%2C%22lastName%22%3A%22Lederer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenya%20Linda%22%2C%22lastName%22%3A%22Bi%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Mechanisms%20driving%20aggressive%20meningiomas%20remain%20poorly%20understood.%20Given%20the%20pivotal%20role%20of%20the%20immune%20microenvironment%20in%20tumor%20progression%2C%20we%20developed%20a%20comprehensive%20atlas%20of%20the%20meningioma%20microenvironment%2C%20with%20a%20view%20toward%20identifying%20modifiable%20opportunities.%5CnMETHODS%3A%20The%20immune%20microenvironment%20of%202%2C727%20meningiomas%20was%20profiled%20using%20orthogonal%20methodologies%2C%20including%2024%20with%20mass%20cytometry%2C%2024%20single-cell%20RNAseq%2C%201%2C437%20bulk%20RNAseq%2C%201%2C125%20DNA%20methylation%2C%20117%20multiplex%20immunofluorescence%2C%20as%20well%20as%20that%20of%205%20paired%20peripheral%20blood%20samples%20and%2010%20human%20meninges.%20Patient-derived%20organotypic%20tumor%20spheroids%20%28PDOTS%29%20were%20established%20to%20assess%20the%20effect%20of%20STING%20stimulation%20combined%20with%20anti-PD-1%20treatment.%5CnRESULTS%3A%20We%20revealed%20a%20rich%20immune%20infiltration%20in%20meningioma%2C%20among%20the%20highest%20across%2034%20human%20cancer%20types%20%28n%5Cu2009%3D%5Cu200912%2C188%29.%20Macrophages%20predominated%20in%20meningioma%20microenvironment%2C%20in%20contrast%20to%20the%20lymphoid%20dominance%20of%20peripheral%20blood%2C%20with%20meninges%20exhibiting%20an%20intermediate%20immune%20profile%20between%20meningiomas%20and%20peripheral%20blood.%20Cellular%20states%20and%20phenotypes%20of%20both%20immune%20and%20tumor%20cells%20shifted%20during%20tumor%20progression%2C%20with%20aggressive%20meningiomas%20possessing%20earlier-stage%2C%20immunosuppressive%20immune%20cells%20and%20proliferative%20tumor%20cells.%20Using%20ex%20vivo%20meningioma%20PDOTS%2C%20we%20demonstrated%20inducible%20responses%20to%20STING%20activation%2C%20marked%20by%20elevated%20cytokine%20release%2C%20which%20were%20synergistic%20when%20combined%20with%20PD-1%20blockade.%5CnCONCLUSIONS%3A%20These%20findings%20offer%20an%20extensive%20resource%20on%20the%20cellular%20heterogeneity%20of%20the%20meningioma%20microenvironment%20and%20provide%20a%20framework%20for%20rational%20therapeutic%20modeling%20and%20strategy%20development.%22%2C%22date%22%3A%222026-05-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fneuonc%5C%2Fnoag022%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241630100%22%2C%22PMCID%22%3A%22PMC13186497%22%2C%22ISSN%22%3A%221523-5866%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T03%3A30%3A44Z%22%7D%7D%2C%7B%22key%22%3A%224W67QHEJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hess%20et%20al.%22%2C%22parsedDate%22%3A%222026-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHess%20JM%2C%20Dzeng%20RK%2C%20Ilie%26%23x15F%3B%20I%2C%20Schapiro%20D%2C%20Iskra%20JJ%2C%20Mirgh%20D%2C%20Nam%20J%2C%20Seeley%20EH%2C%20Verrill%20DE%2C%20Abdelmoula%20WM%2C%20Regan%20MS%2C%20Theocharidis%20G%2C%20Wu%20CL%2C%20Veves%20A%2C%20Agar%20NYR%2C%20Sluder%20AE%2C%20Poznansky%20MC%2C%20S%26%23xEE%3Brbulescu%20RF%2C%20Reeves%20PM.%20MIAAIM%3A%20Multi-omics%20image%20integration%20with%20dimensional%20reduction%20for%20tissue%20state%20mapping.%20PLoS%20Comput%20Biol.%202026%20May%3B22%285%29%3Ae1014274.%20PMCID%3A%20PMC13225665%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22MIAAIM%3A%20Multi-omics%20image%20integration%20with%20dimensional%20reduction%20for%20tissue%20state%20mapping%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20M.%22%2C%22lastName%22%3A%22Hess%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20K.%22%2C%22lastName%22%3A%22Dzeng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iulian%22%2C%22lastName%22%3A%22Ilie%5Cu015f%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Schapiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20J.%22%2C%22lastName%22%3A%22Iskra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Divya%22%2C%22lastName%22%3A%22Mirgh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Nam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%20H.%22%2C%22lastName%22%3A%22Seeley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Verrill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Walid%20M.%22%2C%22lastName%22%3A%22Abdelmoula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Regan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgios%22%2C%22lastName%22%3A%22Theocharidis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chin%20Lee%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aristidis%22%2C%22lastName%22%3A%22Veves%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Y.%20R.%22%2C%22lastName%22%3A%22Agar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ann%20E.%22%2C%22lastName%22%3A%22Sluder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20C.%22%2C%22lastName%22%3A%22Poznansky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruxandra%20F.%22%2C%22lastName%22%3A%22S%5Cu00eerbulescu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20M.%22%2C%22lastName%22%3A%22Reeves%22%7D%5D%2C%22abstractNote%22%3A%22High-parameter%20tissue%20imaging%20enables%20detailed%20molecular%20analysis%20of%20single%20cells%20within%20their%20spatial%20environment.%20A%20current%20challenge%20to%20more%20complete%20tissue%20and%20single-cell%20spatial%20profiling%20is%20in%20situ%20data%20alignment%20across%20imaging%20platforms%20that%20quantify%20multiple%20types%20of%20biomolecules%20at%20differing%20resolutions.%20Here%2C%20we%20describe%20MIAAIM%20%28Multi-omics%20Image%20Alignment%20and%20Analysis%20by%20Information%20Manifolds%29%2C%20a%20modular%20framework%20to%20align%20and%20process%20data%20from%20separate%20imaging%20technologies%20with%20distinct%20imaging%20resolutions%20and%20data%20complexity.%20MIAAIM%20is%20designed%20to%20be%20applied%20to%20align%20and%20analyze%20images%20of%20clinical%20biopsies%20from%20histological%20staining%2C%20imaging%20mass%20cytometry%2C%20and%20mass%20spectrometry%20imaging.%20A%20key%20advantage%20of%20the%20MIAAIM%20approach%20is%20its%20capacity%20to%20identify%20unbiased%20molecular%20phenotypes%20that%20correlate%20with%20cell%20identities%20and%20states%20determined%20using%20high-resolution%20targeted%20immunodetection.%20In%20a%20large%20diabetic%20foot%20ulcer%20%28DFU%29%20biopsy%2C%20this%20strategy%20allowed%20the%20identification%20of%20unique%20molecular%20characteristics%20of%20infiltrating%20immune%20cells%20as%20a%20function%20of%20local%20tissue%20health.%20In%20multi-core%20tissue%20microarrays%20%28TMAs%29%20of%20prostate%20cancer%2C%20MIAAIM%20allowed%20the%20classification%20of%20adjacent%20tumor%20grades%20with%20high%20accuracy%2C%20with%20over%2090%25%20of%20classification%20signal%20sourced%20from%20spatial%20features%2C%20generated%20from%20segmented%20cells%20across%20multiple%20imaging%20modalities%20while%20revealing%20novel%20cell%5C%2F%20immune%20signatures%20of%20the%20disease%20state.%20MIAAIM%20provides%20a%20disease%20and%20cell%20type%20agnostic%20general%20framework%20to%20construct%20multimodal%20tissue%20imaging%20datasets%2C%20yielding%20novel%20insights%20into%20the%20association%20of%20molecular%20analytes%20with%20cell%20subsets%20and%20their%20activation%20states%20for%20the%20analysis%20of%20complex%20tissue%20states.%22%2C%22date%22%3A%222026-05%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1014274%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2242189900%22%2C%22PMCID%22%3A%22PMC13225665%22%2C%22ISSN%22%3A%221553-7358%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T14%3A50%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22FK2UWPEL%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cassandras%20et%20al.%22%2C%22parsedDate%22%3A%222026-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECassandras%20M%2C%20Sanchez%20X%2C%20Hsu%20L%2C%20Huang%20Y%2C%20Getzler%20AJ%2C%20Ganguly%20D%2C%20Baldominos%20P%2C%20Codinachs%20I%2C%20Chuong%20J%2C%20Martin%20EE%2C%20Smith%20BE%2C%20Marina%20E%2C%20Spasic%20M%2C%20Qin%20X%2C%20Parsons%20HA%2C%20Mayer%20EL%2C%20Sarosiek%20KA%2C%20Dougan%20SK%2C%20Mittendorf%20EA%2C%20McAllister%20SS%2C%20Hsu%20YC%2C%20Agudo%20J.%20A%20glucocorticoid-FAS%20axis%20controls%20immune%20evasion%20during%20metastatic%20seeding.%20Nature.%202026%20May%3B653%288114%29%3A567%26%23x2013%3B575.%20PMID%3A%2041781620%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20glucocorticoid-FAS%20axis%20controls%20immune%20evasion%20during%20metastatic%20seeding%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monica%22%2C%22lastName%22%3A%22Cassandras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavier%22%2C%22lastName%22%3A%22Sanchez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20J.%22%2C%22lastName%22%3A%22Getzler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Debolina%22%2C%22lastName%22%3A%22Ganguly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pilar%22%2C%22lastName%22%3A%22Baldominos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ia%22%2C%22lastName%22%3A%22Codinachs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%22%2C%22lastName%22%3A%22Chuong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20E.%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Blake%20E.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleonora%22%2C%22lastName%22%3A%22Marina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milos%22%2C%22lastName%22%3A%22Spasic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xingping%22%2C%22lastName%22%3A%22Qin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heather%20A.%22%2C%22lastName%22%3A%22Parsons%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erica%20L.%22%2C%22lastName%22%3A%22Mayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%20A.%22%2C%22lastName%22%3A%22Sarosiek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20K.%22%2C%22lastName%22%3A%22Dougan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20A.%22%2C%22lastName%22%3A%22Mittendorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandra%20S.%22%2C%22lastName%22%3A%22McAllister%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ya-Chieh%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Agudo%22%7D%5D%2C%22abstractNote%22%3A%22Metastasis%20is%20the%20major%20cause%20of%20death%20for%20patients%20with%20triple-negative%20breast%20cancer%20and%20other%20solid%20malignancies.%20Metastases%20arise%20from%20cancer%20cells%20that%20disseminate%20from%20the%20original%20tumour%2C%20survive%20systemic%20immune%20surveillance%20and%20colonize%20new%20organs1.%20Little%20is%20known%20about%20how%20initial%20disseminated%20tumour%20cells%20%28DTCs%29%20overcome%20anti-tumour%20immunity%20after%20seeding%20a%20new%20organ.%20Here%20we%20use%20a%20visible%20antigen%20in%20a%20model%20of%20triple-negative%20breast%20cancer%20with%20cognate%20CD8%2B%20T%20cells%20to%20study%20the%20mechanisms%20of%20immune%20evasion%20in%20early%20metastatic%20seeding.%20Analysis%20of%20surviving%20DTCs%20revealed%20glucocorticoid%20receptor%20%28GR%29%20activation%20as%20a%20key%20driver%20of%20resistance%20to%20both%20CD8%2B%20T%20cells%20and%20natural%20killer%20cells.%20Niche%20profiling%20using%20an%20optimized%20labelling%20tool%20identified%20FAS-FASL%20as%20a%20key%20pan-cytotoxic%20pathway%20against%20DTCs%2C%20which%20is%20repressed%20by%20GR%20activation.%20Pharmacological%20inhibition%20of%20GR%20in%20combination%20with%20immunotherapy%20reduced%20metastatic%20burden%20and%20expanded%20lifespan%20in%20mice.%20Thus%2C%20we%20identified%20a%20mechanism%20of%20immune%20evasion%20that%20operates%20specifically%20in%20DTCs%2C%20illustrating%20the%20unique%20immune-cancer%20interactions%20at%20this%20stage%20in%20the%20metastatic%20cascade.%20Our%20findings%20suggest%20that%20there%20are%20therapeutic%20opportunities%20to%20eliminate%20DTCs%2C%20separately%20from%20treatments%20aimed%20at%20primary%20tumours%2C%20and%20GR%20inhibition%20is%20one%20promising%20target.%22%2C%22date%22%3A%222026-05%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41586-026-10222-2%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241781620%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221476-4687%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-06-09T18%3A09%3A25Z%22%7D%7D%2C%7B%22key%22%3A%2298FJFGIU%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Gagn%5Cu00e9%20and%20Lin%22%2C%22parsedDate%22%3A%222026-04-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGagn%26%23xE9%3B%20A%2C%20Lin%20JR.%20Moving%20Beyond%20Morphology%20to%20Multiplexed%20Molecular%20Imaging%20as%20the%20Next%20Frontier%20in%20Diagnostic%20Pathology.%20Am%20J%20Pathol.%202026%20Apr%2030%3BS0002-9440%2826%2900123%26%23x2013%3B9.%20PMID%3A%2042069143%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Moving%20Beyond%20Morphology%20to%20Multiplexed%20Molecular%20Imaging%20as%20the%20Next%20Frontier%20in%20Diagnostic%20Pathology%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9anne%22%2C%22lastName%22%3A%22Gagn%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%5D%2C%22abstractNote%22%3A%22Diagnostic%20pathology%20has%20long%20relied%20on%20the%20morphological%20interpretation%20of%20hematoxylin%20and%20eosin%20%28H%26E%29-stained%20tissues%20to%20guide%20diagnosis%20and%20assess%20prognostic%20features.%20While%20pathologists%20intuitively%20recognize%20spatial%20patterns%20and%20architectural%20organization%2C%20these%20assessments%20remain%20largely%20qualitative%20and%20difficult%20to%20quantify%20systematically.%20Immunohistochemistry%20and%20immunofluorescence%20have%20introduced%20molecular%20specificity%20but%20are%20limited%20in%20multiplexing%20capacity%2C%20whereas%20bulk%20genomic%20and%20transcriptomic%20assays%20provide%20high%20molecular%20depth%20but%20lose%20spatial%20context%20by%20averaging%20signals%20across%20heterogeneous%20cell%20populations.%20Recent%20advances%20in%20spatial%20proteomics-including%20mass%20spectrometry-based%20imaging%20and%20cyclic%20immunofluorescence-now%20enable%20multiplexed%2C%20single-cell%20protein%20analysis%20within%20intact%20tissue%20architecture.%20These%20technologies%20have%20revealed%20complex%20immune%20and%20stromal%20microenvironments%2C%20spatially%20organized%20biomarkers%20predictive%20of%20therapeutic%20response%2C%20and%20molecular%20gradients%20underlying%20disease%20progression.%20By%20integrating%20histological%20and%20molecular%20information%2C%20spatial%20proteomics%20bridges%20traditional%20microscopy%20with%20high-dimensional%20omics%2C%20allowing%20quantitative%2C%20spatially%20resolved%20insights%20into%20tissue%20organization%20and%20disease%20mechanisms.%20This%20review%20summarizes%20recent%20developments%20in%20multiplexed%20spatial%20proteomics%20from%20both%20scientific%20and%20pathological%20perspectives%2C%20highlighting%20how%20these%20technologies%20extend%20beyond%20morphology%20to%20quantify%20histologic%20patterns%2C%20refine%20biomarker%20discovery%2C%20and%20facilitate%20clinical%20translation.%20The%20review%20also%20examines%20translational%20challenges%20and%20barriers%20to%20clinical%20implementation%2C%20including%20costs%2C%20standardization%20requirements%2C%20and%20workflow%20integration.%22%2C%22date%22%3A%222026-04-30%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ajpath.2026.03.015%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2242069143%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221525-2191%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T15%3A07%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22C4G2ZQC7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tan%20et%20al.%22%2C%22parsedDate%22%3A%222026-04-24%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETan%20SZK%2C%20Puig-Barbe%20A%2C%20Goutte-Gattat%20D%2C%20Eastwood%20C%2C%20Aevermann%20B%2C%20Avola%20A%2C%20Balhoff%20JP%2C%20Bayindir%20IU%2C%20Belfiore%20J%2C%20Caron%20AR%2C%20Fischer%20DS%2C%20George%20N%2C%20Gyori%20BM%2C%20Haendel%20MA%2C%20Hoyt%20CT%2C%20Kir%20H%2C%20Lubiana%20T%2C%20Matentzoglu%20N%2C%20Overton%20JA%2C%20Peng%20B%2C%20Peters%20B%2C%20Quardokus%20EM%2C%20Ray%20PL%2C%20Roncaglia%20P%2C%20Rivera%20AD%2C%20Stefancsik%20R%2C%20Teh%20WK%2C%20Toro%20S%2C%20Vasilevsky%20N%2C%20Xu%20C%2C%20Zhang%20Y%2C%20Scheuermann%20RH%2C%20Mungall%20CJ%2C%20Diehl%20AD%2C%20Osumi-Sutherland%20D.%20The%20Cell%20Ontology%20in%20the%20age%20of%20single-cell%20omics.%20Sci%20Data.%202026%20Apr%2024%3B13%281%29%3A946.%20PMCID%3A%20PMC13315338%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20Cell%20Ontology%20in%20the%20age%20of%20single-cell%20omics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shawn%20Zheng%20Kai%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aleix%22%2C%22lastName%22%3A%22Puig-Barbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%22%2C%22lastName%22%3A%22Goutte-Gattat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Eastwood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%22%2C%22lastName%22%3A%22Aevermann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alida%22%2C%22lastName%22%3A%22Avola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20P.%22%2C%22lastName%22%3A%22Balhoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ismail%20Ugur%22%2C%22lastName%22%3A%22Bayindir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jasmine%22%2C%22lastName%22%3A%22Belfiore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%20Reane%22%2C%22lastName%22%3A%22Caron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20S.%22%2C%22lastName%22%3A%22Fischer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20A.%22%2C%22lastName%22%3A%22Haendel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Tapley%22%2C%22lastName%22%3A%22Hoyt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huseyin%22%2C%22lastName%22%3A%22Kir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiago%22%2C%22lastName%22%3A%22Lubiana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Matentzoglu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20A.%22%2C%22lastName%22%3A%22Overton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beverly%22%2C%22lastName%22%3A%22Peng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bjoern%22%2C%22lastName%22%3A%22Peters%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%20M.%22%2C%22lastName%22%3A%22Quardokus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20L.%22%2C%22lastName%22%3A%22Ray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paola%22%2C%22lastName%22%3A%22Roncaglia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%20D.%22%2C%22lastName%22%3A%22Rivera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ray%22%2C%22lastName%22%3A%22Stefancsik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%20Kheng%22%2C%22lastName%22%3A%22Teh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%22%2C%22lastName%22%3A%22Toro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Vasilevsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chuan%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yun%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20H.%22%2C%22lastName%22%3A%22Scheuermann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J.%22%2C%22lastName%22%3A%22Mungall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20D.%22%2C%22lastName%22%3A%22Diehl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Osumi-Sutherland%22%7D%5D%2C%22abstractNote%22%3A%22Single-cell%20omics%20technologies%20have%20transformed%20our%20understanding%20of%20cellular%20diversity%20by%20enabling%20high-resolution%20profiling%20of%20individual%20cells.%20However%2C%20the%20unprecedented%20scale%20and%20heterogeneity%20of%20these%20datasets%20demand%20robust%20frameworks%20for%20data%20integration%20and%20annotation.%20The%20Cell%20Ontology%20%28CL%29%20has%20emerged%20as%20a%20pivotal%20resource%20for%20achieving%20FAIR%20%28Findable%2C%20Accessible%2C%20Interoperable%2C%20and%20Reusable%29%20data%20principles%20by%20providing%20standardized%2C%20species-agnostic%20terms%20for%20canonical%20cell%20types%2C%20forming%20a%20core%20component%20of%20a%20wide%20range%20of%20platforms%20and%20tools.%20In%20this%20paper%2C%20we%20describe%20the%20wide%20variety%20of%20uses%20of%20CL%20in%20these%20platforms%20and%20tools%20and%20detail%20ongoing%20work%20to%20improve%20and%20extend%20CL%20content%20including%20the%20addition%20of%20transcriptomic%20types%2C%20working%20closely%20with%20major%20atlasing%20efforts%20including%20the%20Human%20Cell%20Atlas%20and%20the%20Brain%20Initiative%20Cell%20Atlas%20Network%20to%20support%20their%20needs.%20We%20cover%20the%20challenges%20and%20future%20plans%20for%20harmonising%20classical%20and%20transcriptomic%20cell%20type%20definitions%2C%20integrating%20markers%20and%20using%20Large%20Language%20Models%20%28LLMs%29%20to%20improve%20content%20and%20efficiency%20of%20CL%20workflows.%22%2C%22date%22%3A%222026-04-24%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41597-026-07173-8%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2242031777%22%2C%22PMCID%22%3A%22PMC13315338%22%2C%22ISSN%22%3A%222052-4463%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T03%3A31%3A58Z%22%7D%7D%2C%7B%22key%22%3A%2229G23PV3%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mills%20et%20al.%22%2C%22parsedDate%22%3A%222026-03-19%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMills%20CE%2C%20Hug%20C%2C%20Sajeevan%20KA%2C%20Clark%20N%2C%20Victor%20C%2C%20Chung%20M%2C%20Rawat%20S%2C%20D%26%23x2019%3BErasmo%20H%2C%20Moraes%20MP%2C%20Aldridge%20B%2C%20Albers%20MW%2C%20Chowdhury%20R%2C%20Gyori%20BM%2C%20Sorger%20PK.%20Polypharmacology%20is%20an%20enduring%20and%20nearly%20universal%20property%20of%20kinase%20inhibitors%20%5BInternet%5D.%20bioRxiv%3B%202026%20%5Bcited%202026%20July%2017%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.03.17.711623%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.03.17.711623%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Polypharmacology%20is%20an%20enduring%20and%20nearly%20universal%20property%20of%20kinase%20inhibitors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karuna%20Anna%22%2C%22lastName%22%3A%22Sajeevan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Victor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirra%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sameer%22%2C%22lastName%22%3A%22Rawat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hope%22%2C%22lastName%22%3A%22D%5Cu2019Erasmo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%20Pereira%22%2C%22lastName%22%3A%22Moraes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bree%22%2C%22lastName%22%3A%22Aldridge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ratul%22%2C%22lastName%22%3A%22Chowdhury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gyori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%5Cn%20%20%20%20%20%20%20%20%20%20Despite%20decades%20of%20research%2C%20current%20understanding%20of%20the%20spectrum%20of%20targets%20bound%20by%20kinase%20inhibitors%20remains%20incomplete.%20This%20complicates%20mechanism%20of%20action%20studies%2C%20drug%20repurposing%2C%20and%20development%20of%20new%20therapies.%20Here%2C%20we%20describe%20kinome-wide%20profiling%20of%20an%20optimal%20kinase%20library%20%28OKL%29%20comprising%20192%20small%20molecules%20selected%20based%20on%20stage%20of%20clinical%20development%2C%20chemical%20diversity%2C%20and%20target%20coverage.%20Our%20results%20show%20that%20polypharmacology%20is%20widespread%20and%20independent%20of%20regulatory%20approval.%20The%20generally%20understood%20%28%5Cu201cassigned%5Cu201d%29%20targets%20of%20approved%20molecules%20are%20not%20necessarily%20the%20most%20potently%20inhibited%20and%20off-targets%20include%20multiple%20understudied%20kinases.%20Moreover%2C%20median%20selectivity%20has%20not%20increased%20over%20time%20We%20illustrate%20how%20an%20OKL%20in%20combination%20with%20detailed%20kinome%20profiling%20can%20be%20used%20to%20identify%20potential%20toxicity%20targets%2C%20repurpose%20anti-inflammatory%20drugs%20for%20neurodegenerative%20and%20infectious%20diseases%2C%20and%20perform%20chemical%20genetic%20studies.%20Our%20studies%20also%20highlight%20how%20much%20remains%20to%20be%20discovered%20about%20the%20chemistry%20and%20biology%20of%20one%20of%20the%20largest%20classes%20of%20human%20therapeutics.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222026-03-19%22%2C%22DOI%22%3A%2210.64898%5C%2F2026.03.17.711623%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.03.17.711623%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T13%3A46%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22TT63YRYE%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A6889081%2C%22username%22%3A%22arenasg%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Farenasg%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22K%5Cu00f6nig%20et%20al.%22%2C%22parsedDate%22%3A%222026-03-14%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EK%26%23xF6%3Bnig%20LE%2C%20Rodriguez%20S%2C%20Hug%20C%2C%20Daneshvari%20S%2C%20Chung%20A%2C%20Appleman%20M%2C%20Tsai%20M%2C%20Bradshaw%20GA%2C%20Sahin%20A%2C%20Song%20Y%2C%20Zhou%20G%2C%20Eisert%20RJ%2C%20Piccioni%20F%2C%20Marques%20C%2C%20Powley%20S%2C%20Yarmolinsky%20J%2C%20Wainger%20BJ%2C%20Das%20S%2C%20Kalocsay%20M%2C%20Dehghan%20A%2C%20Tzoulaki%20I%2C%20Sokolov%20A%2C%20Sorger%20P%2C%20Root%20DE%2C%20Albers%20MW.%20TYK2%20mediates%20neuroinflammation%20in%20Alzheimer%26%23x2019%3Bs%20disease%20brains%20with%20TDP-43%20pathology.%20Nat%20Commun.%202026%20Mar%2014%3B17%281%29%3A3967.%20PMCID%3A%20PMC13133158%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22TYK2%20mediates%20neuroinflammation%20in%20Alzheimer%27s%20disease%20brains%20with%20TDP-43%20pathology%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20E.%22%2C%22lastName%22%3A%22K%5Cu00f6nig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steve%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clemens%22%2C%22lastName%22%3A%22Hug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shayda%22%2C%22lastName%22%3A%22Daneshvari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Appleman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Max%22%2C%22lastName%22%3A%22Tsai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asli%22%2C%22lastName%22%3A%22Sahin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuyu%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robyn%20J.%22%2C%22lastName%22%3A%22Eisert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Federica%22%2C%22lastName%22%3A%22Piccioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Marques%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sharon%22%2C%22lastName%22%3A%22Powley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Yarmolinsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20J.%22%2C%22lastName%22%3A%22Wainger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sudeshna%22%2C%22lastName%22%3A%22Das%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abbas%22%2C%22lastName%22%3A%22Dehghan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ioanna%22%2C%22lastName%22%3A%22Tzoulaki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Root%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20W.%22%2C%22lastName%22%3A%22Albers%22%7D%5D%2C%22abstractNote%22%3A%22Neuroinflammation%20is%20a%20pathological%20feature%20of%20neurodegenerative%20diseases%20like%20Alzheimer%27s%20disease%20and%20ALS.%20Cytoplasmic%20dsRNA%20%28cdsRNA%29%20triggers%20a%20type-I%20interferon%20response%20in%20human%20neural%20cells%2C%20leading%20to%20their%20death%2C%20and%20is%20found%20in%20neurons%20of%20C9ORF72-ALS%20patients.%20Here%2C%20we%20report%20the%20spatial%20coincidence%20of%20cdsRNA%20and%20pTDP-43%20inclusions%20in%20human%20postmortem%20tissue%20with%20Alzheimer%27s%20disease%20pathology%2C%20and%20upregulated%20interferon%20response%20genes%20in%20affected%20regions.%20CdsRNA%20also%20accumulates%20in%20a%20human%20TDP-43%20G298S%20iPSC%20cortical%20neuronal%20model.%20We%20use%20cryptic%20exon%20detection%20as%20a%20proxy%20for%20TDP-43%20mislocalization%20and%20demonstrate%20that%20FDA-approved%20JAK%20inhibitors%20baricitinib%20and%20ruxolitinib%2C%20which%20block%20interferon%20signaling%2C%20show%20protective%20effects%20only%20in%20brains%20with%20elevated%20cryptic%20exon%20expression.%20A%20CRISPR%20screen%20reveals%20TYK2%20as%20a%20top%20hit%2C%20and%20TYK2%20knockdown%20and%20the%20selective%20TYK2%20inhibitor%20deucravacitinib%20rescue%20cdsRNA-induced%20toxicity.%20We%20find%20parallel%20neuroinflammatory%20mechanisms%2C%20dependent%20on%20TYK2%20-%20a%20potential%20disease-modifying%20target%20-%20for%20TDP-43-associated%20Alzheimer%27s%20disease%20and%20C9ORF72-ALS.%22%2C%22date%22%3A%222026-03-14%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-026-70243-3%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241832177%22%2C%22PMCID%22%3A%22PMC13133158%22%2C%22ISSN%22%3A%222041-1723%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-05-28T20%3A24%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22ABQ6B4VZ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Perez-Villatoro%20et%20al.%22%2C%22parsedDate%22%3A%222026-02-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPerez-Villatoro%20F%2C%20Shabanova%20A%2C%20van%20Wagensveld%20L%2C%20Junquera%20A%2C%20Niemiec%20I%2C%20Hincapi%26%23xE9%3B-Otero%20MM%2C%20Kang%20Z%2C%20Falco%20MM%2C%20Birgin%20K%2C%20Wolf%20S%2C%20Anttila%20E%2C%20Anandagoda%20G%2C%20Casado%20J%2C%20Marcus%20E%2C%20Gaillard%20D%2C%20Kahelin%20E%2C%20Chamchougia%20F%2C%20Salko%20M%2C%20Shah%20S%2C%20Russo%20S%2C%20Chiaro%20J%2C%20Gr%26%23xF6%3Bnholm%20M%2C%20Ndika%20J%2C%20Kari%20OK%2C%20iCAN%20%20iCAN%2C%20Sonke%20GS%2C%20Van%20de%20Vijver%20KK%2C%20Fpm%20Kruitwagen%20R%2C%20van%20der%20Aa%20M%2C%20Virtanen%20A%2C%20Cerullo%20V%2C%20V%26%23xE4%3Bh%26%23xE4%3Brautio%20A%2C%20Sorger%20PK%2C%20Horlings%20HM%2C%20Farkkila%20A.%20Single-cell%20spatial%20atlas%20of%20high-grade%20serous%20ovarian%20cancer%20uncovers%20MHC%20class%20II%20as%20a%20key%20predictor%20of%20spatial%20tumor%20ecosystems%20and%20clinical%20outcomes.%20Cancer%20Discov.%202026%20Feb%209%3B%20PMID%3A%2041661089%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Single-cell%20spatial%20atlas%20of%20high-grade%20serous%20ovarian%20cancer%20uncovers%20MHC%20class%20II%20as%20a%20key%20predictor%20of%20spatial%20tumor%20ecosystems%20and%20clinical%20outcomes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Perez-Villatoro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aleksandra%22%2C%22lastName%22%3A%22Shabanova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lilian%22%2C%22lastName%22%3A%22van%20Wagensveld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ada%22%2C%22lastName%22%3A%22Junquera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Iga%22%2C%22lastName%22%3A%22Niemiec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mar%5Cu00eda%20M.%22%2C%22lastName%22%3A%22Hincapi%5Cu00e9-Otero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ziqi%22%2C%22lastName%22%3A%22Kang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matias%20M.%22%2C%22lastName%22%3A%22Falco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K%5Cu00fcr%5Cu015fat%22%2C%22lastName%22%3A%22Birgin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Wolf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ella%22%2C%22lastName%22%3A%22Anttila%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gayani%22%2C%22lastName%22%3A%22Anandagoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julia%22%2C%22lastName%22%3A%22Casado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Marcus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Duco%22%2C%22lastName%22%3A%22Gaillard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Essi%22%2C%22lastName%22%3A%22Kahelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Foteini%22%2C%22lastName%22%3A%22Chamchougia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matilda%22%2C%22lastName%22%3A%22Salko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saundarya%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Russo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacopo%22%2C%22lastName%22%3A%22Chiaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mikaela%22%2C%22lastName%22%3A%22Gr%5Cu00f6nholm%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Ndika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Otto%20K.%22%2C%22lastName%22%3A%22Kari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22iCAN%22%2C%22lastName%22%3A%22iCAN%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabe%20S.%22%2C%22lastName%22%3A%22Sonke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koen%20K.%22%2C%22lastName%22%3A%22Van%20de%20Vijver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rutgerus%22%2C%22lastName%22%3A%22Fpm%20Kruitwagen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maaike%22%2C%22lastName%22%3A%22van%20der%20Aa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anni%22%2C%22lastName%22%3A%22Virtanen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincenzo%22%2C%22lastName%22%3A%22Cerullo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22V%5Cu00e4h%5Cu00e4rautio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugo%20M.%22%2C%22lastName%22%3A%22Horlings%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anniina%22%2C%22lastName%22%3A%22Farkkila%22%7D%5D%2C%22abstractNote%22%3A%22The%20tumor%20microenvironment%20in%20high-grade%20serous%20ovarian%20carcinoma%20%28HGSC%29%20is%20a%20complex%20network%20of%20malignant-host%20cell%20interactions%2C%20yet%20its%20orchestration%20remains%20poorly%20understood.%20We%20present%20a%20single-cell%20spatial%20atlas%20of%20metastatic%20HGSC%20from%20280%20patients%2C%20integrating%20high-dimensional%20imaging%20and%20molecular%20profiling.%20Analyzing%20929%20single-cell%20maps%2C%20we%20identify%20spatial%20domains%20with%20diverse%20cell%20compositions%20and%20show%20that%20immune%20cell%20co-infiltration%20at%20the%20tumor-stroma%20interface%20impacts%20clinical%20outcomes.%20Using%20CEFIIRA%2C%20we%20find%20that%20tumor%20cell%20MHCII%20expression%20is%20a%20key%20predictor%20of%20prolonged%20survival.%20Validation%20with%20deconvoluted%2C%20single-cell%2C%20and%20two%20distinct%20spatial%20transcriptomic%20datasets%2C%20along%20with%20immunopeptidomic%20analysis%2C%20confirms%20that%20MHCII%20expression%20correlates%20with%20immune%20activation%2C%20antigen%20presentation%2C%20and%20TCR%20clonality.%20Using%20a%20patient-derived%20immuno-oncology%20platform%2C%20we%20demonstrate%20that%20tumor%20MHCII%20expression%20associates%20with%20increased%20CD8%2B%20T%20cell%20cytotoxicity%20after%20PD-1%20blockade%2C%20while%20blocking%20MHCII%20inhibits%20this%20activation.%20Our%20atlas%20offers%20new%20insights%20into%20immune%20activation%2C%20potentially%20improving%20patient%20stratification%20in%20HGSC.%22%2C%22date%22%3A%222026-02-09%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1158%5C%2F2159-8290.CD-25-1492%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241661089%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222159-8290%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-19T16%3A36%3A13Z%22%7D%7D%2C%7B%22key%22%3A%223YQALIJC%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zimmerman%20et%20al.%22%2C%22parsedDate%22%3A%222026-02-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZimmerman%20MP%2C%20Huang%20AY%2C%20Cox%20EK%2C%20Al%20Abosy%20R%2C%20Chong%20WL%2C%20Bastian%20AG%2C%20Vietor%20K%2C%20Choutri%20Y%2C%20Collier%20J%2C%20Zhabotynsky%20V%2C%20Wang%20H%2C%20Fung%20M%2C%20Weiss%20SA%2C%20Robitschek%20EJ%2C%20Lin%20JR%2C%20Vallius%20T%2C%20Pant%20SM%2C%20Sorger%20PK%2C%20Hugo%20W%2C%20Sen%20DR%2C%20Haining%20WN%2C%20Sharpe%20AH%2C%20Miller%20BC.%20Harnessing%20Inflammatory%20Monocytes%20to%20Overcome%20Resistance%20to%20Anti-PD-1%20Immunotherapy%20%5BInternet%5D.%20Immunology%3B%202026%20%5Bcited%202026%20July%2017%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.02.05.704029%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.02.05.704029%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Harnessing%20Inflammatory%20Monocytes%20to%20Overcome%20Resistance%20to%20Anti-PD-1%20Immunotherapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20P%22%2C%22lastName%22%3A%22Zimmerman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%20Y%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20K%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rose%22%2C%22lastName%22%3A%22Al%20Abosy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wan%20Lin%22%2C%22lastName%22%3A%22Chong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20G%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katherine%22%2C%22lastName%22%3A%22Vietor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yacine%22%2C%22lastName%22%3A%22Choutri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jenna%22%2C%22lastName%22%3A%22Collier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vasyl%22%2C%22lastName%22%3A%22Zhabotynsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haiyang%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Fung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20A%22%2C%22lastName%22%3A%22Weiss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%20J%22%2C%22lastName%22%3A%22Robitschek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shishir%20M%22%2C%22lastName%22%3A%22Pant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Willy%22%2C%22lastName%22%3A%22Hugo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Debattama%20R%22%2C%22lastName%22%3A%22Sen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20Nicholas%22%2C%22lastName%22%3A%22Haining%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arlene%20H%22%2C%22lastName%22%3A%22Sharpe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brian%20C%22%2C%22lastName%22%3A%22Miller%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Background%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Resistance%20to%20immune%20checkpoint%20inhibitors%20represents%20a%20major%20therapeutic%20challenge%2C%20as%20less%20than%2050%25%20of%20patients%20with%20melanoma%20achieve%20long-term%20response%20to%20immune%20checkpoint%20inhibitor%20therapy.%20One%20mechanism%20of%20acquired%20resistance%20involves%20somatic%20mutations%2C%20such%20as%20loss%20of%20beta-2%20microglobulin%20%28%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20B2m%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%29%2C%20that%20enable%20tumor%20cells%20to%20evade%20T%20cell-mediated%20killing.%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Methods%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20This%20study%20used%20single-cell%20RNA-seq%2C%20flow%20cytometry%2C%20and%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20ex%20vivo%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20functional%20assays%20to%20characterize%20tumor-infiltrating%20immune%20cells%20in%20antigen%20presentation-deficient%20tumors.%20Tumor-bearing%20mice%20were%20treated%20with%20anti-PD-1%20or%20CD40%20agonist%20antibodies%20and%20cell%20depletion%20or%20cytokine%20blocking%20antibodies%20to%20define%20mechanisms%20of%20action.%20Analysis%20of%20published%20human%20RNA-seq%20datasets%20was%20performed%20to%20dissect%20the%20contributions%20of%20inflammatory%20monocytes%20to%20patient%20outcomes.%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Results%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20We%20found%20an%20increase%20in%20immunosuppressive%20macrophages%20in%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20B2m%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20-null%20tumors.%20We%20hypothesized%20that%20repolarizing%20myeloid%20cells%20may%20restore%20control%20of%20tumor%20growth.%20Treatment%20with%20CD40%20agonist%20antibody%2C%20which%20promotes%20differentiation%20of%20monocytes%20and%20macrophages%20towards%20a%20proinflammatory%20phenotype%2C%20reduced%20tumor%20growth%20and%20improved%20survival%20in%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20B2m%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20-null%20melanoma%20and%20colorectal%20cancer%20models.%20Unexpectedly%2C%20both%20CD8%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2B%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20T%20cells%20and%20NK%20cells%2C%20but%20not%20CD4%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2B%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20T%20cells%2C%20were%20required%20for%20the%20efficacy%20of%20CD40%20agonist%2C%20even%20though%20CD8%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2B%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20T%20cells%20cannot%20directly%20recognize%20antigen%20presentation-deficient%20tumor%20cells.%20Instead%2C%20these%20lymphocytes%20control%20tumor%20growth%20via%20secretion%20of%20IFN%5Cu03b3%2C%20as%20depletion%20of%20IFN%5Cu03b3%20inhibited%20the%20therapeutic%20effect%20of%20CD40%20agonist.%20IFN%5Cu03b3%20receptor%20%28%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Ifngr1%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%29%20expression%20was%20required%20on%20host%20cells%2C%20not%20tumor%20cells%2C%20for%20CD40%20agonist-mediated%20tumor%20control.%20Single-cell%20analysis%20identified%20a%20distinct%20population%20of%20inflammatory%20monocytes%20that%20were%20enriched%20for%20an%20IFN%5Cu03b3%20response%20signature%20in%20CD40%20agonist-treated%20tumors%2C%20suggesting%20that%20these%20cells%20may%20be%20important%20for%20tumor%20control.%20Analysis%20of%20human%20bulk%20and%20single-cell%20RNA-seq%20datasets%20demonstrated%20that%20an%20inflammatory%20monocyte%20signature%20derived%20from%20our%20data%20was%20associated%20with%20improved%20patient%20outcomes%20and%20response%20to%20immune%20checkpoint%20inhibitors.%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20Conclusions%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20These%20data%20demonstrate%20that%20CD8%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2B%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20T%20cells%20contribute%20to%20tumor%20control%20even%20in%20the%20absence%20of%20direct%20antigen%20presentation%20by%20tumor%20cells.%20More%20broadly%2C%20our%20work%20suggests%20that%20strategies%20to%20activate%20the%20effector%20functions%20of%20inflammatory%20monocytes%20may%20limit%20tumor%20growth%20and%20overcome%20acquired%20resistance%20to%20immune%20checkpoint%20inhibitors.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22Immunology%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222026-02-08%22%2C%22DOI%22%3A%2210.64898%5C%2F2026.02.05.704029%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.02.05.704029%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-10-05T17%3A58%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22CFW9E2AG%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brastianos%20et%20al.%22%2C%22parsedDate%22%3A%222026-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBrastianos%20PK%2C%20Dooley%20K%2C%20Geyer%20S%2C%20Gerstner%20ER%2C%20Kaufmann%20TJ%2C%20Iafrate%20AJ%2C%20Martinez-Lage%20M%2C%20Milhem%20M%2C%20Welch%20MR%2C%20Kaley%20TJ%2C%20Drappatz%20J%2C%20Chan%20A%2C%20Kumthekar%20P%2C%20Matsuoka%20CK%2C%20Strowd%20RE%2C%20Cohen%20AL%2C%20Jaeckle%20K%2C%20Robell%20L%2C%20Magge%20RS%2C%20Nam%20JY%2C%20Blondin%20N%2C%20Shaikh%20N%2C%20Rabinowitz%20I%2C%20Thomas%20AA%2C%20Piccioni%20DE%2C%20Brown%20P%2C%20Kaluziak%20S%2C%20Codd%20E%2C%20Cahill%20DP%2C%20Santagata%20S%2C%20Barker%20FG%2C%20Galanis%20E.%20Abemaciclib%20in%20meningiomas%20with%20somatic%20NF2%20or%20CDK%20pathway%20alterations%3A%20the%20phase%202%20Alliance%20A071401%20trial.%20Nat%20Med.%202026%20Feb%3B32%282%29%3A717%26%23x2013%3B724.%20PMCID%3A%20PMC12920099%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Abemaciclib%20in%20meningiomas%20with%20somatic%20NF2%20or%20CDK%20pathway%20alterations%3A%20the%20phase%202%20Alliance%20A071401%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%20K.%22%2C%22lastName%22%3A%22Brastianos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katharine%22%2C%22lastName%22%3A%22Dooley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%22%2C%22lastName%22%3A%22Geyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20R.%22%2C%22lastName%22%3A%22Gerstner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20J.%22%2C%22lastName%22%3A%22Kaufmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20John%22%2C%22lastName%22%3A%22Iafrate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Martinez-Lage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22Milhem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20Roberta%22%2C%22lastName%22%3A%22Welch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20J.%22%2C%22lastName%22%3A%22Kaley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Drappatz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priya%22%2C%22lastName%22%3A%22Kumthekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%20Kamiya%22%2C%22lastName%22%3A%22Matsuoka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roy%20E.%22%2C%22lastName%22%3A%22Strowd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20L.%22%2C%22lastName%22%3A%22Cohen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kurt%22%2C%22lastName%22%3A%22Jaeckle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lindsay%22%2C%22lastName%22%3A%22Robell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajiv%20S.%22%2C%22lastName%22%3A%22Magge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joo%20Yeon%22%2C%22lastName%22%3A%22Nam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%22%2C%22lastName%22%3A%22Blondin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nawal%22%2C%22lastName%22%3A%22Shaikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%22%2C%22lastName%22%3A%22Rabinowitz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alissa%20A.%22%2C%22lastName%22%3A%22Thomas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Piccioni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Kaluziak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Codd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20P.%22%2C%22lastName%22%3A%22Cahill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederick%20G.%22%2C%22lastName%22%3A%22Barker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evanthia%22%2C%22lastName%22%3A%22Galanis%22%7D%5D%2C%22abstractNote%22%3A%22Systemic%20treatments%20are%20limited%20for%20patients%20with%20meningiomas%20that%20have%20progressed%20after%20surgery%20or%20radiation.%20Loss%20of%20NF2%20and%20CDKN2A%5C%2FCDKN2B%20is%20common%20in%20higher-grade%20meningiomas%20and%20promotes%20progression%20in%20preclinical%20models.%20We%20evaluated%20the%20efficacy%20of%20abemaciclib%2C%20a%20cyclin-dependent%20kinase%204%5C%2F6%20inhibitor%2C%20as%20one%20arm%20of%20the%20Alliance%20umbrella%20trial%20A071401%2C%20a%20genomically%20driven%20phase%202%20study%20in%20recurrent%20and%20progressive%20meningiomas.%20Eligible%20patients%20with%20grade%202%20or%203%20tumors%20and%20NF2%20mutations%20or%20CDK%20pathway%20alterations%20were%20treated%20with%20abemaciclib.%20Two%20co-primary%20endpoints%20were%20used%3A%20progression-free%20survival%20at%206%20months%20%28PFS6%29%20and%20response%20rate%20as%20defined%20by%20local%20review%3B%20the%20trial%20would%20be%20declared%20positive%20if%20either%20endpoint%20was%20met.%20The%20success%20threshold%20for%20PFS6%20was%208%20or%20more%20of%2024%20patients%3B%20for%20the%20response%20rate%2C%20it%20was%203%20or%20more%20of%2024%20patients.%20Ninety-six%20patients%20were%20screened%20and%2036%20patients%20received%20treatment.%20The%20mean%20number%20of%20treatment%20cycles%20was%20nine%20and%20the%20median%20follow-up%20was%2021%20months.%20The%20first%2024%20patients%20who%20met%20the%20eligibility%20criteria%20and%20began%20treatment%20could%20be%20evaluated%20for%20the%20primary%20endpoint.%20The%20observed%20PFS6%20rate%20was%2058%25%20%2814%20of%2024%20patients%2C%2095%25%20confidence%20interval%5Cu2009%3D%5Cu200937-78%25%29%2C%20thus%20meeting%20the%20PFS6%20criteria%20for%20promising%20activity.%20The%20best%20response%20was%20stable%20disease%20in%2016%20of%2024%20patients.%20Of%20the%2036%20patients%20who%20started%20treatment%2C%20nine%20had%20a%20grade%203%20and%20two%20had%20grade%204%20adverse%20events%20at%20least%20possibly%20related%20to%20treatment.%20Grade%204%20toxicities%20included%20alanine%20aminotransferase%20elevation%20%281%29%2C%20aspartate%20aminotransferase%20elevation%20%281%29%20and%20vomiting%20%281%29.%20The%20trial%20met%20its%20primary%20endpoint.%20Abemaciclib%20was%20well%20tolerated%20and%20resulted%20in%20improved%20PFS6.%20Abemaciclib%20warrants%20further%20investigation%20for%20patients%20with%20progressive%20grade%202%20or%203%20meningiomas%20harboring%20NF2%20or%20CDK%20pathway%20alterations.%20ClinicalTrials.gov%20registration%20no.%20NCT02523014%20.%22%2C%22date%22%3A%222026-02%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41591-025-04141-4%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241545592%22%2C%22PMCID%22%3A%22PMC12920099%22%2C%22ISSN%22%3A%221546-170X%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T03%3A29%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22ISVFKCBJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pimenta%20et%20al.%22%2C%22parsedDate%22%3A%222026-01-21%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPimenta%20EM%2C%20Garza%20AE%2C%20Camp%20SY%2C%20Park%20J%2C%20Hoffman%20SE%2C%20Valderr%26%23xE1%3Bbano%20L%2C%20Fu%20J%2C%20Bi%20K%2C%20Carson%20MT%2C%20Karam%20J%2C%20Titchen%20BM%2C%20Medjahed%20S%2C%20Khandekar%20MJ%2C%20Shannon%20E%2C%20Kang%20YJ%2C%20Coy%20S%2C%20Lin%20JR%2C%20Nag%20A%2C%20Thorner%20AR%2C%20Gibson%20WJ%2C%20Santagata%20S%2C%20Raut%20CP%2C%20Hornick%20JL%2C%20Merriam%20P%2C%20Solimini%20NL%2C%20George%20S%2C%20Demetri%20GD%2C%20Van%20Allen%20EM.%20Epigenetic%20dysregulation%20of%20metabolic%20programs%20mediates%20liposarcoma%20cell%20plasticity.%20Sci%20Transl%20Med.%202026%20Jan%2021%3B18%28833%29%3Aeadw4689.%20PMCID%3A%20PMC13062979%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Epigenetic%20dysregulation%20of%20metabolic%20programs%20mediates%20liposarcoma%20cell%20plasticity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erica%20M.%22%2C%22lastName%22%3A%22Pimenta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%20E.%22%2C%22lastName%22%3A%22Garza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%20Y.%22%2C%22lastName%22%3A%22Camp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jihye%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samantha%20E.%22%2C%22lastName%22%3A%22Hoffman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Valderr%5Cu00e1bano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jingxin%22%2C%22lastName%22%3A%22Fu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Bi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maximilian%20T.%22%2C%22lastName%22%3A%22Carson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Karam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Breanna%20M.%22%2C%22lastName%22%3A%22Titchen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sofia%22%2C%22lastName%22%3A%22Medjahed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melin%20J.%22%2C%22lastName%22%3A%22Khandekar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erin%22%2C%22lastName%22%3A%22Shannon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yun%20Jee%22%2C%22lastName%22%3A%22Kang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22Coy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anwesha%22%2C%22lastName%22%3A%22Nag%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20R.%22%2C%22lastName%22%3A%22Thorner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20J.%22%2C%22lastName%22%3A%22Gibson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chandrajit%20P.%22%2C%22lastName%22%3A%22Raut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20L.%22%2C%22lastName%22%3A%22Hornick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%22%2C%22lastName%22%3A%22Merriam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%20L.%22%2C%22lastName%22%3A%22Solimini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%22%2C%22lastName%22%3A%22George%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20D.%22%2C%22lastName%22%3A%22Demetri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliezer%20M.%22%2C%22lastName%22%3A%22Van%20Allen%22%7D%5D%2C%22abstractNote%22%3A%22Sarcomas%20are%20rare%20cancers%20thought%20to%20arise%20from%20aberrant%20mesenchymal%20stem%20cell%20%28MSC%29%20differentiation.%20Liposarcoma%20%28LPS%29%20is%20among%20the%20most%20commonly%20diagnosed%20sarcomas%20and%20provides%20insights%20into%20dysfunctional%20differentiation%20through%20its%20well-%20and%20dedifferentiated%20subtypes%20%28WDLPS%20and%20DDLPS%29.%20Despite%20differences%20in%20histology%20and%20clinical%20behavior%2C%20the%20molecular%20pathways%20underlying%20each%20subtype%20remain%20poorly%20defined%2C%20leaving%20patients%20with%20DDLPS%20reliant%20on%20empiric%20chemotherapies.%20We%20applied%20single-nucleus%20multiome%20sequencing%20and%20spatial%20profiling%20to%20human%20normal%20adipose%2C%20WDLPS%2C%20and%20DDLPS%20tissues%20and%20identified%20lineage-specific%20blocks%20in%20differentiation%20within%20LPS.%20We%20found%20that%20DDLPS%20is%20characterized%20by%20loss%20of%20insulin-like%20growth%20factor%201%20%28IGF1%29%20signaling%20and%20activation%20of%20early%20mesenchymal%20and%20glucagon-like%20peptide-1%20%28GLP-1%29-associated%20programs.%20IGF1%20signaling%20loss%20was%20restricted%20to%20the%20DDLPS%20component%20within%20mixed%20histology%20tumors%20and%20correlated%20with%20poor%20survival%20in%20patients%20with%20LPS.%20In%20normal%20adipocytes%2C%20IGF1%20drives%20differentiation%20through%20peroxisome%20proliferator-activated%20receptor%20gamma%202%20%28PPARG2%29.%20We%20found%20that%20DDLPS%20cells%20lack%20PPARG2%2C%20causing%20a%20barrier%20to%20differentiation.%20This%20defect%20rendered%20DDLPS%20cells%20unresponsive%20to%20exogenous%20proadipogenic%20signals.%20Restoration%20of%20PPARG2%20expression%20alone%20was%20sufficient%20to%20reenable%20adipogenesis%2C%20pinpointing%20PPARG2%20as%20the%20key%20molecular%20determinant%20of%20lineage%20fate.%20Last%2C%20IGF1%20deficiency%20in%20DDLPS%20was%20associated%20with%20up-regulation%20of%20the%20IGF1%20receptor%20%28IGF1R%29%2C%20creating%20a%20selective%20vulnerability%20to%20IGF1R-targeted%20antibody-drug%20conjugates.%20In%20summary%2C%20we%20identified%20lineage-specific%20defects%20in%20DDLPS%2C%20with%20PPARG2%20as%20the%20molecular%20mediator%20of%20differentiation%20state%20in%20LPS.%20More%20broadly%2C%20our%20findings%20demonstrate%20how%20defining%20lineage-specific%20mechanisms%20of%20tumor%20state%20can%20inform%20the%20development%20of%20nonchemotherapeutic%20treatment%20approaches.%22%2C%22date%22%3A%222026-01-21%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1126%5C%2Fscitranslmed.adw4689%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241564157%22%2C%22PMCID%22%3A%22PMC13062979%22%2C%22ISSN%22%3A%221946-6242%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T03%3A03%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22LTW4RKJ7%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Darnell%20et%20al.%22%2C%22parsedDate%22%3A%222026-01-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDarnell%20AM%2C%20Chidley%20C%2C%20Paradise%20V%2C%20Cui%20DS%2C%20Davidsen%20K%2C%20Lincoln%20SC%2C%20Abbott%20KL%2C%20Elbashir%20R%2C%20Vander%20Heiden%20CP%2C%20Sorger%20PK%2C%20Sullivan%20LB%2C%20Davis%20JH%2C%20Vander%20Heiden%20MG.%20Ribosome-associated%20quality%20control%20of%20aberrant%20protein%20production%20during%20amino%20acid%20limitation%20%5BInternet%5D.%20bioRxiv%3B%202026%20%5Bcited%202026%20Jan%2020%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.01.14.699605%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.01.14.699605%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Ribosome-associated%20quality%20control%20of%20aberrant%20protein%20production%20during%20amino%20acid%20limitation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alicia%20M.%22%2C%22lastName%22%3A%22Darnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Chidley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Victoria%22%2C%22lastName%22%3A%22Paradise%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danica%20S.%22%2C%22lastName%22%3A%22Cui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristian%22%2C%22lastName%22%3A%22Davidsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20C.%22%2C%22lastName%22%3A%22Lincoln%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keene%20L.%22%2C%22lastName%22%3A%22Abbott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%22%2C%22lastName%22%3A%22Elbashir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Campbell%20P.%22%2C%22lastName%22%3A%22Vander%20Heiden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucas%20B.%22%2C%22lastName%22%3A%22Sullivan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20H.%22%2C%22lastName%22%3A%22Davis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20G.%22%2C%22lastName%22%3A%22Vander%20Heiden%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%5Cn%20%20%20%20%20%20%20%20%20%20Amino%20acids%20can%20become%20limiting%20for%20protein%20synthesis%20through%20depletion%20of%20charged%20tRNAs%2C%20leading%20to%20ribosome%20stalling%20and%20disruption%20of%20translation%20elongation%20at%20specific%20codons.%20To%20assess%20whether%20this%20is%20a%20mechanism%20by%20which%20amino%20acid%20availability%20can%20directly%20influence%20gene%20expression%2C%20we%20designed%20a%20reporter%20library%20to%20measure%20translation%20disruption%20across%20all%20sense%20codons%20in%20the%20context%20of%20amino%20acid%20limitations.%20We%20found%20that%20arginine%20limitation%20consistently%20impairs%20translation%20at%20the%20arginine%20codon%20AGA%2C%20resulting%20in%20synthesis%20of%20proteins%20from%20endogenous%20transcripts.%20In%20contrast%2C%20GCN2%20pathway%20activation%20suppresses%20translation%20disruption%20following%20depletion%20of%20most%20other%20amino%20acids.%20Genome-wide%20screens%20revealed%20that%20the%20ribosome%20quality%20control%20trigger%20%28RQC-T%29%20and%20RQC%20pathways%2C%20which%20resolve%20ribosome%20collisions%20on%20defective%20mRNAs%2C%20catalyze%20ribosome%20splitting%20and%20premature%20fall-off%20in%20response%20to%20arginine%20depletion.%20Additionally%2C%20the%20E3%20ubiquitin%20ligase%20RNF14%2C%20recently%20shown%20to%20clear%20ribosome%20A-site%20obstructions%2C%20promotes%20translation%20disruption%20through%20both%20ribosome%20fall-off%20and%20frameshifting%20during%20arginine%20limitation.%20Together%2C%20these%20data%20show%20that%20the%20RQC%20machinery%20is%20engaged%20by%20tRNA-limited%20ribosomes%20and%20identify%20a%20new%20role%20for%20RNF14%20as%20a%20regulator%20of%20translation%20upon%20arginine%20limitation.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222026-01-15%22%2C%22DOI%22%3A%2210.64898%5C%2F2026.01.14.699605%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.01.14.699605%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-06-09T18%3A35%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22F5M4P7YL%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Weems%20et%20al.%22%2C%22parsedDate%22%3A%222026-01-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWeems%20AD%2C%20Islam%20MT%2C%20Borges%20H%2C%20Yapp%20C%2C%20Perez-Castro%20L%2C%20Nogueira%20P%2C%20Lin%20J%2C%20Maliga%20Z%2C%20Lewis%20AJ%2C%20Kutter%20C%2C%20Mannino%20M%2C%20Vallius%20T%2C%20Santagata%20S%2C%20Sorger%20PK%2C%20Conacci-Sorrell%20M%2C%20Dean%20KM%2C%20Danuser%20GM.%20In%20vivo%20evidence%20for%20bleb-induced%20survival%20signaling%20in%20metastatic%20melanoma%20%5BInternet%5D.%20Cancer%20Biology%3B%202026%20%5Bcited%202026%20Jan%206%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.01.05.697601%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.01.05.697601%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22In%20vivo%20evidence%20for%20bleb-induced%20survival%20signaling%20in%20metastatic%20melanoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Weems%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Md%20Torikul%22%2C%22lastName%22%3A%22Islam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hazel%22%2C%22lastName%22%3A%22Borges%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lizbeth%22%2C%22lastName%22%3A%22Perez-Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%22%2C%22lastName%22%3A%22Nogueira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinlong%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alecxander%20J%22%2C%22lastName%22%3A%22Lewis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camille%22%2C%22lastName%22%3A%22Kutter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Mannino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Karl%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maralice%22%2C%22lastName%22%3A%22Conacci-Sorrell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20M.%22%2C%22lastName%22%3A%22Dean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaudenz%20M.%22%2C%22lastName%22%3A%22Danuser%22%7D%5D%2C%22abstractNote%22%3A%22Bleb%20signaling%20is%20a%20cellular%20process%20in%20which%20pressure-driven%20plasma%20membrane%20protrusions%20generate%20localized%20micron-scale%20membrane%20curvature%20that%20recruits%20cytosolic%20septin%20complexes%2C%20assembling%20signaling%20hubs%20that%20promote%20cell%20survival.%20Our%20prior%20work%20showed%20that%20this%20morphology-encoded%20signaling%20pathway%20is%20necessary%20to%20sustain%20anchorage-independent%20survival%20of%20BRAF%20and%20NRAS%20mutant%20melanoma%20cells%20in%20vitro.%20However%2C%20whether%20bleb-induced%20signaling%20occurs%20in%20vivo%20and%20contributes%20to%20cancer%20progression%20is%20unclear.%20Here%2C%20we%20develop%20complementary%20in%20vivo%20and%20ex%20vivo%20assays%20spanning%20human%20patient%20samples%20and%20mouse%20xenograft%20models%20to%20mechanistically%20interrogate%20bleb%20signaling%20directly%20in%20physiologic%20contexts.%20We%20observe%20that%20bleb-associated%20septin%20hubs%20are%20exclusively%20formed%20in%20poorly%20adherent%20amoeboid%20tumor%20cells%20at%20the%20invasive%20margin%2C%20within%20malignant%20effusions%2C%20and%20at%20distant%20metastatic%20sites%2C%20while%20well-adhered%20cells%20in%20the%20tumor%20interior%20show%20no%20signs%20of%20septin%20hub%20formation.%20Accordingly%2C%20pharmacological%20pathway%20disruption%20specifically%20kills%20disseminated%20tumor%20cells%20within%20these%20low-adhesion%20microenvironments%20while%20having%20no%20appreciable%20effect%20on%20adhered%20cells%20in%20the%20tumor%20interior%2C%20resulting%20in%20reduced%20metastatic%20burden%20and%20delayed%20disease%20recurrence%20in%20vivo.%20This%20work%20confirms%20septin-mediated%20bleb%20signaling%20as%20a%20previously%20unrecognized%20vulnerability%20of%20disseminated%20cancer%20cells%20and%20demonstrates%20that%20this%20morphology-encoded%20pathway%20operates%20in%20vivo%20to%20support%20disease%20progression%2C%20preserving%20cancer%20cell%20viability%20under%20conditions%20in%20which%20cell%20survival%20signals%20from%20the%20environment%20are%20muted.%20These%20findings%20suggest%20novel%20opportunities%20to%20target%20survival%20signaling%20in%20micrometastatic%20disseminated%20cancer%20cells.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22Cancer%20Biology%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222026-01-05%22%2C%22DOI%22%3A%2210.64898%5C%2F2026.01.05.697601%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2026.01.05.697601%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-19T20%3A03%3A13Z%22%7D%7D%2C%7B%22key%22%3A%227FLNF32G%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ribas%20et%20al.%22%2C%22parsedDate%22%3A%222026-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERibas%20GT%2C%20Cunha%20AF%2C%20Avila%20JP%2C%20Giarraputo%20A%2C%20Morena%20L%2C%20Lima%20K%2C%20Gassen%20RB%2C%20Chen%20JY%2C%20Lin%20JR%2C%20Santagata%20S%2C%20Avillach%20CT%2C%20Ryback%20BA%2C%20Lindner%20MS%2C%20Bercovici%20S%2C%20Rosales%20IA%2C%20Kawai%20T%2C%20Nakaya%20HI%2C%20Colvin%20RB%2C%20Borges%20TJ%2C%20Riella%20LV.%20Immune%20profiling%20in%20a%20living%20human%20recipient%20of%20a%20gene-edited%20pig%20kidney.%20Nat%20Med.%202026%20Jan%3B32%281%29%3A270%26%23x2013%3B280.%20PMCID%3A%20PMC12823403%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Immune%20profiling%20in%20a%20living%20human%20recipient%20of%20a%20gene-edited%20pig%20kidney%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20T.%22%2C%22lastName%22%3A%22Ribas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9%20F.%22%2C%22lastName%22%3A%22Cunha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20P.%22%2C%22lastName%22%3A%22Avila%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessia%22%2C%22lastName%22%3A%22Giarraputo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leela%22%2C%22lastName%22%3A%22Morena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karina%22%2C%22lastName%22%3A%22Lima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodrigo%20B.%22%2C%22lastName%22%3A%22Gassen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Yun%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%20T.%22%2C%22lastName%22%3A%22Avillach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Birgitta%20A.%22%2C%22lastName%22%3A%22Ryback%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20S.%22%2C%22lastName%22%3A%22Lindner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sivan%22%2C%22lastName%22%3A%22Bercovici%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivy%20A.%22%2C%22lastName%22%3A%22Rosales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tatsuo%22%2C%22lastName%22%3A%22Kawai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helder%20I.%22%2C%22lastName%22%3A%22Nakaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20B.%22%2C%22lastName%22%3A%22Colvin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thiago%20J.%22%2C%22lastName%22%3A%22Borges%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonardo%20V.%22%2C%22lastName%22%3A%22Riella%22%7D%5D%2C%22abstractNote%22%3A%22Xenotransplantation%20of%20gene-edited%20pig%20kidneys%20offers%20a%20promising%20solution%20to%20the%20shortage%20of%20kidneys%20for%20organ%20transplantation.%20We%20recently%20performed%20a%20gene-edited%20pig%20kidney%20transplantation%20into%20a%20living%20human%20recipient%20with%20end-stage%20kidney%20disease.%20Here%2C%20using%20transcriptomics%2C%20proteomics%2C%20metabolomics%20and%20multiplexed%20imaging%2C%20we%20conducted%20high-dimensional%20immune%20profiling%20in%20this%20individual.%20Despite%20profound%20depletion%20of%20circulating%20T%20cells%2C%20early%20T%20cell-mediated%20rejection%20occurred%20within%201%20week%20after%20transplantation%2C%20likely%20driven%20by%20subtherapeutic%20immunosuppression%20and%20the%20presence%20of%20residual%20CD8%2B%20T%20cells%20in%20lymph%20nodes.%20This%20T%20cell-mediated%20rejection%20event%20was%20reversed%20by%20intensified%20immunosuppression.%20After%20treatment%2C%20adaptive%20immunity%20remained%20suppressed%2C%20whereas%20innate%20immune%20activation%2C%20characterized%20by%20sustained%20monocyte%20and%20macrophage%20activity%20along%20with%20elevated%20levels%20of%20interleukin-1%20beta%20and%20granulocyte-macrophage%20colony-stimulating%20factor%2C%20persisted.%20Comparative%20transcriptomic%20analysis%20showed%20that%20xenograft%20rejection%20profiles%20resembled%20those%20typically%20observed%20in%20human%20allograft%20rejection%2C%20while%20also%20revealing%20unique%20innate%20immune%20signatures.%20We%20did%20not%20detect%20antibody-mediated%20rejection.%20The%20levels%20of%20circulating%20pig%20donor-derived%20cell-free%20DNA%20rose%20during%20the%20initial%20rejection%20episode%20and%20declined%20with%20treatment%2C%20supporting%20the%20potential%20of%20cell-free%20DNA%20measurements%20as%20a%20noninvasive%20biomarker%20of%20xenograft%20rejection.%20These%20findings%20define%20the%20distinct%20immune%20landscape%20of%20kidney%20xenotransplantation%20and%20highlight%20the%20need%20for%20regimens%20targeting%20both%20innate%20and%20adaptive%20immunity%20to%20improve%20outcomes.%22%2C%22date%22%3A%222026-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41591-025-04053-3%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241507576%22%2C%22PMCID%22%3A%22PMC12823403%22%2C%22ISSN%22%3A%221546-170X%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-10-05T18%3A25%3A39Z%22%7D%7D%2C%7B%22key%22%3A%228D8XN6FS%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Burn%20et%20al.%22%2C%22parsedDate%22%3A%222026-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBurn%20TN%2C%20Schr%26%23xF6%3Bder%20J%2C%20Gandolfo%20LC%2C%20Osman%20M%2C%20Wainwright%20EN%2C%20Lam%20EYN%2C%20McDonald%20KM%2C%20Evans%20RB%2C%20Li%20S%2C%20Rawlinson%20D%2C%20Dryburgh%20L%2C%20Zaid%20A%2C%20Maliga%20Z%2C%20Schienstock%20D%2C%20Meiser%20P%2C%20Lee%20HJ%2C%20Lai%20H%2C%20Moreira%20ML%2C%20Zareie%20P%2C%20Lee%20LHY%2C%20Huq%20L%2C%20Christo%20SN%2C%20Seow%20JJW%2C%20Ching%20KA%2C%20Guillaume%20SM%2C%20Knezevic%20K%2C%20Park%20SL%2C%20Evrard%20M%2C%20Waithman%20J%2C%20Gebhardt%20T%2C%20Mueller%20SN%2C%20Riddiough%20GE%2C%20Perini%20MV%2C%20Tsao%20SCH%2C%20Speed%20TP%2C%20Sorger%20PK%2C%20Loi%20S%2C%20Carbone%20FR%2C%20Gras%20S%2C%20Fisher%20TS%2C%20Baaten%20BJ%2C%20Dawson%20MA%2C%20Mackay%20LK.%20Antigen%20reactivity%20defines%20tissue-resident%20memory%20and%20exhausted%20T%26%23x2009%3Bcells%20in%20tumors.%20Nat%20Immunol.%202026%20Jan%3B27%281%29%3A98%26%23x2013%3B109.%20PMCID%3A%20PMC12764432%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Antigen%20reactivity%20defines%20tissue-resident%20memory%20and%20exhausted%20T%5Cu2009cells%20in%20tumors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20N.%22%2C%22lastName%22%3A%22Burn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Schr%5Cu00f6der%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luke%20C.%22%2C%22lastName%22%3A%22Gandolfo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maleika%22%2C%22lastName%22%3A%22Osman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elanor%20N.%22%2C%22lastName%22%3A%22Wainwright%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enid%20Y.%20N.%22%2C%22lastName%22%3A%22Lam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keely%20M.%22%2C%22lastName%22%3A%22McDonald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%20B.%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shihan%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Rawlinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lachlan%22%2C%22lastName%22%3A%22Dryburgh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Zaid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominick%22%2C%22lastName%22%3A%22Schienstock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippa%22%2C%22lastName%22%3A%22Meiser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hyun%20Jae%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hongjin%22%2C%22lastName%22%3A%22Lai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcela%20L.%22%2C%22lastName%22%3A%22Moreira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pirooz%22%2C%22lastName%22%3A%22Zareie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis%20H.-Y.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lutfi%22%2C%22lastName%22%3A%22Huq%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%20N.%22%2C%22lastName%22%3A%22Christo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justine%20J.%20W.%22%2C%22lastName%22%3A%22Seow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keith%20A.%22%2C%22lastName%22%3A%22Ching%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%20M.%22%2C%22lastName%22%3A%22Guillaume%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathy%22%2C%22lastName%22%3A%22Knezevic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%20L.%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maximilien%22%2C%22lastName%22%3A%22Evrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Waithman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Gebhardt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20N.%22%2C%22lastName%22%3A%22Mueller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgina%20E.%22%2C%22lastName%22%3A%22Riddiough%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcos%20V.%22%2C%22lastName%22%3A%22Perini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%20C.%20H.%22%2C%22lastName%22%3A%22Tsao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Terence%20P.%22%2C%22lastName%22%3A%22Speed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sherene%22%2C%22lastName%22%3A%22Loi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francis%20R.%22%2C%22lastName%22%3A%22Carbone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Gras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20S.%22%2C%22lastName%22%3A%22Fisher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bas%20J.%22%2C%22lastName%22%3A%22Baaten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20A.%22%2C%22lastName%22%3A%22Dawson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20K.%22%2C%22lastName%22%3A%22Mackay%22%7D%5D%2C%22abstractNote%22%3A%22CD8%2B%20T%5Cu2009cells%20are%20an%20important%20weapon%20in%20the%20therapeutic%20armamentarium%20against%20cancer.%20While%20CD8%2BCD103%2B%20T%5Cu2009cells%20with%20a%20tissue-resident%20memory%20T%20%28TRM%29%20cell%20phenotype%20are%20associated%20with%20favorable%20prognoses%2C%20the%20tumor%20microenvironment%20also%20contains%20dysfunctional%20exhausted%20T%20%28TEX%29%20cells%20that%20exhibit%20a%20variety%20of%20TRM-like%20features.%20Here%20we%20deconvolute%20TRM%20and%20TEX%20cells%20across%20human%20cancers%2C%20ascribing%20markers%20and%20gene%20signatures%20that%20distinguish%20these%20populations%20and%20enable%20their%20functional%20distinction.%20Although%20TRM%20cells%20have%20superior%20functionality%20and%20are%20associated%20with%20long-term%20survival%20post-tumor%20resection%2C%20they%20are%20not%20associated%20with%20responsiveness%20to%20immune%20checkpoint%20blockade.%20Tumor-associated%20TEX%20and%20TRM%20cells%20are%20clonally%20distinct%2C%20with%20the%20latter%20comprising%20tumor-independent%20bystanders%20and%20tumor-specific%20cells%20segregated%20from%20cognate%20antigen.%20Intratumoral%20TRM%20cells%20can%20be%20forced%20toward%20an%20exhausted%20fate%20when%20chronic%20antigen%20stimulation%20occurs%2C%20indicating%20that%20the%20presence%20or%20absence%20of%20continuous%20antigen%20exposure%20within%20the%20microenvironment%20is%20the%20key%20distinction%20between%20tumor-associated%20TEX%20and%20TRM%20populations.%20These%20results%20highlight%20unique%20functions%20for%20TRM%20and%20TEX%20cells%20in%20tumor%20control%2C%20underscoring%20the%20need%20for%20distinct%20strategies%20to%20harness%20these%20populations%20for%20cancer%20therapies.%22%2C%22date%22%3A%222026-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41590-025-02347-9%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241461987%22%2C%22PMCID%22%3A%22PMC12764432%22%2C%22ISSN%22%3A%221529-2916%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-19T20%3A15%3A30Z%22%7D%7D%2C%7B%22key%22%3A%22PLITWB9E%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Warchol%20et%20al.%22%2C%22parsedDate%22%3A%222026-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWarchol%20S%2C%20Guo%20G%2C%20Knitte%20J%2C%20Freeman%20D%2C%20Shalla%20U%2C%20Muhlich%20JL%2C%20Sorger%20PK%2C%20Pfister%20H.%20SEAL%3A%20Spatially-resolved%20Embedding%20Analysis%20with%20Linked%20Imaging%20Data.%20IEEE%20Trans%20Vis%20Comput%20Graph.%202026%20Jan%3B32%281%29%3A484%26%23x2013%3B494.%20PMCID%3A%20PMC13130870%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22SEAL%3A%20Spatially-resolved%20Embedding%20Analysis%20with%20Linked%20Imaging%20Data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Warchol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Grace%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%22%2C%22lastName%22%3A%22Knitte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Usha%22%2C%22lastName%22%3A%22Shalla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%20L.%22%2C%22lastName%22%3A%22Muhlich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanspeter%22%2C%22lastName%22%3A%22Pfister%22%7D%5D%2C%22abstractNote%22%3A%22Dimensionality%20reduction%20techniques%20help%20analysts%20make%20sense%20of%20complex%2C%20high-dimensional%20spatial%20datasets%2C%20such%20as%20multiplexed%20tissue%20imaging%2C%20satellite%20imagery%2C%20and%20astronomical%20observations%2C%20by%20projecting%20data%20attributes%20into%20a%20two-dimensional%20space.%20However%2C%20these%20techniques%20typically%20abstract%20away%20crucial%20spatial%2C%20positional%2C%20and%20morphological%20contexts%2C%20complicating%20interpretation%20and%20limiting%20insights.%20To%20address%20these%20limitations%2C%20we%20present%20SEAL%2C%20an%20interactive%20visual%20analytics%20system%20designed%20to%20bridge%20the%20gap%20between%20abstract%202D%20embeddings%20and%20their%20rich%20spatial%20imaging%20context.%20SEAL%20introduces%20a%20novel%20hybrid-embedding%20visualization%20that%20preserves%20image%20and%20morphological%20information%20while%20integrating%20critical%20high-dimensional%20feature%20data.%20By%20adapting%20set%20visualization%20methods%2C%20SEAL%20allows%20analysts%20to%20identify%2C%20visualize%2C%20and%20compare%20selections-defined%20manually%20or%20algorithmically-in%20both%20the%20embedding%20and%20original%20spatial%20views%2C%20facilitating%20a%20deeper%20understanding%20of%20the%20spatial%20arrangement%20and%20morphological%20characteristics%20of%20entities%20of%20interest.%20To%20elucidate%20differences%20between%20selected%20sets%20of%20items%2C%20SEAL%20employs%20a%20scalable%20surrogate%20model%20to%20calculate%20feature%20importance%20scores%2C%20identifying%20the%20most%20influential%20features%20governing%20the%20position%20of%20objects%20within%20embeddings.%20These%20importance%20scores%20are%20visually%20summarized%20across%20selections%2C%20with%20mathematical%20set%20operations%20enabling%20detailed%20comparative%20analyses.%20We%20demonstrate%20SEAL%27s%20effectiveness%20and%20versatility%20through%20three%20case%20studies%3A%20colorectal%20cancer%20tissue%20analysis%20with%20a%20pharmacologist%2C%20melanoma%20investigation%20with%20a%20cell%20biologist%2C%20and%20exploration%20of%20sky%20survey%20data%20with%20an%20astronomer.%20These%20studies%20underscore%20the%20importance%20of%20integrating%20image%20context%20into%20embedding%20spaces%20when%20interpreting%20complex%20imaging%20datasets.%20Implemented%20as%20a%20standalone%20tool%20while%20also%20integrating%20seamlessly%20with%20computational%20notebooks%2C%20SEAL%20provides%20an%20interactive%20platform%20for%20spatially%20informed%20exploration%20of%20high-dimensional%20datasets%2C%20significantly%20enhancing%20interpretability%20and%20insight%20generation.%22%2C%22date%22%3A%222026-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1109%5C%2FTVCG.2025.3634794%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241379922%22%2C%22PMCID%22%3A%22PMC13130870%22%2C%22ISSN%22%3A%221941-0506%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T03%3A31%3A30Z%22%7D%7D%2C%7B%22key%22%3A%22B99338KT%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rapisuwon%20et%20al.%22%2C%22parsedDate%22%3A%222026-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERapisuwon%20S%2C%20Slingluff%20CL%2C%20Wargo%20JA%2C%20Sullivan%20RJ%2C%20Izar%20B%2C%20Lin%20JR%2C%20Mauldin%20IS%2C%20Olson%20WC%2C%20Tran%20CA%2C%20Schwartzman%20GH%2C%20Gibney%20GT%2C%20Al-Refaie%20W%2C%20Atkins%20MB.%20Effects%20of%20Vemurafenib%20%26%23xB1%3B%20Cobimetinib%20on%20Intratumoral%20and%20Host%20Immunity%20in%20Patients%20With%20BRAFV600%20Mutant%20Melanoma%3A%20Implications%20for%20Combination%20With%20Immunotherapy.%20Cancer%20Med.%202026%20Jan%3B15%281%29%3Ae71526.%20PMCID%3A%20PMC12789045%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Effects%20of%20Vemurafenib%20%5Cu00b1%20Cobimetinib%20on%20Intratumoral%20and%20Host%20Immunity%20in%20Patients%20With%20BRAFV600%20Mutant%20Melanoma%3A%20Implications%20for%20Combination%20With%20Immunotherapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suthee%22%2C%22lastName%22%3A%22Rapisuwon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Craig%20L.%22%2C%22lastName%22%3A%22Slingluff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20A.%22%2C%22lastName%22%3A%22Wargo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryan%20J.%22%2C%22lastName%22%3A%22Sullivan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Izar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ileana%20S.%22%2C%22lastName%22%3A%22Mauldin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Walter%20C.%22%2C%22lastName%22%3A%22Olson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20A.%22%2C%22lastName%22%3A%22Tran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabrielle%20H.%22%2C%22lastName%22%3A%22Schwartzman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%20T.%22%2C%22lastName%22%3A%22Gibney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Waddah%22%2C%22lastName%22%3A%22Al-Refaie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20B.%22%2C%22lastName%22%3A%22Atkins%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Prior%20studies%20in%20patients%20with%20BRAF-mutant%20melanoma%20have%20shown%20increased%20density%20of%20tumor%20infiltrating%20lymphocytes%20%28TIL%29%20after%202%5Cu2009weeks%20of%20BRAF%20%28BRAFi%29%5Cu2009%5Cu00b1%5Cu2009MEK%20inhibition%20%28MEKi%29%2C%20but%20did%20not%20characterize%20the%20functional%20state%20or%20clonal%20diversity%20of%20TIL%20over%20time.%20We%20evaluated%20sequential%20tumor%20biopsies%20during%20therapy%20to%20test%20the%20hypotheses%20that%20BRAF%5C%2FMEKi%20would%20increase%20TIL%20to%20day%2029%2C%20with%20increases%20in%20IFN%5Cu03b3%20signatures%20and%20T-cell%20homing%20receptor%20ligands%20and%20expansion%20of%20functional%20intratumoral%20tumor-reactive%20CD8%20T-cells%20and%20TIL%20clonality%20in%20the%20tumor%20microenvironment.%5CnMETHODS%3A%20Subjects%20with%20biopsy-accessible%20BRAF-mutant%20advanced%20melanoma%20received%20vemurafenib%2B%5C%2F-cobimetinib.%20Tumor%20biopsies%20were%20obtained%20at%20baseline%20and%20days%208%2C%2015%2C%20and%2029%20on%20therapy.%20Tumors%20were%20analyzed%20by%20quantitative%20immunofluorescence%20%28QIF%29%2C%20NanoString%2C%20and%20TCRseq.%5CnRESULTS%3A%20Five%20patients%20were%20enrolled.%20All%20had%20an%20initial%20tumor%20response%20followed%20by%20subsequent%20progression.%20In%20four%20patients%2C%20both%20CD8%2B%20and%20CD4%2B%20TIL%20density%20increased%20by%20day%208%20or%2015%20per%20QIF%20and%20continued%20to%20increase%20at%20day%2029%20in%20two.%20Gene%20expression%20data%20showed%20upregulation%20of%20genes%5C%2Fpathways%20associated%20with%20immunologic%20rejection%20of%20cancer%2C%20including%20Class%20I%20and%20II%20MHC%20expression%2C%20antigen%20processing%5C%2Fpresentation%2C%20and%20critical%20T-cell%20attracting%20chemokines.%20TCRv%5Cu03b2%20clonal%20expansion%20was%20observed%20in%203%20patients%2C%20but%20most%20diminished%20after%20day%2015.%5CnCONCLUSIONS%3A%20Data%20from%20this%20study%20provides%20provocative%20evidence%20that%2C%20while%20BRAF%2B%5C%2F-MEK%20inhibitor%20therapy%20produces%20an%20increase%20in%20overall%20and%20clonal%20T%20cell%20infiltrates%2C%20there%20is%20limited%20evidence%20for%20generation%20of%20new%20or%20persistent%20tumor%20immunity.%20Thus%2C%20BRAFi%5C%2FMEKi%20therapy%20may%20enable%20tumor-reactive%20T%20cells%20to%20infiltrate%20tumors%20but%20tumor%20control%20does%20not%20appear%20to%20depend%20on%20priming%20new%20immune%20responses.%22%2C%22date%22%3A%222026-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1002%5C%2Fcam4.71526%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241514118%22%2C%22PMCID%22%3A%22PMC12789045%22%2C%22ISSN%22%3A%222045-7634%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-19T20%3A10%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22MHVHR29R%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rossine%20et%20al.%22%2C%22parsedDate%22%3A%222025-12-18%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ERossine%20F%2C%20Sanchez%20C%2C%20Eaton%20D%2C%20Paulsson%20J%2C%20Baym%20M.%20Intracellular%20competition%20shapes%20plasmid%20population%20dynamics.%20Science.%20New%20York%2C%20N.Y.%3B%202025%20Dec%2018%3B390%286779%29%3Aeadx0665.%20PMCID%3A%20PMC13316098%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Intracellular%20competition%20shapes%20plasmid%20population%20dynamics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Rossine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Sanchez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Eaton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%22%2C%22lastName%22%3A%22Paulsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22From%20populations%20of%20multicellular%20organisms%20to%20selfish%20genetic%20elements%2C%20conflicts%20between%20levels%20of%20biological%20organization%20are%20central%20to%20evolution.%20Plasmids%20are%20extrachromosomal%2C%20self-replicating%20genetic%20elements%20that%20face%20selective%20pressures%20from%20their%20hosts%20but%20also%20compete%20within%20the%20host%20cell%20for%20replication%20resources.%20Although%20theory%20indicates%20that%20within-cell%20selection%20matters%20for%20plasmid%20evolution%2C%20experimental%20measurement%20of%20these%20dynamics%20has%20remained%20elusive.%20We%20measured%20within-cell%20fitness%20of%20competing%20Escherichia%20coli%20plasmids%20and%20characterized%20their%20drift%20and%20selective%20dynamics.%20We%20made%20synthetic%20plasmid%20dimers%20that%20can%20be%20split%20in%20a%20controlled%20way%20to%20create%20balanced%20competition%2C%20which%20we%20probed%20experimentally.%20Incompatible%20plasmids%20coexist%20for%20an%20extended%20time%20owing%20to%20methylation-based%20replication%20control.%20Moreover%2C%20less%20transcriptionally%20active%20plasmids%20display%20a%20within-cell%20advantage%20and%20fix%20preferentially%2C%20favoring%20gene%20loss.%20Critically%2C%20fixation%20depends%20nontrivially%20on%20the%20interplay%20between%20plasmid%20transcription%20and%20translation.%20Our%20results%20show%20that%20plasmid%20evolution%20is%20driven%20by%20within-%20and%20between-cell%20dynamics.%22%2C%22date%22%3A%222025-12-18%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1126%5C%2Fscience.adx0665%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241264676%22%2C%22PMCID%22%3A%22PMC13316098%22%2C%22ISSN%22%3A%221095-9203%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T14%3A37%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22PT8X8BDH%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shi%20et%20al.%22%2C%22parsedDate%22%3A%222025-12-15%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EShi%20Y%2C%20Maliga%20Z%2C%20Vallius%20T%2C%20Pant%20SM%2C%20Pelletier%20R%2C%20Kobs%20B%2C%20Solanky%20P%2C%20He%20Y%2C%20Van%20Allen%20E%2C%20Santagata%20S%2C%20Ott%20P%2C%20Lian%20CG%2C%20Buchbinder%20E%2C%20Liu%20D%2C%20Sorger%20PK.%20Mechanisms%20of%20tumor%20persistence%20in%20metastatic%20melanoma%20following%20successful%20immunotherapy%20%5BInternet%5D.%20bioRxiv%3B%202025%20%5Bcited%202025%20Dec%2016%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2025.12.11.692633%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2025.12.11.692633%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Mechanisms%20of%20tumor%20persistence%20in%20metastatic%20melanoma%20following%20successful%20immunotherapy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yingxiao%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shishir%20M%22%2C%22lastName%22%3A%22Pant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%22%2C%22lastName%22%3A%22Pelletier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brigette%22%2C%22lastName%22%3A%22Kobs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priyanka%22%2C%22lastName%22%3A%22Solanky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yiwen%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliezer%22%2C%22lastName%22%3A%22Van%20Allen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Ott%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20G%22%2C%22lastName%22%3A%22Lian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Buchbinder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Karl%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Persistent%20stable%20lesions%20represent%20a%20common%20but%20ambiguous%20outcome%20in%20melanoma%20patients%20receiving%20immune%20checkpoint%20inhibitors%20%28ICIs%29.%20However%2C%20these%20lesions%20are%20infrequently%20removed%20and%20poorly%20characterized.%20Here%2C%20we%20perform%20in-depth%20multi-omics%20spatial%20profiling%20on%20persistent%20stable%20lesions%20from%20six%20ICI-treated%20patients.%20In%20one%2C%20the%20proportion%20of%20viable%20and%20proliferating%20tumor%20cells%20was%20similar%20to%20that%20of%20site-matched%20tumors%20from%20patients%20progressing%20during%20ICI.%20Extensive%20infiltration%20with%20cytotoxic%20T%20cells%20and%20a%20high%20level%20of%20programmed%20cell%20death%20were%20also%20observed.%20Some%20quiescent%20cancer%20cells%20were%20present%2C%20but%20this%20was%20not%20the%20dominant%20tumor%20state.%20A%20second%20stable%20lesion%2C%20while%20pathologically%20negative%2C%20also%20contained%20proliferative%20tumor%20nests%20with%20proximate%20immune%20cells.%20These%20findings%20provide%20evidence%20in%20patients%20for%20extended%20tumor%20mass%20dormancy%20in%20which%20cell%20death%20balances%20ongoing%20proliferation%20and%20further%20demonstrate%20that%20persistent%20stable%20lesions%20can%20be%20reservoirs%20of%20viable%20tumor%20cells%20with%20implications%20for%20clinical%20monitoring%20and%20management.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-12-15%22%2C%22DOI%22%3A%2210.64898%5C%2F2025.12.11.692633%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.64898%5C%2F2025.12.11.692633%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-19T20%3A36%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22UZ8XXMS2%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Deng%20et%20al.%22%2C%22parsedDate%22%3A%222025-12-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDeng%20X%2C%20Bradshaw%20GA%2C%20Kalocsay%20M%2C%20Mitchison%20T.%20Tubulin%20regulates%20stability%20and%20localization%20of%20STMN2%20by%20binding%20preferentially%20to%20its%20soluble%20form.%20J%20Cell%20Biol.%202025%20Dec%201%3B224%2812%29%3Ae202502192.%20PMCID%3A%20PMC12803766%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tubulin%20regulates%20stability%20and%20localization%20of%20STMN2%20by%20binding%20preferentially%20to%20its%20soluble%20form%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%22%2C%22lastName%22%3A%22Mitchison%22%7D%5D%2C%22abstractNote%22%3A%22The%20small%2C%20tubulin-binding%20protein%20STMN2%20is%20highly%20expressed%20in%20neurons%20and%20is%20implicated%20in%20amyotrophic%20lateral%20sclerosis.%20STMN2%20degrades%20rapidly%20and%20accumulates%20at%20axotomy%20sites%2C%20suggesting%20fast%20turnover%20is%20crucial%20for%20its%20neuroprotective%20function.%20We%20show%20that%20STMN2%20was%20primarily%20degraded%20by%20the%20ubiquitin-proteasome%20system.%20Its%20membrane-targeting%20N-terminal%20domain%20promoted%20fast%20turnover%2C%20whereas%20its%20tubulin-binding%20domain%20promoted%20stabilization.%20Proximity%20labeling%20and%20imaging%20showed%20that%20tubulin%20binding%20reduced%20STMN2%20targeting%20to%20trans-Golgi%20network%20membranes.%20Pull-down%20assays%20showed%20that%20tubulin%20binds%20preferentially%20to%20soluble%20over%20membrane-bound%20STMN2.%20Our%20observations%20suggest%20that%20STMN2%20interconverts%20between%20a%20soluble%2C%20tubulin-bound%20form%20and%20a%20membrane-bound%2C%20tubulin-free%20form%2C%20and%20is%20rapidly%20degraded%20when%20released%20from%20both%20membranes%20and%20tubulin.%20We%20propose%20that%20tubulin%20binding%20sequesters%20and%20stabilizes%20STMN2%2C%20while%20its%20neuroprotective%20function%20involves%20an%20unknown%20membrane%20activity.%22%2C%22date%22%3A%222025-12-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1083%5C%2Fjcb.202502192%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241171096%22%2C%22PMCID%22%3A%22PMC12803766%22%2C%22ISSN%22%3A%221540-8140%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T03%3A32%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22HQDJN4UA%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ludin%20et%20al.%22%2C%22parsedDate%22%3A%222025-11-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELudin%20A%2C%20Stirtz%20GL%2C%20Tal%20A%2C%20Nirmal%20AJ%2C%20Pfaff%20KL%2C%20Manos%20M%2C%20Besson%20N%2C%20Eskndir%20N%2C%20Porter%20B%2C%20Jones%20SM%2C%20Faulkner%20HM%2C%20Gong%20Q%2C%20Liu%20S%2C%20Barrera%20I%2C%20Wu%20L%2C%20Pessoa%20Rodrigues%20C%2C%20Sahu%20A%2C%20Jerison%20E%2C%20Alessi%20JV%2C%20Ricciuti%20B%2C%20Richardson%20DS%2C%20Weiss%20JD%2C%20Moreau%20HM%2C%20Stanhope%20ME%2C%20Afeyan%20AB%2C%20Sefton%20J%2C%20McCall%20WD%2C%20Formato%20E%2C%20Yang%20S%2C%20Zhou%20Y%2C%20Hoytema%20van%20Konijnenburg%20DP%2C%20Cole%20HL%2C%20Cordova%20M%2C%20Deng%20L%2C%20Rajadhyaksha%20M%2C%20Quake%20SR%2C%20Awad%20MM%2C%20Chen%20F%2C%20Wucherpfennig%20KW%2C%20Sorger%20PK%2C%20Hodi%20FS%2C%20Rodig%20SJ%2C%20Murphy%20GF%2C%20Zon%20LI.%20CRATER%20tumor%20niches%20facilitate%20CD8%2B%20T%20cell%20engagement%20and%20correspond%20with%20immunotherapy%20success.%20Cell.%202025%20Nov%2026%3B188%2824%29%3A6720-6736.e26.%20PMCID%3A%20PMC12604482%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22CRATER%20tumor%20niches%20facilitate%20CD8%2B%20T%20cell%20engagement%20and%20correspond%20with%20immunotherapy%20success%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aya%22%2C%22lastName%22%3A%22Ludin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgia%20L.%22%2C%22lastName%22%3A%22Stirtz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asaf%22%2C%22lastName%22%3A%22Tal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%20L.%22%2C%22lastName%22%3A%22Pfaff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Manos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%22%2C%22lastName%22%3A%22Besson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nebiyat%22%2C%22lastName%22%3A%22Eskndir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Billie%22%2C%22lastName%22%3A%22Porter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20M.%22%2C%22lastName%22%3A%22Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%20M.%22%2C%22lastName%22%3A%22Faulkner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiyu%22%2C%22lastName%22%3A%22Gong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophia%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irving%22%2C%22lastName%22%3A%22Barrera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lijian%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cecilia%22%2C%22lastName%22%3A%22Pessoa%20Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aditi%22%2C%22lastName%22%3A%22Sahu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Jerison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joao%20V.%22%2C%22lastName%22%3A%22Alessi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biagio%22%2C%22lastName%22%3A%22Ricciuti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Douglas%20S.%22%2C%22lastName%22%3A%22Richardson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jodi%20D.%22%2C%22lastName%22%3A%22Weiss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hadley%20M.%22%2C%22lastName%22%3A%22Moreau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meredith%20E.%22%2C%22lastName%22%3A%22Stanhope%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20B.%22%2C%22lastName%22%3A%22Afeyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Sefton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wyatt%20D.%22%2C%22lastName%22%3A%22McCall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Formato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Song%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20P.%22%2C%22lastName%22%3A%22Hoytema%20van%20Konijnenburg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%20L.%22%2C%22lastName%22%3A%22Cole%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Cordova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liang%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milind%22%2C%22lastName%22%3A%22Rajadhyaksha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20R.%22%2C%22lastName%22%3A%22Quake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20M.%22%2C%22lastName%22%3A%22Awad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fei%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%20W.%22%2C%22lastName%22%3A%22Wucherpfennig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20Stephen%22%2C%22lastName%22%3A%22Hodi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20J.%22%2C%22lastName%22%3A%22Rodig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20F.%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonard%20I.%22%2C%22lastName%22%3A%22Zon%22%7D%5D%2C%22abstractNote%22%3A%22T%20cell-mediated%20tumor%20killing%20underlies%20immunotherapy%20success.%20Here%2C%20we%20used%20long-term%20in%20vivo%20imaging%20and%20high-resolution%20spatial%20transcriptomics%20of%20zebrafish%20endogenous%20melanoma%2C%20as%20well%20as%20multiplex%20imaging%20of%20human%20melanoma%2C%20to%20identify%20domains%20facilitating%20the%20immune%20response%20during%20immunotherapy.%20We%20identified%20cancer%20regions%20of%20antigen%20presentation%20and%20T%20cell%20engagement%20and%20retention%20%28CRATERs%29%20as%20pockets%20at%20the%20stroma-melanocyte%20boundaries%20of%20zebrafish%20and%20human%20melanoma.%20CRATERs%20are%20rich%20in%20antigen-recognition%20molecules%2C%20harboring%20the%20highest%20density%20of%20CD8%2B%20T%20cells%20in%20tumors.%20In%20zebrafish%2C%20CD8%2B%20T%20cells%20formed%20prolonged%20interactions%20with%20melanoma%20cells%20within%20CRATERs%2C%20characteristic%20of%20antigen%20recognition.%20Following%20immunostimulatory%20treatment%2C%20CRATERs%20expanded%2C%20becoming%20the%20major%20sites%20of%20activated%20CD8%2B%20T%20cell%20accumulation%20and%20tumor%20killing.%20In%20humans%2C%20elevation%20in%20CRATER%20density%20in%20biopsies%20following%20immune%20checkpoint%20blockade%20%28ICB%29%20therapy%20correlated%20with%20a%20clinical%20response%20to%20therapy.%20CRATERs%20are%20structures%20that%20show%20active%20tumor%20killing%20and%20may%20be%20useful%20as%20a%20diagnostic%20indicator%20for%20immunotherapy%20success.%22%2C%22date%22%3A%222025-11-26%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cell.2025.09.021%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241109214%22%2C%22PMCID%22%3A%22PMC12604482%22%2C%22ISSN%22%3A%221097-4172%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T03%3A29%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22R24E9Q62%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Girnius%20et%20al.%22%2C%22parsedDate%22%3A%222025-11-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGirnius%20N%2C%20Vallius%20T%2C%20Chen%20W%2C%20Launonen%20IM%2C%20Palomino-Echeverria%20S%2C%20Lin%20JR%2C%20Mills%20CE%2C%20Kauppila%20S%2C%20Kronqvist%20P%2C%20Ellonen%20A%2C%20Perala%20M%2C%20Withnell%20E%2C%20Chen%20YA%2C%20Secrier%20M%2C%20Santagata%20S%2C%20Sorger%20PK%2C%20Farkkila%20A.%20Integrative%20single-cell%20and%20spatial%20mapping%20of%20oxidative%20stress%20response%20uncovers%20GCLC%2B%20mesenchymal%20tumor%20cell%20state%20linked%20with%20favorable%20outcomes%20in%20triple%20negative%20breast%20cancer%20%5BInternet%5D.%20bioRxiv%3B%202025%20%5Bcited%202026%20Jan%2026%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.11.06.686771%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.11.06.686771%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Integrative%20single-cell%20and%20spatial%20mapping%20of%20oxidative%20stress%20response%20uncovers%20GCLC%2B%20mesenchymal%20tumor%20cell%20state%20linked%20with%20favorable%20outcomes%20in%20triple%20negative%20breast%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nomeda%22%2C%22lastName%22%3A%22Girnius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenqing%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inga-Maria%22%2C%22lastName%22%3A%22Launonen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Palomino-Echeverria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caitlin%20E.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silja%22%2C%22lastName%22%3A%22Kauppila%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pauliina%22%2C%22lastName%22%3A%22Kronqvist%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antti%22%2C%22lastName%22%3A%22Ellonen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merja%22%2C%22lastName%22%3A%22Perala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eloise%22%2C%22lastName%22%3A%22Withnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-An%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Secrier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anniina%22%2C%22lastName%22%3A%22Farkkila%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20Inhibiting%20oxidative%20stress%20response%20%28OSR%29%20proteins%20has%20been%20suggested%20as%20a%20therapeutic%20strategy%20in%20triple%20negative%20breast%20cancer%20%28TNBC%29.%20However%2C%20the%20cell%20type%20specificity%20and%20spatial%20distribution%20of%20OSR%20genes%20and%20proteins%2C%20such%20as%20GCLC%20and%20NQO1%2C%20is%20unknown.%20Using%20single%20cell%20and%20spatial%20transcriptomics%20datasets%20we%20found%20that%20OSR%20genes%20were%20highly%20expressed%20in%20TNBC%20tumor%20cells%2C%20which%20localized%20in%20spatial%20clusters.%20Multiplex%20immunofluorescence%20imaging%20of%20345%20TNBC%20samples%20from%20186%20patients%20demonstrated%20that%20OSR%20proteins%20GCLC%20and%20NQO1%20exhibit%20distinct%20expression%20profiles%20across%20tumor%2C%20immune%2C%20and%20stromal%20cell%20populations%20and%20are%20elevated%20in%20inflamed%20histological%20regions.%20Tumor%20cell%20OSR%20protein%20expression%20was%20associated%20with%20the%20composition%20of%20the%20adjacent%20cellular%20neighborhood.%20Furthermore%2C%20we%20identified%20GCLC%20and%20vimentin%20positive%20%28GCLC%2BVIM%2B%29%20mesenchymal-like%20tumor%20cells%2C%20residing%20near%20immune%20cells%20and%20exhibiting%20increased%20proliferation%20and%20decreased%20anastasis%20signatures%2C%20suggesting%20sensitivity%20to%20chemotherapy.%20Across%20a%20panel%20of%20thirteen%20TNBC%20cell%20lines%2C%20GCLC%20expression%20was%20positively%20correlated%20with%20sensitivity%20to%20cisplatin.%20Cox%20regression%20analysis%20revealed%20that%20patients%20with%20higher%20proportions%20of%20GCLC%2BVIM%2B%20tumor%20cells%20had%20a%20longer%20overall%20survival.%20Collectively%2C%20our%20results%20demonstrate%20that%20individual%20OSR%20proteins%20are%20expressed%20in%20distinct%20microenvironments%20and%20tumor%20cell%20states%2C%20potentially%20contributing%20to%20patient%20outcomes.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-11-07%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.11.06.686771%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.11.06.686771%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-20T22%3A06%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22VZPBZXY8%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Stopka%20et%20al.%22%2C%22parsedDate%22%3A%222025-11-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EStopka%20SA%2C%20Bodineau%20C%2C%20Baquer%20G%2C%20Lin%20JR%2C%20Hossain%20MA%2C%20Martinez%20CJ%2C%20Regan%20MS%2C%20Ruiz%20D%2C%20Fletcher%20SM%2C%20Pourqui%26%23xE9%3B%20O%2C%20Lutsenko%20S%2C%20Payne%20CN%2C%20Agar%20JN%2C%20Mazitschek%20R%2C%20McDannold%20NJ%2C%20Sorger%20PK%2C%20Santagata%20S%2C%20Agar%20NYR.%20Spatial%20Profiling%20of%20Elements%20through%20Matrix-Assisted%20Laser%20Desorption%20Ionization%20Mass%20Spectrometry%20Imaging.%20Anal%20Chem.%202025%20Nov%207%3B%20PMID%3A%2041201007%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Spatial%20Profiling%20of%20Elements%20through%20Matrix-Assisted%20Laser%20Desorption%20Ionization%20Mass%20Spectrometry%20Imaging%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylwia%20A.%22%2C%22lastName%22%3A%22Stopka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cl%5Cu00e9ment%22%2C%22lastName%22%3A%22Bodineau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerard%22%2C%22lastName%22%3A%22Baquer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jia-Ren%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Md%20Amin%22%2C%22lastName%22%3A%22Hossain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Camilla%20J.%22%2C%22lastName%22%3A%22Martinez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Regan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Ruiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stecia-Marie%22%2C%22lastName%22%3A%22Fletcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Pourqui%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Svetlana%22%2C%22lastName%22%3A%22Lutsenko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Connor%20N.%22%2C%22lastName%22%3A%22Payne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20N.%22%2C%22lastName%22%3A%22Agar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ralph%22%2C%22lastName%22%3A%22Mazitschek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathan%20J.%22%2C%22lastName%22%3A%22McDannold%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Y.%20R.%22%2C%22lastName%22%3A%22Agar%22%7D%5D%2C%22abstractNote%22%3A%22Matrix-assisted%20laser%20desorption%20ionization%20mass%20spectrometry%20imaging%20%28MALDI%20MSI%29%20is%20widely%20used%20for%20biomolecular%20mapping%20but%20has%20not%20been%20extensively%20applied%20for%20direct%20element%20imaging.%20Established%20techniques%20such%20as%20LA-ICP-MS%20and%20SIMS%20provide%20high%20sensitivity%20for%20elemental%20analysis%20but%20lack%20the%20ability%20to%20simultaneously%20map%20elements%20and%20biomolecules.%20Here%2C%20we%20demonstrate%20the%20feasibility%20of%20MALDI%20MSI%20for%20direct%20spatial%20element%20profiling%20across%20multiple%20biological%20contexts.%20We%20optimized%20MALDI%20MSI%20parameters%5Cu2500including%20laser%20power%2C%20ionization%20conditions%2C%20and%20mass%20resolving%20power%5Cu2500to%20enable%20the%20detection%20of%20endogenous%20and%20exogenous%20elements%20such%20as%20Fe%2C%20Ca%2C%20Gd%2C%20Pt%2C%20and%20Cl.%20Using%20a%20combination%20of%20high-resolution%20FTICR-MS%20and%20timsTOF%20MSI%2C%20we%20assessed%20ionization%20efficiency%2C%20spectral%20fidelity%2C%20and%20isotopic%20accuracy.%20The%20method%20was%20applied%20to%20murine%20developmental%20models%2C%20genetic%20metal%20accumulation%20disorders%2C%20and%20platinum-based%20chemotherapy%20distributions%20in%20tumors.%20Our%20results%20demonstrate%20that%20MALDI%20MSI%20enables%20element%20detection%20while%20preserving%20spatial%20integrity.%20Computational%20modeling%20and%20spectral%20similarity%20analysis%20confirmed%20the%20reliability%20of%20isotopologue%20distributions.%20These%20findings%20establish%20MALDI%20MSI%20as%20a%20viable%20alternative%20for%20high-resolution%20element%20imaging%2C%20offering%20a%20complementary%20approach%20to%20LA-ICP-MS%20and%20SIMS%20by%20integrating%20atomic%20and%20biomolecular%20spatial%20distributions.%20This%20method%20expands%20the%20analytical%20capabilities%20of%20MALDI%20MSI%20and%20opens%20new%20avenues%20for%20metallomics%2C%20pharmacokinetics%2C%20and%20disease%20biomarker%20research.%22%2C%22date%22%3A%222025-11-07%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1021%5C%2Facs.analchem.5c05632%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241201007%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221520-6882%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-19T21%3A02%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22M3WUZVXP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Li%20et%20al.%22%2C%22parsedDate%22%3A%222025-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ELi%20D%2C%20Wan%20G%2C%20Wu%20X%2C%20Wu%20X%2C%20Chen%20X%2C%20He%20Y%2C%20Chen%20Z%2C%20Sorger%20PK%2C%20Zhao%20C.%20Multi-Modal%20Foundation%20Models%20for%20Computational%20Pathology%3A%20A%20Survey.%20Transact%20Mach%20Learn%20Res.%202025%20Nov%3B2025%3A5715.%20PMCID%3A%20PMC13081565%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multi-Modal%20Foundation%20Models%20for%20Computational%20Pathology%3A%20A%20Survey%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dong%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guihong%22%2C%22lastName%22%3A%22Wan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xintao%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xinyu%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaohui%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhong%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chen%22%2C%22lastName%22%3A%22Zhao%22%7D%5D%2C%22abstractNote%22%3A%22Foundation%20models%20have%20emerged%20as%20a%20powerful%20paradigm%20in%20computational%20pathology%20%28CPath%29%2C%20enabling%20scalable%20and%20generalizable%20analysis%20of%20histopathological%20images.%20While%20early%20developments%20centered%20on%20uni-modal%20models%20trained%20solely%20on%20visual%20data%2C%20recent%20advances%20have%20highlighted%20the%20promise%20of%20multi-modal%20foundation%20models%20that%20integrate%20heterogeneous%20data%20sources%20such%20as%20textual%20reports%2C%20structured%20domain%20knowledge%2C%20and%20molecular%20profiles.%20In%20this%20survey%2C%20we%20provide%20a%20comprehensive%20and%20up-to-date%20review%20of%20multi-modal%20foundation%20models%20in%20CPath%2C%20with%20a%20particular%20focus%20on%20models%20built%20upon%20hematoxylin%20and%20eosin%20%28H%26E%29%20stained%20whole%20slide%20images%20%28WSIs%29%20and%20tile-level%20representations.%20We%20categorize%2034%20state-of-the-art%20multi-modal%20foundation%20models%20into%20three%20major%20paradigms%3A%20vision-language%2C%20vision-knowledge%20graph%2C%20and%20vision-gene%20expression.%20We%20further%20divide%20vision-language%20models%20into%20non-LLM-based%20and%20LLM-based%20approaches.%20Additionally%2C%20we%20analyze%2030%20available%20multi-modal%20datasets%20tailored%20for%20pathology%2C%20grouped%20into%20image-text%20pairs%2C%20instruction%20datasets%2C%20and%20image-other%20modality%20pairs.%20Our%20survey%20also%20presents%20a%20taxonomy%20of%20downstream%20tasks%2C%20highlights%20training%20and%20evaluation%20strategies%2C%20and%20identifies%20key%20challenges%20and%20future%20directions.%20We%20aim%20for%20this%20survey%20to%20serve%20as%20a%20valuable%20resource%20for%20researchers%20and%20practitioners%20working%20at%20the%20intersection%20of%20pathology%20and%20AI.%22%2C%22date%22%3A%222025-11%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241994199%22%2C%22PMCID%22%3A%22PMC13081565%22%2C%22ISSN%22%3A%222835-8856%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-05-04T14%3A11%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22ZTBZPZJU%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhou%20et%20al.%22%2C%22parsedDate%22%3A%222025-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EZhou%20FY%2C%20Marin%20Z%2C%20Yapp%20C%2C%20Zou%20Q%2C%20Nanes%20BA%2C%20Daetwyler%20S%2C%20Jamieson%20AR%2C%20Islam%20MT%2C%20Jenkins%20E%2C%20Gihana%20GM%2C%20Lin%20J%2C%20Borges%20HM%2C%20Chang%20BJ%2C%20Weems%20A%2C%20Morrison%20SJ%2C%20Sorger%20PK%2C%20Fiolka%20R%2C%20Dean%20KM%2C%20Danuser%20G.%20Universal%20consensus%203D%20segmentation%20of%20cells%20from%202D%20segmented%20stacks.%20Nat%20Methods.%202025%20Nov%3B22%2811%29%3A2386%26%23x2013%3B2399.%20PMCID%3A%20PMC12615268%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Universal%20consensus%203D%20segmentation%20of%20cells%20from%202D%20segmented%20stacks%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%20Y.%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zach%22%2C%22lastName%22%3A%22Marin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiongjing%22%2C%22lastName%22%3A%22Zou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20A.%22%2C%22lastName%22%3A%22Nanes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephan%22%2C%22lastName%22%3A%22Daetwyler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20R.%22%2C%22lastName%22%3A%22Jamieson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Md%20Torikul%22%2C%22lastName%22%3A%22Islam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%22%2C%22lastName%22%3A%22Jenkins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabriel%20M.%22%2C%22lastName%22%3A%22Gihana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinlong%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hazel%20M.%22%2C%22lastName%22%3A%22Borges%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bo-Jui%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Weems%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%20J.%22%2C%22lastName%22%3A%22Morrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reto%22%2C%22lastName%22%3A%22Fiolka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20M.%22%2C%22lastName%22%3A%22Dean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaudenz%22%2C%22lastName%22%3A%22Danuser%22%7D%5D%2C%22abstractNote%22%3A%22Cell%20segmentation%20is%20the%20foundation%20of%20a%20wide%20range%20of%20microscopy-based%20biological%20studies.%20Deep%20learning%20has%20revolutionized%20two-dimensional%20%282D%29%20cell%20segmentation%2C%20enabling%20generalized%20solutions%20across%20cell%20types%20and%20imaging%20modalities.%20This%20has%20been%20driven%20by%20the%20ease%20of%20scaling%20up%20image%20acquisition%2C%20annotation%20and%20computation.%20However%2C%20three-dimensional%20%283D%29%20cell%20segmentation%2C%20requiring%20dense%20annotation%20of%202D%20slices%2C%20still%20poses%20substantial%20challenges.%20Manual%20labeling%20of%203D%20cells%20to%20train%20broadly%20applicable%20segmentation%20models%20is%20prohibitive.%20Even%20in%20high-contrast%20images%20annotation%20is%20ambiguous%20and%20time-consuming.%20Here%20we%20develop%20a%20theory%20and%20toolbox%2C%20u-Segment3D%2C%20for%202D-to-3D%20segmentation%2C%20compatible%20with%20any%202D%20method%20generating%20pixel-based%20instance%20cell%20masks.%20u-Segment3D%20translates%20and%20enhances%202D%20instance%20segmentations%20to%20a%203D%20consensus%20instance%20segmentation%20without%20training%20data%2C%20as%20demonstrated%20on%2011%20real-life%20datasets%2C%20comprising%20%3E70%2C000%20cells%2C%20spanning%20single%20cells%2C%20cell%20aggregates%20and%20tissue.%20Moreover%2C%20u-Segment3D%20is%20competitive%20with%20native%203D%20segmentation%2C%20even%20exceeding%20when%20cells%20are%20crowded%20and%20have%20complex%20morphologies.%22%2C%22date%22%3A%222025-11%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41592-025-02887-w%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241219412%22%2C%22PMCID%22%3A%22PMC12615268%22%2C%22ISSN%22%3A%221548-7105%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-12-17T14%3A35%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22IP5WA6ZD%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A5018704%2C%22username%22%3A%22AlyceChen%22%2C%22name%22%3A%22Alyce%20A%20Chen%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Falycechen%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Williams%20et%20al.%22%2C%22parsedDate%22%3A%222025-10-22%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EWilliams%20JB%2C%20Pant%20SM%2C%20Kley%20AL%2C%20Rajmalani%20BA%2C%20Yapp%20C%2C%20Zhang%20J%2C%20Rotrosen%20E%2C%20Sales%20A%2C%20Sorger%20PK%2C%20Kupper%20TS.%20Regulatory%20T%20cells%20inhibit%20CD8%2B%20TRM-like%20cells%20during%20the%20early%20stages%20of%20tumor%20immune%20escape%20%5BInternet%5D.%20bioRxiv%3B%202025%20%5Bcited%202025%20Oct%2023%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.10.21.683143%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.10.21.683143%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Regulatory%20T%20cells%20inhibit%20CD8%2B%20TRM-like%20cells%20during%20the%20early%20stages%20of%20tumor%20immune%20escape%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20B%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shishir%20M%22%2C%22lastName%22%3A%22Pant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20L%22%2C%22lastName%22%3A%22Kley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bharat%20A%22%2C%22lastName%22%3A%22Rajmalani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiang%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Rotrosen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelika%22%2C%22lastName%22%3A%22Sales%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Karl%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20S%22%2C%22lastName%22%3A%22Kupper%22%7D%5D%2C%22abstractNote%22%3A%22Tissue-resident%20memory%20T%20%28TRM%29%20cells%20are%20increasingly%20recognized%20as%20crucial%20components%20of%20tumor%20immunosurveillance%20and%20potential%20targets%20in%20cancer%20immunotherapy.%20However%2C%20studying%20TRM%20cells%20within%20the%20tumor%20microenvironment%20%28TME%29%20has%20been%20challenging%20due%20to%20limitations%20in%20existing%20tumor%20models.%20Traditional%20cell%20lines%20injected%20subcutaneously%20fail%20to%20replicate%20the%20biological%20cues%20of%20dermal%20and%20epidermal%20tumors%2C%20and%20many%20genetically%20engineered%20mouse%20models%20%28GEMMs%29%20lack%20a%20specific%20tumor%20antigen%20for%20tracking%20immune%20responses.%20Here%2C%20we%20use%20an%20autochthonous%20Braf%5C%2FPTEN%20model%20of%20melanoma%2C%20modified%20to%20express%20OVA%20as%20a%20tumor-specific%20model%20antigen%2C%20to%20show%20that%20CD103%2B%20TRM-like%20cells%20orchestrate%20the%20initial%20antitumor%20immune%20response%20and%20this%20response%20is%20antagonized%20by%20infiltration%20of%20regulatory%20T%20%28Treg%29%20cells.%20Longitudinal%20spatial%20profiling%20%28cyclic%20immunofluorescence%29%20and%20flow%20cytometry%20analysis%20of%20Braf%5C%2FPTEN%5C%2FOVA%20mice%20show%20that%20TRM-like%20cells%20rapidly%20fill%20a%20stable%20niche%20in%20the%20tumor.%20These%20TRM-like%20cells%20are%20phenotypically%20and%20transcriptionally%20distinct%20from%20other%20T%20cells%2C%20expressing%20low%20levels%20of%20PD-1%20and%20Tim-3%2C%20but%20uniquely%20expressed%20CD101%20and%20GzmB.%20Depletion%20of%20Treg%20cells%20led%20to%20augmentation%20of%20the%20OVA-specific%20antitumor%20immune%20response%20involving%20activation%20of%20TRM-like%20CD8%2B%20TILs%2C%20substantial%20CD8%2B%20and%20CD4%2B%20T%20cell%20infiltration%2C%20and%20a%20decrease%20in%20tumor%20growth.%20Depletion%20of%20CD8%2B%20T%20cells%20prior%20to%20Treg%20depletion%20blunted%20T%20cell%20recruitment%20to%20the%20tumor.%20These%20data%20show%20that%20immune%20escape%20is%20mediated%20by%20the%20ability%20of%20Tregs%20to%20suppress%20early%20antitumor%20responses%20and%20T%20cell%20recruitment%20by%20TRM-like%20cells.%22%2C%22genre%22%3A%22preprint%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-10-22%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.10.21.683143%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.10.21.683143%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T13%3A23%3A16Z%22%7D%7D%2C%7B%22key%22%3A%228Y2Y3GNJ%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tarantino%20et%20al.%22%2C%22parsedDate%22%3A%222025-10-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ETarantino%20G%2C%20Zaremba%20A%2C%20Vallius%20T%2C%20Woodnorth%20M%2C%20Hua%20Y%2C%20Pelletier%20R%2C%20Lopez%20Leon%20M%2C%20Shi%20Y%2C%20Maliga%20Z%2C%20Makhzami%20S%2C%20Aprati%20TJ%2C%20Karlas%20B%2C%20Glutsch%20V%2C%20Schilling%20B%2C%20Hassel%20J%2C%20Berking%20C%2C%20Utikal%20J%2C%20Meier%20F%2C%20Meiss%20F%2C%20Heinzerling%20L%2C%20Kahler%20K%2C%20Chen%20J%2C%20Zimmer%20L%2C%20Sucker%20A%2C%20Livingstone%20E%2C%20Hadaschik%20E%2C%20Lian%20C%2C%20Murphy%20G%2C%20Semenov%20YR%2C%20Boland%20GM%2C%20Sorger%20PK%2C%20Rambow%20F%2C%20Liu%20D%2C%20Schadendorf%20D.%20Multiomic%20profiling%20of%20a%20unique%20in-transit%20melanoma%20cohort%20identifies%20melanoma%20differentiation%20as%20predictor%20of%20tumor%20progression%20and%20therapy%20response%20%5BInternet%5D.%20bioRxiv%3B%202025%20%5Bcited%202025%20Oct%203%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.10.01.679282%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.10.01.679282%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Multiomic%20profiling%20of%20a%20unique%20in-transit%20melanoma%20cohort%20identifies%20melanoma%20differentiation%20as%20predictor%20of%20tumor%20progression%20and%20therapy%20response%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giuseppe%22%2C%22lastName%22%3A%22Tarantino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Zaremba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuulia%22%2C%22lastName%22%3A%22Vallius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Woodnorth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yichao%22%2C%22lastName%22%3A%22Hua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roxanne%22%2C%22lastName%22%3A%22Pelletier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariana%22%2C%22lastName%22%3A%22Lopez%20Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yingxiao%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samira%22%2C%22lastName%22%3A%22Makhzami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tyler%20J%22%2C%22lastName%22%3A%22Aprati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bojan%22%2C%22lastName%22%3A%22Karlas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valerie%22%2C%22lastName%22%3A%22Glutsch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bastian%22%2C%22lastName%22%3A%22Schilling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%22%2C%22lastName%22%3A%22Hassel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carola%22%2C%22lastName%22%3A%22Berking%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jochen%22%2C%22lastName%22%3A%22Utikal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Friedegund%22%2C%22lastName%22%3A%22Meier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22Meiss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Heinzerling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katharina%22%2C%22lastName%22%3A%22Kahler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jiajia%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Zimmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antje%22%2C%22lastName%22%3A%22Sucker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Livingstone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eva%22%2C%22lastName%22%3A%22Hadaschik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Lian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yevgeniy%20R%22%2C%22lastName%22%3A%22Semenov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Genevieve%20M%22%2C%22lastName%22%3A%22Boland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%22%2C%22lastName%22%3A%22Rambow%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%22%2C%22lastName%22%3A%22Schadendorf%22%7D%5D%2C%22abstractNote%22%3A%22Melanoma%20patients%20with%20in-transit%20metastasis%20%28ITM%29%2C%20a%20stage%20of%20disease%20where%20melanoma%20has%20metastasized%20to%20sites%20in%20between%20the%20primary%20lesion%20and%20draining%20lymph%20node%2C%20vary%20significantly%20in%20their%20clinical%20outcomes%2C%20but%20the%20biology%20driving%20differential%20outcomes%20in%20ITM%20is%20poorly%20understood.%20To%20elucidate%20the%20mechanisms%20of%20differential%20outcomes%2C%20we%20utilized%20multimodal%20molecular%20profiling%20%28WES%2C%20RNA-seq%2C%20highly%20multiplexed%20immunofluorescence%2C%20spatial%20transcriptomics%29%20in%201%29%20evolutionary%20analysis%20of%20longitudinal%20tumor%20samples%20and%202%29%20identifying%20prognostic%20tumor%20intrinsic%20and%20microenvironmental%20features%20in%20a%20unique%20cohort%20of%20patients%20with%20unresectable%20ITM.%20Among%20other%20findings%2C%20we%20observed%20a%20persistent%20dedifferentiated%20AXL%5Cu207a%5C%2FNGFR%5Cu207a%20clonal%20lineage%20pre-existing%20and%20following%20immune%20checkpoint%20blockade%20in%20in-transit%20and%20distant%20metastases.%20Concordantly%2C%20we%20found%20that%20low%20pigmentation%20and%20high%20T%20cell%20exhaustion%20signatures%20were%20independently%20associated%20with%20distant%20progression.%20Our%20findings%20highlight%20tumor%20cell%20state%20and%20immune%20dysfunction%20as%20key%20predictors%20and%20potential%20biomarkers%20of%20metastatic%20risk%20in%20ITM.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-10-02%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.10.01.679282%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.10.01.679282%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-20T16%3A55%3A37Z%22%7D%7D%2C%7B%22key%22%3A%22BVZ2X6RW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yapp%20et%20al.%22%2C%22parsedDate%22%3A%222025-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EYapp%20C%2C%20Nirmal%20AJ%2C%20Zhou%20F%2C%20Wong%20AYH%2C%20Tefft%20JB%2C%20Lu%20YD%2C%20Shang%20Z%2C%20Maliga%20Z%2C%20Llopis%20PM%2C%20Murphy%20GF%2C%20Lian%20CG%2C%20Danuser%20G%2C%20Santagata%20S%2C%20Sorger%20PK.%20Highly%20multiplexed%203D%20profiling%20of%20cell%20states%20and%20immune%20niches%20in%20human%20tumors.%20Nat%20Methods%20%5BInternet%5D.%202025%20Oct%3B22%2810%29%3A2180%26%23x2013%3B2193.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41592-025-02824-x%27%3Ehttps%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41592-025-02824-x%3C%5C%2Fa%3E%20PMCID%3A%20PMC12510885%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Highly%20multiplexed%203D%20profiling%20of%20cell%20states%20and%20immune%20niches%20in%20human%20tumors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ajit%20J.%22%2C%22lastName%22%3A%22Nirmal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alex%20Y.%20H.%22%2C%22lastName%22%3A%22Wong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juliann%20B.%22%2C%22lastName%22%3A%22Tefft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%20Daniel%22%2C%22lastName%22%3A%22Lu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhiguo%22%2C%22lastName%22%3A%22Shang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zoltan%22%2C%22lastName%22%3A%22Maliga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paula%20Montero%22%2C%22lastName%22%3A%22Llopis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20F.%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%20G.%22%2C%22lastName%22%3A%22Lian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaudenz%22%2C%22lastName%22%3A%22Danuser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%5D%2C%22abstractNote%22%3A%22Diseases%20such%20as%20cancer%20involve%20alterations%20in%20cell%20proportions%2C%20states%20and%20interactions%2C%20as%20well%20as%20complex%20changes%20in%20tissue%20morphology%20and%20architecture.%20Histopathological%20diagnosis%20of%20disease%20and%20most%20multiplexed%20spatial%20profiling%20relies%20on%20inspecting%20thin%20%284-5%5Cu2009%5Cu00b5m%29%20specimens.%20Here%20we%20describe%20a%20high-plex%20cyclic%20immunofluorescence%20method%20for%20three-dimensional%20tissue%20imaging%20and%20use%20it%20to%20show%20that%20few%2C%20if%20any%2C%20cells%20are%20intact%20in%20conventional%20thin%20tissue%20sections%2C%20reducing%20the%20accuracy%20of%20cell%20phenotyping%20and%20interaction%20analysis.%20However%2C%20three-dimensional%20cyclic%20immunofluorescence%20of%20sections%20eightfold%20to%20tenfold%20thicker%20enables%20accurate%20morphological%20assessment%20of%20diverse%20protein%20markers%20in%20intact%20tumor%2C%20immune%20and%20stromal%20cells.%20Moreover%2C%20the%20high%20resolution%20of%20this%20confocal%20approach%20generates%20images%20of%20cells%20in%20a%20preserved%20tissue%20environment%20at%20a%20level%20of%20detail%20previously%20limited%20to%20cell%20culture.%20Precise%20imaging%20of%20cell%20membranes%20also%20makes%20it%20possible%20to%20detect%20and%20map%20cell-cell%20contacts%20and%20juxtracrine%20signaling%20complexes%20in%20immune%20cell%20niches.%22%2C%22date%22%3A%222025-10%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41592-025-02824-x%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41592-025-02824-x%22%2C%22PMID%22%3A%2241023436%22%2C%22PMCID%22%3A%22PMC12510885%22%2C%22ISSN%22%3A%221548-7105%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T03%3A34%3A09Z%22%7D%7D%2C%7B%22key%22%3A%2293MUP3QW%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cort%5Cu00e9s-R%5Cu00edos%20et%20al.%22%2C%22parsedDate%22%3A%222025-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ECort%26%23xE9%3Bs-R%26%23xED%3Bos%20J%2C%20Rodriguez-Fernandez%20M%2C%20Sorger%20PK%2C%20Fr%26%23xF6%3Bhlich%20F.%20Dynamic%20modelling%20of%20cell%20cycle%20arrest%20through%20integrated%20single-cell%20and%20mathematical%20modelling%20approaches.%20PLoS%20Comput%20Biol.%202025%20Oct%3B21%2810%29%3Ae1012890.%20PMCID%3A%20PMC12520361%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Dynamic%20modelling%20of%20cell%20cycle%20arrest%20through%20integrated%20single-cell%20and%20mathematical%20modelling%20approaches%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Javiera%22%2C%22lastName%22%3A%22Cort%5Cu00e9s-R%5Cu00edos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Rodriguez-Fernandez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Karl%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabian%22%2C%22lastName%22%3A%22Fr%5Cu00f6hlich%22%7D%5D%2C%22abstractNote%22%3A%22Highly%20multiplexed%20imaging%20assays%20allow%20simultaneous%20quantification%20of%20multiple%20protein%20and%20phosphorylation%20markers%2C%20providing%20a%20static%20snapshots%20of%20cell%20types%20and%20states.%20Pseudo-time%20techniques%20can%20transform%20these%20static%20snapshots%20of%20unsynchronized%20cells%20into%20dynamic%20trajectories%2C%20enabling%20the%20study%20of%20dynamic%20processes%20such%20as%20development%20trajectories%20and%20the%20cell%20cycle.%20Such%20ordering%20also%20enables%20training%20of%20mathematical%20models%20on%20these%20data%2C%20but%20technical%20challenges%20have%20hitherto%20made%20it%20difficult%20to%20integrate%20multiple%20experimental%20conditions%2C%20limiting%20the%20predictive%20power%20and%20insights%20these%20models%20can%20generate.%20In%20this%20work%2C%20we%20propose%20data%20processing%20and%20model%20training%20approaches%20for%20integrating%20multiplexed%2C%20multi-condition%20immunofluorescence%20data%20with%20mathematical%20modelling.%20We%20devise%20training%20strategies%20for%20mathematical%20models%20that%20are%20applicable%20to%20datasets%20where%20cells%20exhibit%20oscillatory%20as%20well%20as%20arrested%20dynamics%20and%20use%20them%20to%20train%20a%20cell%20cycle%20model%20on%20a%20dataset%20of%20MCF-10A%20mammary%20epithelial%20cells%20exposed%20to%20cell-cycle%20arresting%20small%20molecules.%20We%20validate%20the%20model%20by%20investigating%20predicted%20growth%20factor%20sensitivities%20and%20responses%20to%20inhibitors%20of%20cells%20at%20different%20initial%20conditions.%20We%20anticipate%20that%20our%20framework%20will%20generalise%20to%20other%20highly%20multiplexed%20measurement%20techniques%20such%20as%20mass-cytometry%2C%20rendering%20larger%20bodies%20of%20data%20accessible%20to%20dynamic%20modelling%20and%20paving%20the%20way%20to%20deeper%20biological%20insights.%22%2C%22date%22%3A%222025-10%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pcbi.1012890%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2241056332%22%2C%22PMCID%22%3A%22PMC12520361%22%2C%22ISSN%22%3A%221553-7358%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-20T17%3A01%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22W9VS7S4L%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A6889081%2C%22username%22%3A%22arenasg%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Farenasg%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Jain%20et%20al.%22%2C%22parsedDate%22%3A%222025-09-25%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJain%20Y%2C%20Jepson%20J%2C%20Chen%20R%2C%20Maier%20E%2C%20Herr%20BW%2C%20Puig-Barbe%20A%2C%20Quardokus%20EM%2C%20Qaurooni%20D%2C%20Yapp%20C%2C%20Ewing%20SL%2C%20Enninful%20A%2C%20Farzad%20N%2C%20Bueckle%20A%2C%20Easter%20QT%2C%20Matuck%20B%2C%20Zhu%20C%2C%20Monte%20EM%2C%20Purkerson%20JM%2C%20Jehrio%20M%2C%20Misra%20RS%2C%20Fan%20R%2C%20Ginty%20F%2C%20Karunamurthy%20A%2C%20Fan%20J%2C%20Campbell-Thompson%20M%2C%20Pryhuber%20GS%2C%20Byrd%20KM%2C%20Hickey%20JW%2C%20B%26%23xF6%3Brner%20K.%20Exploring%20endothelial%20cell%20environments%20across%20organs%20in%20spatially%20resolved%20omics%20data%20%5BInternet%5D.%20bioRxiv%3B%202025%20%5Bcited%202025%20Nov%2021%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.09.23.678129%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.09.23.678129%3C%5C%2Fa%3E%20PMCID%3A%20PMC12485928%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Exploring%20endothelial%20cell%20environments%20across%20organs%20in%20spatially%20resolved%20omics%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yashvardhan%22%2C%22lastName%22%3A%22Jain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jodie%22%2C%22lastName%22%3A%22Jepson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roy%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Maier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20W.%22%2C%22lastName%22%3A%22Herr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aleix%22%2C%22lastName%22%3A%22Puig-Barbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%20M.%22%2C%22lastName%22%3A%22Quardokus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danial%22%2C%22lastName%22%3A%22Qaurooni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clarence%22%2C%22lastName%22%3A%22Yapp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%20L.%22%2C%22lastName%22%3A%22Ewing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Archibald%22%2C%22lastName%22%3A%22Enninful%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Negin%22%2C%22lastName%22%3A%22Farzad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Bueckle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Quinn%20T.%22%2C%22lastName%22%3A%22Easter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruno%22%2C%22lastName%22%3A%22Matuck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chenchen%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%20Marie%22%2C%22lastName%22%3A%22Monte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20M.%22%2C%22lastName%22%3A%22Purkerson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Jehrio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ravi%20S.%22%2C%22lastName%22%3A%22Misra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rong%22%2C%22lastName%22%3A%22Fan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fiona%22%2C%22lastName%22%3A%22Ginty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arivarasan%22%2C%22lastName%22%3A%22Karunamurthy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%22%2C%22lastName%22%3A%22Fan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martha%22%2C%22lastName%22%3A%22Campbell-Thompson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gloria%20S.%22%2C%22lastName%22%3A%22Pryhuber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20M.%22%2C%22lastName%22%3A%22Byrd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20W.%22%2C%22lastName%22%3A%22Hickey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katy%22%2C%22lastName%22%3A%22B%5Cu00f6rner%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%5Cn%20%20%20%20%20%20%20%20%20%20Endothelial%20cells%20are%20ubiquitously%20present%20in%20the%20human%20body%20and%20line%20the%20luminal%20surface%20of%20blood%20and%20lymphatic%20vessels.%20The%20oxygen-dependence%20of%20cells%20impacts%20their%20proximity%20to%20blood%20vessels%2C%20and%20consequently%2C%20to%20endothelial%20cells%20depending%20on%20their%20functional%20properties%20and%20priorities.%20This%20paper%20presents%20cell-to-nearest-endothelial-cell%20distance%20distributions%20for%20various%20cell%20types%20using%20399%20spatially%20resolved%20omics%20datasets%20from%2014%20studies%20comprising%2012%20tissue%20types%20with%20a%20total%20of%2047%2C349%2C496%20cells.%20Additionally%2C%20we%20developed%20an%20open-source%20web-based%20interactive%20tool%2C%20Cell%20Distance%20Explorer%2C%20that%20allows%20researchers%20to%20interactively%20visualize%20cell%20graphs%20and%20linkages%20in%202D%20and%203D%20datasets.%20Finally%2C%20we%20present%20a%20hierarchical%20neighborhood%20analysis%20focused%20on%20the%20endothelial%20cell%20neighborhoods%20in%20small%20and%20large%20intestine%20datasets.%20This%20paper%20provides%20an%20open-access%20resource%20%28datasets%2C%20tools%2C%20and%20analyses%29%20to%20characterize%20and%20compare%20cell%20distances%20and%20cell%20neighborhoods%20in%20spatially%20resolved%20omics%20data.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-09-25%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.09.23.678129%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.09.23.678129%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-20T20%3A02%3A18Z%22%7D%7D%2C%7B%22key%22%3A%22PHLK6X2J%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22lastModifiedByUser%22%3A%7B%22id%22%3A6889081%2C%22username%22%3A%22arenasg%22%2C%22name%22%3A%22%22%2C%22links%22%3A%7B%22alternate%22%3A%7B%22href%22%3A%22https%3A%5C%2F%5C%2Fwww.zotero.org%5C%2Farenasg%22%2C%22type%22%3A%22text%5C%2Fhtml%22%7D%7D%7D%2C%22creatorSummary%22%3A%22Barkai%20et%20al.%22%2C%22parsedDate%22%3A%222025-09-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBarkai%20O%2C%20Zhang%20B%2C%20Turnes%20BL%2C%20Arab%20M%2C%20Yarmolinsky%20DA%2C%20Zhang%20Z%2C%20Barrett%20LB%2C%20Woolf%20CJ.%20A%20machine%20learning%20tool%20with%20light-based%20image%20analysis%20for%20automatic%20classification%20of%203D%20pain%20behaviors.%20Cell%20Rep%20Methods.%202025%20Sept%2015%3B5%289%29%3A101145.%20PMCID%3A%20PMC12539238%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20machine%20learning%20tool%20with%20light-based%20image%20analysis%20for%20automatic%20classification%20of%203D%20pain%20behaviors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omer%22%2C%22lastName%22%3A%22Barkai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biyao%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruna%20Lenfers%22%2C%22lastName%22%3A%22Turnes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryam%22%2C%22lastName%22%3A%22Arab%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20A.%22%2C%22lastName%22%3A%22Yarmolinsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zihe%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%20B.%22%2C%22lastName%22%3A%22Barrett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifford%20J.%22%2C%22lastName%22%3A%22Woolf%22%7D%5D%2C%22abstractNote%22%3A%22Detailed%20assessment%20of%20pain-related%20behaviors%20in%20animals%20is%20essential%20for%20both%20exploring%20pain%20mechanisms%20and%20evaluating%20analgesic%20efficacy.%20While%20pose%20estimation%20tools%20have%20advanced%20automated%20behavior%20analysis%2C%20current%20existing%20algorithms%20often%20do%20not%20account%20for%20an%20animal%27s%20body-part%20contact%20intensity%20with-and%20distance%20from-the%20surface%2C%20a%20critical%20nuance%20for%20measuring%20certain%20pain-related%20responses%20like%20paw%20withdrawal%20%28%5C%22flinching%5C%22%29.%20These%20subtle%20responses%20continue%20to%20require%20time-consuming%20and%20subjective%20human%20scoring.%20Here%2C%20we%20present%20BAREfoot%20%28behavior%20with%20automatic%20recognition%20and%20evaluation%29%2C%20a%20supervised%20machine%20learning%20%28ML%29%20algorithm%20that%20combines%20pose%20estimation%20with%20light-based%20analysis%20of%20body-part%20contact%20and%20elevation%20to%20automatically%20detect%20pain%20behaviors%20in%20freely%20moving%20mice.%20We%20show%20the%20utility%20and%20accuracy%20of%20this%20algorithm%20for%20capturing%20a%20range%20of%20pain-related%20behavioral%20bouts%20using%20a%20bottom-up%20animal%20behavior%20platform%20and%20its%20application%20for%20robust%20drug%20screening.%20This%20open-source%20algorithm%20is%20adaptable%20for%20detecting%20diverse%20behaviors%20across%20species%20and%20experimental%20platforms.%22%2C%22date%22%3A%222025-09-15%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.crmeth.2025.101145%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2240876461%22%2C%22PMCID%22%3A%22PMC12539238%22%2C%22ISSN%22%3A%222667-2375%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-20T20%3A56%3A40Z%22%7D%7D%2C%7B%22key%22%3A%2297PJKHTP%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kaul%20et%20al.%22%2C%22parsedDate%22%3A%222025-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKaul%20A%2C%20Souque%20C%2C%20Holland%20M%2C%20Baym%20M.%20Genomic%20resistance%20in%20historical%20clinical%20isolates%20increased%20in%20frequency%20and%20mobility%20after%20the%20age%20of%20antibiotics.%20Microb%20Genom.%202025%20Sept%3B11%289%29%3A001474.%20PMCID%3A%20PMC12401160%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Genomic%20resistance%20in%20historical%20clinical%20isolates%20increased%20in%20frequency%20and%20mobility%20after%20the%20age%20of%20antibiotics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arya%22%2C%22lastName%22%3A%22Kaul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9lia%22%2C%22lastName%22%3A%22Souque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mische%22%2C%22lastName%22%3A%22Holland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Baym%22%7D%5D%2C%22abstractNote%22%3A%22Antibiotic%20resistance%20is%20frequently%20observed%20shortly%20after%20the%20clinical%20introduction%20of%20an%20antibiotic.%20Whether%20and%20how%20frequently%20that%20resistance%20occurred%20before%20the%20introduction%20is%20harder%20to%20determine%2C%20as%20isolates%20could%20not%20have%20been%20tested%20for%20resistance%20before%20an%20antibiotic%20was%20discovered.%20Historical%20collections%2C%20like%20the%20British%20National%20Collection%20of%20Type%20Cultures%20%28NCTC%29%2C%20stretching%20back%20to%201885%2C%20provide%20a%20window%20into%20this%20history.%20Here%2C%20we%20match%201%2C817%20sequenced%20high-quality%20genomes%20from%20the%20NCTC%20collection%20to%20their%20respective%20year%20of%20isolation%20to%20study%20resistance%20genes%20before%20and%20concurrent%20with%20the%20age%20of%20antibiotics.%20Concordant%20with%20previous%20work%2C%20we%20find%20resistance%20genes%20in%20both%20pathogens%20and%20environmental%20samples%20before%20the%20age%20of%20antibiotics.%20While%20generally%20rare%20before%20the%20introduction%20of%20an%20antibiotic%2C%20we%20find%20an%20associated%20increase%20in%20frequency%20with%20antibiotic%20introduction.%20Finally%2C%20we%20observe%20a%20trend%20of%20resistance%20elements%20becoming%20both%20increasingly%20mobile%20and%20nested%20within%20multiple%20mobile%20elements%20as%20time%20goes%20on.%20More%20broadly%2C%20our%20findings%20suggest%20that%20likely%20functional%20antibiotic%20resistance%20genes%20were%20circulating%20in%20clinically%20relevant%20isolates%20before%20the%20age%20of%20antibiotics%2C%20but%20human%20usage%20is%20associated%20with%20increasing%20both%20their%20overall%20prevalence%20and%20mobility.%22%2C%22date%22%3A%222025-09%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1099%5C%2Fmgen.0.001474%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2240889132%22%2C%22PMCID%22%3A%22PMC12401160%22%2C%22ISSN%22%3A%222057-5858%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T14%3A36%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22AYCCT22C%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Van%20Itallie%20et%20al.%22%2C%22parsedDate%22%3A%222025-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EVan%20Itallie%20E%2C%20Sonnett%20M%2C%20Kalocsay%20M%2C%20W%26%23xFC%3Bhr%20M%2C%20Peshkin%20L%2C%20Kirschner%20MW.%20Transitions%20in%20the%20proteome%20and%20phospho-proteome%20during%20Xenopus%20laevis%20development.%20Dev%20Biol.%202025%20Sept%3B525%3A155%26%23x2013%3B171.%20PMCID%3A%20PMC12255230%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transitions%20in%20the%20proteome%20and%20phospho-proteome%20during%20Xenopus%20laevis%20development%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Van%20Itallie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Sonnett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22W%5Cu00fchr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leonid%22%2C%22lastName%22%3A%22Peshkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%20W.%22%2C%22lastName%22%3A%22Kirschner%22%7D%5D%2C%22abstractNote%22%3A%22Vertebrate%20development%20from%20an%20egg%20to%20a%20complex%20multi-cell%20organism%20is%20accompanied%20by%20multiple%20phases%20of%20genome-scale%20changes%20in%20the%20repertoire%20of%20proteins%20and%20their%20post-translational%20modifications.%20While%20much%20has%20been%20learned%20at%20the%20RNA%20level%2C%20we%20know%20less%20about%20changes%20at%20the%20protein%20level.%20In%20this%20paper%2C%20we%20present%20a%20deep%20analysis%20of%20changes%20of%20%5Cu223c15%2C000%20proteins%20and%20%5Cu223c11%2C500%20phospho-sites%20at%2011%20developmental%20time%20points%20in%20Xenopus%20laevis%20embryos%20ranging%20from%20the%20stage%20VI%20oocyte%20to%20the%20juvenile%20tadpole.%20We%20find%20that%20the%20most%20dramatic%20changes%20to%20the%20proteome%20occur%20during%20the%20transition%20to%20functional%20organ%20systems%2C%20which%20occurs%20as%20the%20embryo%20becomes%20a%20tadpole.%20At%20that%20time%2C%20the%20absolute%20amount%20of%20non-yolk%20protein%20increases%20two-fold%2C%20and%20there%20is%20a%20shift%20in%20the%20balance%20of%20expression%20from%20proteins%20regulating%20gene%20expression%20to%20receptors%2C%20ligands%2C%20and%20proteins%20involved%20in%20cell-cell%20and%20cell-environment%20interactions.%20Between%20the%20early%20and%20late%20tadpole%2C%20the%20median%20increase%20for%20membrane%20and%20secreted%20proteins%20is%20substantially%20higher%20than%20that%20of%20nuclear%20proteins.%20To%20begin%20to%20appreciate%20changes%20at%20the%20post-translational%20level%2C%20we%20have%20measured%20quantitative%20phospho-proteomic%20data%20across%20the%20same%20developmental%20stages.%20In%20contrast%20to%20the%20significant%20protein%20changes%20that%20are%20concentrated%20at%20the%20end%20of%20the%20time%20series%2C%20the%20most%20significant%20phosphorylation%20changes%20are%20concentrated%20in%20the%20very%20early%20stages%20of%20development.%20A%20clear%20exception%20are%20phosphorylations%20of%20proteins%20involved%20in%20gene%20expression%3A%20these%20increase%20just%20after%20fertilization%2C%20with%20patterns%20that%20are%20highly%20correlated%20with%20the%20underlying%20protein%20changes.%20To%20facilitate%20the%20interpretation%20of%20this%20unique%20phospho-proteome%20data%20set%2C%20we%20created%20a%20pipeline%20for%20identifying%20homologous%20human%20phosphorylations%20from%20the%20measured%20Xenopus%20phospho-proteome.%20Collectively%2C%20our%20data%20reveal%20multiple%20coordinated%20transitions%20in%20protein%20and%20phosphorylation%20profiles%2C%20reflecting%20distinct%20developmental%20strategies%20and%20providing%20an%20extensive%20resource%20to%20further%20explore%20developmental%20biology%20at%20the%20proteomic%20and%20phospho-proteomic%20levels.%22%2C%22date%22%3A%222025-09%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ydbio.2025.05.022%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2240466852%22%2C%22PMCID%22%3A%22PMC12255230%22%2C%22ISSN%22%3A%221095-564X%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-07-17T03%3A32%3A13Z%22%7D%7D%2C%7B%22key%22%3A%225BFPRZMG%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Alessi%20et%20al.%22%2C%22parsedDate%22%3A%222025-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAlessi%20JV%2C%20Lindsay%20JR%2C%20Giobbie-Hurder%20A%2C%20Sharma%20B%2C%20Felt%20K%2C%20Kumari%20P%2C%20Mazor%20T%2C%20Cerami%20E%2C%20Lotter%20W%2C%20Altreuter%20J%2C%20Weirather%20J%2C%20Dryg%20I%2C%20Hoebel%20K%2C%20Manos%20M%2C%20Adib%20E%2C%20Curtis%20JD%2C%20Ricciuti%20B%2C%20Di%20Federico%20A%2C%20Ghandour%20F%2C%20Saad%20E%2C%20Wang%20XA%2C%20Pecci%20F%2C%20Holovatska%20M%2C%20Gandhi%20MM%2C%20Hughes%20ME%2C%20O%26%23x2019%3BMeara%20TA%2C%20Chan%20SJ%2C%20Pfaff%20K%2C%20Konstantinopoulos%20PA%2C%20Hodi%20FS%2C%20Shipp%20MA%2C%20Signoretti%20S%2C%20Choueiri%20T%2C%20Wei%20XX%2C%20Santagata%20S%2C%20Hanna%20GJ%2C%20Lin%20NU%2C%20Tolaney%20SM%2C%20Liu%20J%2C%20Sorger%20PK%2C%20Lindeman%20N%2C%20Sholl%20LM%2C%20Nowak%20JA%2C%20Barbie%20D%2C%20Awad%20MM%2C%20Johnson%20BE%2C%20Rodig%20SJ.%20Immunoprofiling%20at%20an%20Institutional%20Scale%20Reveals%20That%20High%20Numbers%20of%20Intratumoral%20CD8%2B%20and%20PD-1%2B%20Cells%20Predict%20Superior%20Patient%20Survival%20Across%20Major%20Cancer%20Types%20Independent%20of%20Major%20Risk%20Factors.%20JCO%20Precis%20Oncol.%202025%20Sept%3B9%3Ae2500240.%20PMCID%3A%20PMC12419029%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Immunoprofiling%20at%20an%20Institutional%20Scale%20Reveals%20That%20High%20Numbers%20of%20Intratumoral%20CD8%2B%20and%20PD-1%2B%20Cells%20Predict%20Superior%20Patient%20Survival%20Across%20Major%20Cancer%20Types%20Independent%20of%20Major%20Risk%20Factors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joao%20V.%22%2C%22lastName%22%3A%22Alessi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20R.%22%2C%22lastName%22%3A%22Lindsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anita%22%2C%22lastName%22%3A%22Giobbie-Hurder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bijaya%22%2C%22lastName%22%3A%22Sharma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristen%22%2C%22lastName%22%3A%22Felt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priti%22%2C%22lastName%22%3A%22Kumari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tali%22%2C%22lastName%22%3A%22Mazor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethan%22%2C%22lastName%22%3A%22Cerami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Lotter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Altreuter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Weirather%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%22%2C%22lastName%22%3A%22Dryg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katharina%22%2C%22lastName%22%3A%22Hoebel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Manos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elio%22%2C%22lastName%22%3A%22Adib%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20D.%22%2C%22lastName%22%3A%22Curtis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biagio%22%2C%22lastName%22%3A%22Ricciuti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessandro%22%2C%22lastName%22%3A%22Di%20Federico%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fatme%22%2C%22lastName%22%3A%22Ghandour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eddy%22%2C%22lastName%22%3A%22Saad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xin-An%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Federica%22%2C%22lastName%22%3A%22Pecci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marta%22%2C%22lastName%22%3A%22Holovatska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malini%20M.%22%2C%22lastName%22%3A%22Gandhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20E.%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tess%20A.%22%2C%22lastName%22%3A%22O%27Meara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabrina%20J.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%22%2C%22lastName%22%3A%22Pfaff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Panagiotis%20A.%22%2C%22lastName%22%3A%22Konstantinopoulos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20Stephan%22%2C%22lastName%22%3A%22Hodi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%20A.%22%2C%22lastName%22%3A%22Shipp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabina%22%2C%22lastName%22%3A%22Signoretti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toni%22%2C%22lastName%22%3A%22Choueiri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao%20X.%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22Santagata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Glenn%20J.%22%2C%22lastName%22%3A%22Hanna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%20U.%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20M.%22%2C%22lastName%22%3A%22Tolaney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joyce%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20K.%22%2C%22lastName%22%3A%22Sorger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%22%2C%22lastName%22%3A%22Lindeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lynette%20M.%22%2C%22lastName%22%3A%22Sholl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20A.%22%2C%22lastName%22%3A%22Nowak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Barbie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20M.%22%2C%22lastName%22%3A%22Awad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20E.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20J.%22%2C%22lastName%22%3A%22Rodig%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Retrospective%20studies%20have%20found%20associations%20between%20the%20number%20of%20intratumoral%20immune%20cells%20and%20patient%20outcomes%20for%20specific%20cancers%20treated%20with%20targeted%20therapies.%20However%2C%20the%20clinical%20value%20of%20routinely%20quantifying%20intratumoral%20immune%20biomarkers%20using%20a%20digital%20pathology%20platform%20in%20the%20pan-cancer%20setting%20within%20an%20active%20clinical%20laboratory%20has%20not%20been%20established.%5CnMETHODS%3A%20We%20developed%20ImmunoProfile%2C%20a%20daily%20clinical%20workflow%20that%20integrates%20automated%20multiplex%20immunofluorescence%20tissue%20staining%2C%20digital%20slide%20imaging%2C%20and%20machine%20learning-assisted%20scoring%20to%20quantify%20intratumoral%20CD8%2B%2C%20PD-1%2B%2C%20CD8%2BPD-1%2B%2C%20and%20FOXP3%2B%20immune%20cells%20and%20PD-L1%20expression%20in%20formalin-fixed%2C%20paraffin-embedded%20tissue%20samples%20in%20a%20standardized%20and%20reproducible%20manner.%20We%20prospectively%20applied%20ImmunoProfile%20to%20biopsies%20collected%20from%202%2C023%20unselected%20patients%20with%20cancer%20over%20a%203-year%20period%20in%20the%20clinical%20laboratory%20and%20correlated%20the%20results%20with%20patient%20survival.%5CnRESULTS%3A%20In%20the%20pan-cancer%20cohort%2C%20patients%20with%20high%20numbers%20of%20intratumoral%20CD8%2B%20or%20PD-1%2B%20cells%20in%20had%20significantly%20lower%20risks%20of%20death%20compared%20with%20those%20with%20low%20numbers%20%28CD8%2B%3A%20high%20v%20low%20hazard%20ratio%20%5BHR%5D%2C%200.62%20%5B95%25%20CI%2C%200.48%20to%200.81%5D%2C%20Wald%20P%20%3D%20.002%3B%20PD-1%2B%3A%20high%20v%20low%20HR%2C%200.65%20%5B95%25%20CI%2C%200.51%20to%200.83%5D%3B%20P%20%3D%20.0009%29%20after%20adjusting%20for%20risk%20factors%2C%20including%20cancer%20type.%20In%20subset%20analyses%2C%20patients%20with%20high%20numbers%20of%20intratumoral%20CD8%2B%2C%20PD-1%2B%2C%20and%5C%2For%20CD8%2BPD-1%2B%20cells%20showed%20lower%20risks%20of%20death%20from%20non-small%20cell%20lung%2C%20colorectal%2C%20breast%2C%20esophagogastric%2C%20head%20and%20neck%2C%20pancreatic%2C%20and%20ovarian%20cancers%20after%20considering%20clinical%20risk%20factors%2C%20including%20American%20Joint%20Committee%20on%20Cancer%20stage%2C%20and%20despite%20varying%20therapies%20%28all%20P%20%3C%20.05%29.%5CnCONCLUSION%3A%20Routinely%20quantifying%20intratumoral%20CD8%2B%20and%20PD-1%2B%20cells%20with%20a%20clinically%20validated%20digital%20pathology%20platform%20predicts%20patient%20survival%20across%20major%20cancer%20types%2C%20independent%20of%20clinical%20stage%20and%20despite%20diverse%20treatment%20regimens.%22%2C%22date%22%3A%222025-09%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1200%5C%2FPO-25-00240%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2240906987%22%2C%22PMCID%22%3A%22PMC12419029%22%2C%22ISSN%22%3A%222473-4284%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-20T21%3A31%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22URKKUBVV%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Johnson%20et%20al.%22%2C%22parsedDate%22%3A%222025-08-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJohnson%20WC%2C%20Alivisatos%20A%2C%20Smith%20TC%2C%20Van%20N%2C%20Soni%20V%2C%20Wallach%20JB%2C%20Clark%20NA%2C%20Fitzgerald%20TA%2C%20Whiteley%20JJ%2C%20Tan%20S%2C%20Sokolov%20A%2C%20Ando%20DM%2C%20Schnappinger%20D%2C%20Rhee%20KY%2C%20Aldridge%20BB.%20Integration%20of%20multi-modal%20measurements%20identifies%20critical%20mechanisms%20of%20tuberculosis%20drug%20action.%20Cell%20Syst.%202025%20Aug%2020%3B16%288%29%3A101348.%20PMCID%3A%20PMC12365861%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Integration%20of%20multi-modal%20measurements%20identifies%20critical%20mechanisms%20of%20tuberculosis%20drug%20action%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20C.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ares%22%2C%22lastName%22%3A%22Alivisatos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Trever%20C.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nhi%22%2C%22lastName%22%3A%22Van%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%22%2C%22lastName%22%3A%22Soni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20B.%22%2C%22lastName%22%3A%22Wallach%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicholas%20A.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20A.%22%2C%22lastName%22%3A%22Fitzgerald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%20J.%22%2C%22lastName%22%3A%22Whiteley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shumin%22%2C%22lastName%22%3A%22Tan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Artem%22%2C%22lastName%22%3A%22Sokolov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%20Michael%22%2C%22lastName%22%3A%22Ando%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%22%2C%22lastName%22%3A%22Schnappinger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyu%20Y.%22%2C%22lastName%22%3A%22Rhee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bree%20B.%22%2C%22lastName%22%3A%22Aldridge%22%7D%5D%2C%22abstractNote%22%3A%22Treatments%20for%20tuberculosis%20remain%20lengthy%2C%20motivating%20a%20search%20for%20new%20drugs%20with%20novel%20mechanisms%20of%20action.%20However%2C%20it%20remains%20challenging%20to%20determine%20the%20direct%20targets%20of%20a%20drug%20and%20which%20disrupted%20cellular%20processes%20lead%20to%20bacterial%20killing.%20We%20developed%20a%20computational%20tool%2C%20DECIPHAER%20%28decoding%20cross-modal%20information%20of%20pharmacologies%20via%20autoencoders%29%2C%20to%20select%20the%20important%20correlated%20transcriptional%20and%20morphological%20responses%20of%20Mycobacterium%20tuberculosis%20to%20treatment.%20By%20finding%20a%20reduced%20feature%20space%2C%20DECIPHAER%20highlighted%20essential%20features%20of%20cellular%20damage.%20DECIPHAER%20provides%20cell-death-relevant%20insight%20into%20uni-modal%20datasets%2C%20enabling%20interrogation%20of%20drug%20treatment%20responses%20for%20which%20transcriptional%20data%20are%20unavailable.%20Using%20morphological%20data%20alone%20with%20DECIPHAER%2C%20we%20discovered%20that%20respiration%20inhibition%20by%20the%20polypharmacological%20drugs%20SQ109%20and%20BM212%20can%20influence%20cell%20death%20more%20than%20their%20effects%20on%20the%20cell%20wall.%20This%20study%20demonstrates%20that%20DECIPHAER%20can%20extract%20the%20critical%20shared%20information%20from%20multi-modal%20measurements%20to%20identify%20cell-death-relevant%20mechanisms%20of%20TB%20drugs.%20A%20record%20of%20this%20paper%27s%20transparent%20peer%20review%20process%20is%20included%20in%20the%20supplemental%20information.%22%2C%22date%22%3A%222025-08-20%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cels.2025.101348%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2240738114%22%2C%22PMCID%22%3A%22PMC12365861%22%2C%22ISSN%22%3A%222405-4720%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-20T21%3A37%3A35Z%22%7D%7D%2C%7B%22key%22%3A%228UXIBRTH%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mahmoud%20et%20al.%22%2C%22parsedDate%22%3A%222025-08-16%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMahmoud%20N%2C%20Qin%20X%2C%20Bzeih%20W%2C%20Khabibullin%20D%2C%20Alchoueiry%20M%2C%20Safi%20S%2C%20Chami%20J%2C%20Han%20T%2C%20Salem%20S%2C%20Priolo%20C%2C%20Chakraborty%20AA%2C%20Sarosiek%20KA%2C%20Henske%20EP.%20BCL-xL%20dependency%20in%20chromophobe%20renal%20cell%20carcinoma.%20Cancer%20Gene%20Ther.%202025%20Aug%2016%3B%20PMID%3A%2040819113%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22BCL-xL%20dependency%20in%20chromophobe%20renal%20cell%20carcinoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Mahmoud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xingping%22%2C%22lastName%22%3A%22Qin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wafaa%22%2C%22lastName%22%3A%22Bzeih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damir%22%2C%22lastName%22%3A%22Khabibullin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michel%22%2C%22lastName%22%3A%22Alchoueiry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%22%2C%22lastName%22%3A%22Safi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joelle%22%2C%22lastName%22%3A%22Chami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiegang%22%2C%22lastName%22%3A%22Han%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samer%22%2C%22lastName%22%3A%22Salem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carmen%22%2C%22lastName%22%3A%22Priolo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhishek%20A.%22%2C%22lastName%22%3A%22Chakraborty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristopher%20A.%22%2C%22lastName%22%3A%22Sarosiek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20P.%22%2C%22lastName%22%3A%22Henske%22%7D%5D%2C%22abstractNote%22%3A%22Chromophobe%20renal%20cell%20carcinoma%20%28ChRCC%29%20is%20the%20third%20most%20common%20subtype%20of%20kidney%20cancer%2C%20with%20limited%20therapeutic%20options.%20Using%20BH3%20profiling%20to%20screen%20ChRCC-derived%20cell%20lines%2C%20we%20discovered%20that%20BH3%20peptides%20targeting%20BCL-xL%20promote%20apoptosis%20in%20ChRCC.%20Downregulation%20of%20BCL2L1%20is%20sufficient%20to%20induce%20apoptosis%20in%20ChRCC-derived%20cells%2C%20consistent%20with%20our%20screening%20results.%20BCL2L1%2C%20encoding%20BCL-xL%2C%20is%20fourfold%20upregulated%20in%20ChRCC%20compared%20to%20normal%20kidney%20and%20has%20the%20second%20highest%20expression%20in%20The%20Cancer%20Genome%20Atlas.%20BCL2L1%20downregulation%20enhances%20MCL-1%20expression%2C%20suggesting%20a%20possible%20compensatory%20role%20for%20MCL-1.%20Based%20on%20these%20results%2C%20we%20evaluated%20two%20BH3%20mimetics%2C%20A-1331852%20%28targeting%20BCL-xL%29%20and%20S63845%20%28targeting%20MCL-1%29.%20Their%20combination%20resulted%20in%2080%25%20cell%20death.%20DT2216%2C%20a%20proteolysis-targeting%20chimera%20%28PROTAC%29%20that%20targets%20BCL-xL%20for%20degradation%2C%20induced%20cleaved%20PARP%20and%20caspase%203%2C%20indicators%20of%20apoptosis.%20ChRCC%20cells%20are%20known%20to%20be%20highly%20sensitive%20to%20ferroptosis.%20We%20combined%20A-1331852%20and%20S63845%20with%20IKE%20or%20RSL3%20%28ferroptosis-inducing%20drugs%29.%20BCL-xL%20and%20MCL-1%20inhibition%20enhanced%20the%20susceptibility%20to%20ferroptosis%2C%20suggesting%20a%20link%20between%20apoptosis%20and%20ferroptosis%20in%20ChRCC.%20These%20data%20indicate%20that%20BCL-xL%20maintains%20ChRCC%20cell%20survival%20by%20suppressing%20apoptosis.%20The%20BCL-xL-specific%20PROTAC%20DT2216%2C%20currently%20in%20clinical%20trials%2C%20may%20provide%20an%20opportunity%20for%20ChRCC%20therapy.%22%2C%22date%22%3A%222025-08-16%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41417-025-00953-1%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2240819113%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221476-5500%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222026-02-20T21%3A41%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22TK5IDK3K%22%2C%22library%22%3A%7B%22id%22%3A2576724%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Das%20et%20al.%22%2C%22parsedDate%22%3A%222025-08-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%20%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EDas%20T%2C%20Bradshaw%20GA%2C%20Hyer%20J%2C%20Masek%20M%2C%20Kuo%20YM%2C%20Bachmann-Gagescu%20R%2C%20Kalocsay%20M%2C%20Nachury%20MV.%20BBSome-Mediated%20Clearance%20of%20Ubiquitinated%20IMPG2%20Defines%20a%20Constitutive%20Ciliary%20Retrieval%20Pathway%20in%20Photoreceptors%20%5BInternet%5D.%20bioRxiv%3B%202025%20%5Bcited%202025%20Nov%2021%5D.%20Available%20from%3A%20%3Ca%20class%3D%27zp-ItemURL%27%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.07.29.667331%27%3Ehttp%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.07.29.667331%3C%5C%2Fa%3E%20PMCID%3A%20PMC12324355%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22BBSome-Mediated%20Clearance%20of%20Ubiquitinated%20IMPG2%20Defines%20a%20Constitutive%20Ciliary%20Retrieval%20Pathway%20in%20Photoreceptors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tirthasree%22%2C%22lastName%22%3A%22Das%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%20A.%22%2C%22lastName%22%3A%22Bradshaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanette%22%2C%22lastName%22%3A%22Hyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Markus%22%2C%22lastName%22%3A%22Masek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yien-Ming%22%2C%22lastName%22%3A%22Kuo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ruxandra%22%2C%22lastName%22%3A%22Bachmann-Gagescu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marian%22%2C%22lastName%22%3A%22Kalocsay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxence%20V.%22%2C%22lastName%22%3A%22Nachury%22%7D%5D%2C%22abstractNote%22%3A%22ABSTRACT%5Cn%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20The%20BBSome%20mediates%20the%20retrieval%20of%20ubiquitinated%20membrane%20proteins%20from%20cilia%2C%20but%20its%20physiological%20cargoes%20in%20photoreceptors%20remain%20largely%20unidentified.%20Here%2C%20we%20find%20that%20K63-linked%20ubiquitin%20%28UbK63%29%20chains%20accumulate%20in%20the%20outer%20segment%20%28OS%2C%20equivalent%20of%20cilia%29%20of%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Bbs4%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cu2212%5C%2F%5Cu2212%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20photoreceptors%20from%20the%20onset%20of%20OS%20formation.%20Through%20quantitative%20profiling%20of%20the%20UbK63-associated%20OS%20proteome%2C%20we%20identify%20the%20transmembrane%20fragment%20of%20interphotoreceptor%20matrix%20proteoglycan%202%20%28IMPG2%5Cn%20%20%20%20%20%20%20%20%20%20%20%20m%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%29%20as%20a%20principal%20cargo%20of%20the%20BBSome.%20In%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Bbs4%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cu2212%5C%2F%5Cu2212%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20mice%2C%20ubiquitinated%20IMPG2%5Cn%20%20%20%20%20%20%20%20%20%20%20%20m%5Cn%20%20%20%20%20%20%20%20%20%20%20%20aberrantly%20accumulates%20in%20OSs%2C%20and%20disruption%20of%20IMPG2%5Cn%20%20%20%20%20%20%20%20%20%20%20%20m%5Cn%20%20%20%20%20%20%20%20%20%20%20%20ubiquitination%20impairs%20its%20retrieval%20and%20clearance.%20Because%20full-length%20IMPG2%20traffics%20to%20the%20OS%20to%20deliver%20its%20extracellular%20domain%20to%20the%20matrix%2C%20our%20data%20support%20a%20model%20in%20which%20IMPG2%5Cn%20%20%20%20%20%20%20%20%20%20%20%20m%5Cn%20%20%20%20%20%20%20%20%20%20%20%20undergoes%20constitutive%20cycling%20between%20the%20inner%20and%20outer%20segments.%20These%20findings%20redefine%20the%20BBSome%5Cu2019s%20role%20in%20photoreceptors%20from%20quality%20control%20to%20constitutive%20membrane%20protein%20turnover.%22%2C%22genre%22%3A%22%22%2C%22repository%22%3A%22bioRxiv%22%2C%22archiveID%22%3A%22%22%2C%22date%22%3A%222025-08-01%22%2C%22DOI%22%3A%2210.1101%5C%2F2025.07.29.667331%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fbiorxiv.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1101%5C%2F2025.07.29.667331%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%22IXMHRBF6%22%5D%2C%22dateModified%22%3A%222025-11-21T16%3A55%3A35Z%22%7D%7D%5D%7D
1.
Kader T, Chen YA, Hug CB, Lin JR, Muhlich JL, Coy S, Jung E, Schwartz LE, Fazio T, Chiu C, Ryall ST, Drescher CW, Sorger PK, Drapkin R, Santagata S. Spatial Integration of Protein and Chromosomal States Reveals Early Copy-Number Changes and Genotype-Associated Immune Neighborhoods in Serous Ovarian Cancer Evolution. Cancer Discov. 2026 Sept 1;16(9):1750–1764. PMCID: PMC13530990
1.
Yue S, Guo Z, Pan C, Jing XA, Tao L, Nguyen T, Tang J, Chan Y, Contreras-Trujillo H, Jiang D, Yan X, Xiang H, Liu X, Bloom C, Ediriwickrema A, Koschade S, Wang X, Wang Z, Shu N, Shi Y, McKim DB, Lu R, Majeti R, Zhang C, Ying QL. Expansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapy. Cell. 2026 Aug 20;189(17):5378-5395.e11. PMID: 42320470
1.
Rudra Gupta T, Polley MYC, Redd R, Lee EQ, Arrillaga-Romany I, Gilbert MR, Tan Y, Touat M, Drappatz J, Welch MR, Galanis E, Ahluwalia MS, Colman H, Nabors LB, Hepel J, Elinzano H, Schiff D, Chukwueke UN, Beroukhim R, Nayak L, McFaline-Figueroa JR, Batchelor TT, Kaley TJ, Lu-Emerson C, Mellinghoff IK, Bi WL, Arnaout O, Peruzzi PP, Haas-Kogan D, Tanguturi S, Aizer A, Doherty L, Santagata S, Meredith DM, Chiocca EA, Reardon DA, Ligon KL, Weller M, Mehta MP, Wen PY, Trippa L, Rahman R. Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data. J Clin Oncol. 2026 July 20;44(21):2048–2058. PMCID: PMC13418303
1.
Ma Y, Tagore M, Hunter MV, Huang TH, Montal E, Weiss JM, Shi Y, Vallius T, Sorger PK, White RM. Restraint of melanoma progression by cells in the local skin environment. Elife. 2026 June 30;13:RP101974. PMCID: PMC13318302
1.
Zamora AD, Pai SV, Mears KS, Rossine F, Owen SV, Baym M. SOS-mediated prophage induction constrains resistance evolution to DNA-damaging antibiotics [Internet]. bioRxiv; 2026 [cited 2026 July 17]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.06.23.733845
1.
Gonzalez Castro LN, Wu YC, Lin JR, Santiago-Ribeiro MJ, Laurenge A, Carpentier A, Coy S, Lin NU, Mokhtari K, Ligon KL, Touat M, Santagata S. Clinical responses to trastuzumab deruxtecan in molecularly defined ependymoma. NPJ Precis Oncol. 2026 June 20; PMID: 42321415
1.
Xu R, Wu G, Rice S, Booker M, Weekes J, Bell H, Gao Y, Nirmal AJ, Liu H, Ciantra Z, Luo Q, Fortune A, Whalen K, Guanci T, Wan Y, Louissaint A, Nordberg JJ, Lin JR, Hemann M, Manalis SR, Armand P, Smith E, Jacobson CA, Tolstorukov M, Murakami MA, Sorger PK, Weinstock DM, Song L, Lane AA. Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy. Blood Adv. 2026 June 9;10(11):3845–3855. PMCID: PMC13234471
1.
Ogbonna EC, Talemi SR, Maliga Z, Zhao Z, Yapp C, Pant SM, Lu YD, Muhlich J, Gagné A, Martinot AJ, Coy S, Santagata S, Shih AR, Solomon IH, Naidoo T, Aldridge BB, Steyn AJC, Sorger PK. Modeling development of tertiary lymphoid structures in pulmonary tuberculosis by 3D profiling and trajectory analysis [Internet]. bioRxiv; 2026 [cited 2026 June 8]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.06.02.725201
1.
Li B, Mitchison TJ. Rebinding drives cellular retention of small-molecule drugs with abundant targets. Proc Natl Acad Sci U S A. 2026 May 26;123(21):e2531949123. PMCID: PMC13213988
1.
Wong AYH, Lu YD, Zhao Z, Zhou F, Park H, Maliga Z, Anang YNA, Coy S, Danuser G, Santagata S, Yapp C, Sorger PK. Volumetric Cyclic Immunofluorescence for 3D Spatial Profiling of Immune Structures in Human FFPE Tissue [Internet]. bioRxiv; 2026 [cited 2026 May 26]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.05.17.725158
1.
Petrova V, Mills CE, Hug C, Cetinkaya-Fisgin A, Splaine J, Fouladzadeh S, Hakim S, Powell R, Zhen S, Chung M, Bradshaw GA, Deng T, Singec I, Wang Q, Kawaguchi R, Jonnagaddala H, Barrett LB, Smith JA, Kalocsay M, Gyori BM, Hoke A, Sorger PK, Woolf CJ. A human iPSC-derived sensory neuron platform for high-throughput discovery of neuroprotectants against chemotherapy-induced peripheral neuropathy. Cell Rep Med. 2026 May 19;7(5):102787. PMCID: PMC13198234
1.
Shi Y, Savchenko A, Brase JC, Reardon B, Ricker CA, Park J, Tarantino G, Manos MP, Huang AY, Van Allen EM, Garraway LA, Flaherty KT, Liu D. Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in BRAF -Mutant Melanoma [Internet]. bioRxiv; 2026 [cited 2026 July 17]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.05.09.721157 PMCID: PMC13192995
1.
Cheng X, Zhang Y, Qian C, Holdridge E, Ananda G, Jiang T, Ni J, Xie S, Gu H, Ji R, Ivanova EV, Nucci MR, Wang Z, Chen K, Kochupurakkal B, Freeman GJ, Shapiro GI, Liu J, Konstantinopoulos PA, Matulonis U, Zhao JJ. Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer. Nat Commun. 2026 May 4;17(1):5994. PMCID: PMC13347040
1.
Guo X, Moynihan ZA, Driver J, Patel RV, Bhave VM, Maury EA, Knelson EH, Guo H, Lin JR, Coy SM, Wang A, Gupta S, Hoffman SE, Dunn IF, Dunn GP, Petti A, Choi BD, Choudhury A, Raleigh DR, Wei K, Reardon DA, Barbie D, Lederer JA, Santagata S, Bi WL. Meningioma microenvironment harbors a rich immune landscape that evolves with biological state. Neuro Oncol. 2026 May 1;28(5):1193–1208. PMCID: PMC13186497
1.
Hess JM, Dzeng RK, Ilieş I, Schapiro D, Iskra JJ, Mirgh D, Nam J, Seeley EH, Verrill DE, Abdelmoula WM, Regan MS, Theocharidis G, Wu CL, Veves A, Agar NYR, Sluder AE, Poznansky MC, Sîrbulescu RF, Reeves PM. MIAAIM: Multi-omics image integration with dimensional reduction for tissue state mapping. PLoS Comput Biol. 2026 May;22(5):e1014274. PMCID: PMC13225665
1.
Cassandras M, Sanchez X, Hsu L, Huang Y, Getzler AJ, Ganguly D, Baldominos P, Codinachs I, Chuong J, Martin EE, Smith BE, Marina E, Spasic M, Qin X, Parsons HA, Mayer EL, Sarosiek KA, Dougan SK, Mittendorf EA, McAllister SS, Hsu YC, Agudo J. A glucocorticoid-FAS axis controls immune evasion during metastatic seeding. Nature. 2026 May;653(8114):567–575. PMID: 41781620
1.
Gagné A, Lin JR. Moving Beyond Morphology to Multiplexed Molecular Imaging as the Next Frontier in Diagnostic Pathology. Am J Pathol. 2026 Apr 30;S0002-9440(26)00123–9. PMID: 42069143
1.
Tan SZK, Puig-Barbe A, Goutte-Gattat D, Eastwood C, Aevermann B, Avola A, Balhoff JP, Bayindir IU, Belfiore J, Caron AR, Fischer DS, George N, Gyori BM, Haendel MA, Hoyt CT, Kir H, Lubiana T, Matentzoglu N, Overton JA, Peng B, Peters B, Quardokus EM, Ray PL, Roncaglia P, Rivera AD, Stefancsik R, Teh WK, Toro S, Vasilevsky N, Xu C, Zhang Y, Scheuermann RH, Mungall CJ, Diehl AD, Osumi-Sutherland D. The Cell Ontology in the age of single-cell omics. Sci Data. 2026 Apr 24;13(1):946. PMCID: PMC13315338
1.
Mills CE, Hug C, Sajeevan KA, Clark N, Victor C, Chung M, Rawat S, D’Erasmo H, Moraes MP, Aldridge B, Albers MW, Chowdhury R, Gyori BM, Sorger PK. Polypharmacology is an enduring and nearly universal property of kinase inhibitors [Internet]. bioRxiv; 2026 [cited 2026 July 17]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.03.17.711623
1.
König LE, Rodriguez S, Hug C, Daneshvari S, Chung A, Appleman M, Tsai M, Bradshaw GA, Sahin A, Song Y, Zhou G, Eisert RJ, Piccioni F, Marques C, Powley S, Yarmolinsky J, Wainger BJ, Das S, Kalocsay M, Dehghan A, Tzoulaki I, Sokolov A, Sorger P, Root DE, Albers MW. TYK2 mediates neuroinflammation in Alzheimer’s disease brains with TDP-43 pathology. Nat Commun. 2026 Mar 14;17(1):3967. PMCID: PMC13133158
1.
Perez-Villatoro F, Shabanova A, van Wagensveld L, Junquera A, Niemiec I, Hincapié-Otero MM, Kang Z, Falco MM, Birgin K, Wolf S, Anttila E, Anandagoda G, Casado J, Marcus E, Gaillard D, Kahelin E, Chamchougia F, Salko M, Shah S, Russo S, Chiaro J, Grönholm M, Ndika J, Kari OK, iCAN iCAN, Sonke GS, Van de Vijver KK, Fpm Kruitwagen R, van der Aa M, Virtanen A, Cerullo V, Vähärautio A, Sorger PK, Horlings HM, Farkkila A. Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomes. Cancer Discov. 2026 Feb 9; PMID: 41661089
1.
Zimmerman MP, Huang AY, Cox EK, Al Abosy R, Chong WL, Bastian AG, Vietor K, Choutri Y, Collier J, Zhabotynsky V, Wang H, Fung M, Weiss SA, Robitschek EJ, Lin JR, Vallius T, Pant SM, Sorger PK, Hugo W, Sen DR, Haining WN, Sharpe AH, Miller BC. Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 Immunotherapy [Internet]. Immunology; 2026 [cited 2026 July 17]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.02.05.704029
1.
Brastianos PK, Dooley K, Geyer S, Gerstner ER, Kaufmann TJ, Iafrate AJ, Martinez-Lage M, Milhem M, Welch MR, Kaley TJ, Drappatz J, Chan A, Kumthekar P, Matsuoka CK, Strowd RE, Cohen AL, Jaeckle K, Robell L, Magge RS, Nam JY, Blondin N, Shaikh N, Rabinowitz I, Thomas AA, Piccioni DE, Brown P, Kaluziak S, Codd E, Cahill DP, Santagata S, Barker FG, Galanis E. Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial. Nat Med. 2026 Feb;32(2):717–724. PMCID: PMC12920099
1.
Pimenta EM, Garza AE, Camp SY, Park J, Hoffman SE, Valderrábano L, Fu J, Bi K, Carson MT, Karam J, Titchen BM, Medjahed S, Khandekar MJ, Shannon E, Kang YJ, Coy S, Lin JR, Nag A, Thorner AR, Gibson WJ, Santagata S, Raut CP, Hornick JL, Merriam P, Solimini NL, George S, Demetri GD, Van Allen EM. Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity. Sci Transl Med. 2026 Jan 21;18(833):eadw4689. PMCID: PMC13062979
1.
Darnell AM, Chidley C, Paradise V, Cui DS, Davidsen K, Lincoln SC, Abbott KL, Elbashir R, Vander Heiden CP, Sorger PK, Sullivan LB, Davis JH, Vander Heiden MG. Ribosome-associated quality control of aberrant protein production during amino acid limitation [Internet]. bioRxiv; 2026 [cited 2026 Jan 20]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.01.14.699605
1.
Weems AD, Islam MT, Borges H, Yapp C, Perez-Castro L, Nogueira P, Lin J, Maliga Z, Lewis AJ, Kutter C, Mannino M, Vallius T, Santagata S, Sorger PK, Conacci-Sorrell M, Dean KM, Danuser GM. In vivo evidence for bleb-induced survival signaling in metastatic melanoma [Internet]. Cancer Biology; 2026 [cited 2026 Jan 6]. Available from: http://biorxiv.org/lookup/doi/10.64898/2026.01.05.697601
1.
Ribas GT, Cunha AF, Avila JP, Giarraputo A, Morena L, Lima K, Gassen RB, Chen JY, Lin JR, Santagata S, Avillach CT, Ryback BA, Lindner MS, Bercovici S, Rosales IA, Kawai T, Nakaya HI, Colvin RB, Borges TJ, Riella LV. Immune profiling in a living human recipient of a gene-edited pig kidney. Nat Med. 2026 Jan;32(1):270–280. PMCID: PMC12823403
1.
Burn TN, Schröder J, Gandolfo LC, Osman M, Wainwright EN, Lam EYN, McDonald KM, Evans RB, Li S, Rawlinson D, Dryburgh L, Zaid A, Maliga Z, Schienstock D, Meiser P, Lee HJ, Lai H, Moreira ML, Zareie P, Lee LHY, Huq L, Christo SN, Seow JJW, Ching KA, Guillaume SM, Knezevic K, Park SL, Evrard M, Waithman J, Gebhardt T, Mueller SN, Riddiough GE, Perini MV, Tsao SCH, Speed TP, Sorger PK, Loi S, Carbone FR, Gras S, Fisher TS, Baaten BJ, Dawson MA, Mackay LK. Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors. Nat Immunol. 2026 Jan;27(1):98–109. PMCID: PMC12764432
1.
Warchol S, Guo G, Knitte J, Freeman D, Shalla U, Muhlich JL, Sorger PK, Pfister H. SEAL: Spatially-resolved Embedding Analysis with Linked Imaging Data. IEEE Trans Vis Comput Graph. 2026 Jan;32(1):484–494. PMCID: PMC13130870
1.
Rapisuwon S, Slingluff CL, Wargo JA, Sullivan RJ, Izar B, Lin JR, Mauldin IS, Olson WC, Tran CA, Schwartzman GH, Gibney GT, Al-Refaie W, Atkins MB. Effects of Vemurafenib ± Cobimetinib on Intratumoral and Host Immunity in Patients With BRAFV600 Mutant Melanoma: Implications for Combination With Immunotherapy. Cancer Med. 2026 Jan;15(1):e71526. PMCID: PMC12789045
1.
Rossine F, Sanchez C, Eaton D, Paulsson J, Baym M. Intracellular competition shapes plasmid population dynamics. Science. New York, N.Y.; 2025 Dec 18;390(6779):eadx0665. PMCID: PMC13316098
1.
Shi Y, Maliga Z, Vallius T, Pant SM, Pelletier R, Kobs B, Solanky P, He Y, Van Allen E, Santagata S, Ott P, Lian CG, Buchbinder E, Liu D, Sorger PK. Mechanisms of tumor persistence in metastatic melanoma following successful immunotherapy [Internet]. bioRxiv; 2025 [cited 2025 Dec 16]. Available from: http://biorxiv.org/lookup/doi/10.64898/2025.12.11.692633
1.
Deng X, Bradshaw GA, Kalocsay M, Mitchison T. Tubulin regulates stability and localization of STMN2 by binding preferentially to its soluble form. J Cell Biol. 2025 Dec 1;224(12):e202502192. PMCID: PMC12803766
1.
Ludin A, Stirtz GL, Tal A, Nirmal AJ, Pfaff KL, Manos M, Besson N, Eskndir N, Porter B, Jones SM, Faulkner HM, Gong Q, Liu S, Barrera I, Wu L, Pessoa Rodrigues C, Sahu A, Jerison E, Alessi JV, Ricciuti B, Richardson DS, Weiss JD, Moreau HM, Stanhope ME, Afeyan AB, Sefton J, McCall WD, Formato E, Yang S, Zhou Y, Hoytema van Konijnenburg DP, Cole HL, Cordova M, Deng L, Rajadhyaksha M, Quake SR, Awad MM, Chen F, Wucherpfennig KW, Sorger PK, Hodi FS, Rodig SJ, Murphy GF, Zon LI. CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success. Cell. 2025 Nov 26;188(24):6720-6736.e26. PMCID: PMC12604482
1.
Girnius N, Vallius T, Chen W, Launonen IM, Palomino-Echeverria S, Lin JR, Mills CE, Kauppila S, Kronqvist P, Ellonen A, Perala M, Withnell E, Chen YA, Secrier M, Santagata S, Sorger PK, Farkkila A. Integrative single-cell and spatial mapping of oxidative stress response uncovers GCLC+ mesenchymal tumor cell state linked with favorable outcomes in triple negative breast cancer [Internet]. bioRxiv; 2025 [cited 2026 Jan 26]. Available from: http://biorxiv.org/lookup/doi/10.1101/2025.11.06.686771
1.
Stopka SA, Bodineau C, Baquer G, Lin JR, Hossain MA, Martinez CJ, Regan MS, Ruiz D, Fletcher SM, Pourquié O, Lutsenko S, Payne CN, Agar JN, Mazitschek R, McDannold NJ, Sorger PK, Santagata S, Agar NYR. Spatial Profiling of Elements through Matrix-Assisted Laser Desorption Ionization Mass Spectrometry Imaging. Anal Chem. 2025 Nov 7; PMID: 41201007
1.
Li D, Wan G, Wu X, Wu X, Chen X, He Y, Chen Z, Sorger PK, Zhao C. Multi-Modal Foundation Models for Computational Pathology: A Survey. Transact Mach Learn Res. 2025 Nov;2025:5715. PMCID: PMC13081565
1.
Zhou FY, Marin Z, Yapp C, Zou Q, Nanes BA, Daetwyler S, Jamieson AR, Islam MT, Jenkins E, Gihana GM, Lin J, Borges HM, Chang BJ, Weems A, Morrison SJ, Sorger PK, Fiolka R, Dean KM, Danuser G. Universal consensus 3D segmentation of cells from 2D segmented stacks. Nat Methods. 2025 Nov;22(11):2386–2399. PMCID: PMC12615268
1.
Williams JB, Pant SM, Kley AL, Rajmalani BA, Yapp C, Zhang J, Rotrosen E, Sales A, Sorger PK, Kupper TS. Regulatory T cells inhibit CD8+ TRM-like cells during the early stages of tumor immune escape [Internet]. bioRxiv; 2025 [cited 2025 Oct 23]. Available from: http://biorxiv.org/lookup/doi/10.1101/2025.10.21.683143
1.
Tarantino G, Zaremba A, Vallius T, Woodnorth M, Hua Y, Pelletier R, Lopez Leon M, Shi Y, Maliga Z, Makhzami S, Aprati TJ, Karlas B, Glutsch V, Schilling B, Hassel J, Berking C, Utikal J, Meier F, Meiss F, Heinzerling L, Kahler K, Chen J, Zimmer L, Sucker A, Livingstone E, Hadaschik E, Lian C, Murphy G, Semenov YR, Boland GM, Sorger PK, Rambow F, Liu D, Schadendorf D. Multiomic profiling of a unique in-transit melanoma cohort identifies melanoma differentiation as predictor of tumor progression and therapy response [Internet]. bioRxiv; 2025 [cited 2025 Oct 3]. Available from: http://biorxiv.org/lookup/doi/10.1101/2025.10.01.679282
1.
Yapp C, Nirmal AJ, Zhou F, Wong AYH, Tefft JB, Lu YD, Shang Z, Maliga Z, Llopis PM, Murphy GF, Lian CG, Danuser G, Santagata S, Sorger PK. Highly multiplexed 3D profiling of cell states and immune niches in human tumors. Nat Methods [Internet]. 2025 Oct;22(10):2180–2193. Available from: https://www.nature.com/articles/s41592-025-02824-x PMCID: PMC12510885
1.
Cortés-Ríos J, Rodriguez-Fernandez M, Sorger PK, Fröhlich F. Dynamic modelling of cell cycle arrest through integrated single-cell and mathematical modelling approaches. PLoS Comput Biol. 2025 Oct;21(10):e1012890. PMCID: PMC12520361
1.
Jain Y, Jepson J, Chen R, Maier E, Herr BW, Puig-Barbe A, Quardokus EM, Qaurooni D, Yapp C, Ewing SL, Enninful A, Farzad N, Bueckle A, Easter QT, Matuck B, Zhu C, Monte EM, Purkerson JM, Jehrio M, Misra RS, Fan R, Ginty F, Karunamurthy A, Fan J, Campbell-Thompson M, Pryhuber GS, Byrd KM, Hickey JW, Börner K. Exploring endothelial cell environments across organs in spatially resolved omics data [Internet]. bioRxiv; 2025 [cited 2025 Nov 21]. Available from: http://biorxiv.org/lookup/doi/10.1101/2025.09.23.678129 PMCID: PMC12485928
1.
Barkai O, Zhang B, Turnes BL, Arab M, Yarmolinsky DA, Zhang Z, Barrett LB, Woolf CJ. A machine learning tool with light-based image analysis for automatic classification of 3D pain behaviors. Cell Rep Methods. 2025 Sept 15;5(9):101145. PMCID: PMC12539238
1.
Kaul A, Souque C, Holland M, Baym M. Genomic resistance in historical clinical isolates increased in frequency and mobility after the age of antibiotics. Microb Genom. 2025 Sept;11(9):001474. PMCID: PMC12401160
1.
Van Itallie E, Sonnett M, Kalocsay M, Wühr M, Peshkin L, Kirschner MW. Transitions in the proteome and phospho-proteome during Xenopus laevis development. Dev Biol. 2025 Sept;525:155–171. PMCID: PMC12255230
1.
Alessi JV, Lindsay JR, Giobbie-Hurder A, Sharma B, Felt K, Kumari P, Mazor T, Cerami E, Lotter W, Altreuter J, Weirather J, Dryg I, Hoebel K, Manos M, Adib E, Curtis JD, Ricciuti B, Di Federico A, Ghandour F, Saad E, Wang XA, Pecci F, Holovatska M, Gandhi MM, Hughes ME, O’Meara TA, Chan SJ, Pfaff K, Konstantinopoulos PA, Hodi FS, Shipp MA, Signoretti S, Choueiri T, Wei XX, Santagata S, Hanna GJ, Lin NU, Tolaney SM, Liu J, Sorger PK, Lindeman N, Sholl LM, Nowak JA, Barbie D, Awad MM, Johnson BE, Rodig SJ. Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors. JCO Precis Oncol. 2025 Sept;9:e2500240. PMCID: PMC12419029
1.
Johnson WC, Alivisatos A, Smith TC, Van N, Soni V, Wallach JB, Clark NA, Fitzgerald TA, Whiteley JJ, Tan S, Sokolov A, Ando DM, Schnappinger D, Rhee KY, Aldridge BB. Integration of multi-modal measurements identifies critical mechanisms of tuberculosis drug action. Cell Syst. 2025 Aug 20;16(8):101348. PMCID: PMC12365861
1.
Mahmoud N, Qin X, Bzeih W, Khabibullin D, Alchoueiry M, Safi S, Chami J, Han T, Salem S, Priolo C, Chakraborty AA, Sarosiek KA, Henske EP. BCL-xL dependency in chromophobe renal cell carcinoma. Cancer Gene Ther. 2025 Aug 16; PMID: 40819113
1.
Das T, Bradshaw GA, Hyer J, Masek M, Kuo YM, Bachmann-Gagescu R, Kalocsay M, Nachury MV. BBSome-Mediated Clearance of Ubiquitinated IMPG2 Defines a Constitutive Ciliary Retrieval Pathway in Photoreceptors [Internet]. bioRxiv; 2025 [cited 2025 Nov 21]. Available from: http://biorxiv.org/lookup/doi/10.1101/2025.07.29.667331 PMCID: PMC12324355